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Abstract 
Catalyst 117 was previously reported in the Jones group and demonstrated to a very good 
catalyst at 1 mol% catalyst load. With the optimized conditions, a wide range of N-
arylimines can be reduced in good yield and enantioselectivity by trichlorosilane. Followed 
this previous discovery, the project now is extending the application this methodology, 
investigating the mechanism and designing more efficient catalysts. 
A chromatography process for the synthesis of catalyst 117 was developed. Asymmetric 
reduction of both N-aryl and N-alkyl ketimines can be performed using trichlorosilane 
catalyzed by 117 at 1 mol% catalyst loading. The scalability of this process was 
demonstrated. This catalyst can also facilitate the reduction of -enamino esters by 
trichlorosilane with good yield and high enantioselectivity albeit with the necessity of a high 
catalyst loading and benzoic acid as an additive. 
An asymmetric reductive amination of ketones with both aromatic and aliphatic amines was 
achieved in good yield and high enantioselectivity at 1 mol% catalyst loading. Sterically 
hindered ketones also undergo reductive amination in good yield and enantioselectivity by a 
two-step one-pot procedure. The asymmetric synthesis of (+)-NPS R-568 in good yield and 
high enantioselectivity using the two-step one-pot procedure demonstrated the potential 
utility of this catalyst to the pharmaceutical industry. Lewis acidic TMSOTf can improve the 
yield in direct reductive amination, but showed a negative effect on the enantioselectivity. 
Initial investigations into the mechanism have resulted in unprecedented discoveries. Both 
the NMR study of catalyst 117 and the discovery of a new highly active catalyst 263 place 
the Matsumura transition state model into doubt. Although no signals were detectable to 
support the hypercoordinate silane species by NMR experiments, in-situ ReactIR data 
showed that there might be some interactions between trichlorosilane and catalysts. A new 
tentative transition state model was proposed according to the study of structure/activity of 
catalysts and the preliminary in-situ IR data. 
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1. Introduction 
Enantiomers of a chiral molecule may display different biological activities, since 
interactions at a molecular level with intrinsically chiral receptors and related binding sites 
can lead to diastereomeric intermediates. In extreme cases, one enantiomer may be an 
effective therapeutic drug whereas the other exhibits toxicity. The catastrophic example of 
thalidomide is well-known (Figure 1). Thalidomide was chiefly sold and prescribed in the 
racemic form as an antiemetic medicine to combat morning sickness in pregnant women. 
Unfortunately, it had a tendency to induce birth defects, and from 1956 to 1962, 
approximately 10,000 children in Africa and Europe were born with severe malformations 
because their mothers had taken thalidomide during pregnancy. Further studies showed that 
the (R) enantiomer is effective against morning sickness while the (S) had devastating effects 
on the development of an unborn foetus.
1
 More recently research disclosed that the (R) and 
(S) enantiomers of thalidomide can interconvert in blood plasma,
2
 meaning that both isomers 
will be biologically available even if pure (R)-thalidomide or (S)-thalidomide is given to 
patients. Though administering only one enantiomer will not prevent the teratogenic effect, 
the case indicates how important it is to independently study biological and chemical 
behaviours of both enantiomers in vivo for the development of new medicines. 
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O
O
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O
O N
O
O
NH
O
O
(S)-thalidomide (R)-thalidomide
 
Figure 1 
The increased interest in asymmetric synthesis from both pharmaceutical industry and 
academia has enhanced the need for developing effective methods for the preparation of 
enantiopure chemicals. Among the various methods used to obtain enantiomerically pure 
chemicals, catalytic asymmetric synthesis is one of the most desirable yet the most 
challenging of methodologies, since use of a small amount of chiral catalyst can afford large 
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amounts of chiral product, just as enzymes do in biological systems.
3
 
Chiral amines are widely distributed in Nature and medicine (Figure 2), with the amino 
group playing a significant role in their bioactivities. 
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Figure 2 
For the preparation of chiral amines, the use of starting materials containing a carbon-
nitrogen double bond, including tautomeric -enamino esters, has been widely explored. The 
desired products have been produced by asymmetric addition of nucleophiles including 
carbon based reagents (leading to chiral secondary or tertiary amines) or a reducing agent 
(leading to chiral secondary amines). 
1.1 Nucleophilic addition to nitrogen-containing double bonds 
The asymmetric addition of nucleophiles to the carbon-nitrogen double bond of an imine 
provides a convenient and efficient route to optically active amines bearing a stereogenic 
centre at the nitrogen -position. Methodologies for asymmetric C-C bond formation by 
nucleophilic addition to a carbon-nitrogen double bond based on both chiral substituent 
induction and chiral ligand asymmetric induction have been developed. 
Readily available enantiopure amines have been widely employed to prepare chiral imines,
4 
usually by condensation with the corresponding carbonyl compounds. In 1982, Takahashi 
and co-workers reported the first example of a chiral substituent-controlled asymmetric 
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addition of organolithium or organomagnesium reagents to imines derived from aldehydes 
and (S)-valinol or phenylglycinol.
5
 For example, benzylmagnesium chloride or aryllithium 
compounds can be added to imine 1 in moderate to high yields forming single 
diastereomeric adducts. The transition state was proposed to be a metallo-chelate 3. 
Coordination of the alkoxy group and the lone electron pair on nitrogen of the imine was 
proposed to lead to a preferred Si-face addition of the organometallic reagent (Scheme 1). 
R1 H
N
OH
35-90% R
1 R2
HN
OH
1 2 3
de>98%R1=Ph, 4-MeOC6H4, 2-and 3-thienyl, 2-furyl;
R2=Bn, Ph, 4-MeOC6H4, 4-MeC6H4, 4-ClC6H4;
M=Mg, Li
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Scheme 1 
Asymmetric synthesis of enantiopure -substituted alanine derivatives by addition of 
Grignard reagents to the cyclic imine 4 has been described by Harwood et al. Single 
diastereoisomers 5 were obtained in all cases with moderate to high yield.
6
 Cleavage of the 
morpholinone was performed by hydrogenolysis to afford the -substituted alanine 
derivatives 6 (Scheme 2). 
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H2N COOH
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6
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Scheme 2 
N-Chiral sulfinimines are versatile intermediates for the preparation of chiral amines.
7
 
Several strategically different methods have been developed for the synthesis of 
enantiomerically pure sulfinimines, such as the asymmetric oxidation of sulfenimines and 
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the condensation of enantiopure primary sulfinamides with aldehydes and ketones.
8
 
Organometallic reagents, such as organolithiums and Grignard reagents, add to sulfinimines 
to give sulfinamides in high diastereoselectivities and yields.
9
 For example, Shaw and 
DeSolms at Merck applied this method to the synthesis of farnesyl protein transferase 
inhibitors 8 and it is quite interesting that reversals in diastereoselectivity are obtained in the 
Grignard versus alkyllithium addition to ketimine 7 (Scheme 3).
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Scheme 3 
Lin and co-workers reported that the zinc-mediated allylation to chiral (R)-N-tert-
butanesulfinyl imines derived from both aromatic and aliphatic aldehydes can be stereo-
controlled by simply varying the reaction conditions (Scheme 4).
11
 Two acyclic transition 
state models were proposed to explain the opposite diastereoselectivity rather than the six-
membered ring transition state claimed by Ellman and Foubelo.
12
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Scheme 4 
In 1990, Tomioka and co-workers reported the first catalytic asymmetric addition of 
organolithium reagents to carbon-nitrogen double bonds of imines, the stereochemistry of 
which was controlled by a chiral amino-ether ligand 10 (Scheme 5).
13
 With 5 mol% of 
ligand 10, enantiomerically enriched amine 11 was produced in moderate ee, but signified 
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the beginning of catalytic methods of asymmetric addition of organometallic reagents to 
carbon-nitrogen double bonds. 
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Scheme 5 
Denmark and co-workers showed that bisoxazolines 14 can induce the asymmetric addition 
of lithium reagents to aromatic, olefinic and aliphatic aldimines (Scheme 6).
14
 A systematic 
examination of the influence of the bridging group of the ligand was also carried out.
14c
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Scheme 6 
Dialkylzinc reagents are less nucleophilic organometallic compounds and react slowly or not 
at all with imines due to the limited polarity of C-Zn bond. However, the mild reactivity 
means that dialkylzinc reagents have a high functional group tolerance compared to 
magnesium and lithium reagents. In the past few years, several chiral ligand-metal 
complexes such as copper,
15
 zirconium or hafnium,
16
 have been used to accelerate the 
addition of dialkylzinc reagents to the carbon-nitrogen double bonds of imines. 
Hoveyda et al. reported catalytic asymmetric alkylation of aryl and alkylimines with alkyl 
zinc reagents activated by [Zr(OiPr)4]HOiPr and a small peptide ligand 15 derived from 
valine and phenylalanine (Scheme 7).
17
 Thereafter, a three-component asymmetric alkylation 
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was also described by the same group, which involved imine formation from an aldehyde 
and o-anisidine, followed by enantioselective alkylation with the zinc reagent.
18
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Scheme 7 
Screening of a series of chiral peptide ligands derived from valine and phenylalanine 
allowed the alkylation of -ketimine esters and trifluoromethylketimines to afford the amine 
products with quaternary carbon stereogenic centres in good yield and enantioselectivity.
19
 
For example, methylation of imine 16 employing the chiral ligand 17 gave the amine 18 in 
95% yield with >98% ee (Scheme 8). 
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Scheme 8 
Copper complexes have been widely used as catalysts in this area due to their ability to both 
activate a C=N double bond of an imine and facilitate alkyl group transfer.
20
 Tomioka and 
co-workers
 
reported the asymmetric addition of diethylzinc to imines using a copper 
complex with a chiral amidophosphine 20.
21
 Imines 19 bearing tosyl, mesyl, or 2-
trimethylsilylethanesulfonyl groups on the nitrogen atom were used as substrates to afford 
the addition products 21 with high enantioselectivity and high chemical yield (Scheme 9). 
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Scheme 9 
The same group also reported the asymmetric addition of dimethylzinc and diisopropylzinc 
to N-tosyl imines 22 to give amines 23 with good enantioselectivity and high yield when the 
more bulky amidophosphane ligand 24 was employed (Scheme 10).
22
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Scheme 10 
The asymmetric synthesis of diarylmethylamines by arylation of N-tosyl and N-nosyl 
arylimines with arylboroxines, aryboronic acids and potassium organotrifluoroborates have 
recently been developed using rhodium-based catalysts.
23
 Chiral dienes were reported to be 
highly effective ligands for this process. For example, Hayashi recently reported the highly 
enantioselective addition of potassium organotrifluoroborates to both N-tosyl and N-nosyl 
arylketimines with the chiral diene ligand 25 (Scheme 11).
24
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Scheme 11 
Lin and co-workers recently reported that N-tosylalkylaldimines can be arylated with 
arylboronic acids in high yield and excellent enantioselectivity when chiral diene 26 was 
used as a ligand (Scheme 12).
25
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Scheme 12 
An asymmetric Mannich reaction catalyzed by small organic molecules provides a facile 
route to optically active - or -amino acid derivatives and 1,3-amino alcohols.26 Both syn- 
and anti-selective Mannich reactions have been developed. For example, Barbas et al.
 
reported that reactions of aldehydes with N-p-methoxyphenyl (PMP)-protected glyoxylate 
imine 27 can afford enantiomerically enriched -aminoaldehydes in the presence of proline-
type catalysts at room temperature (Scheme 13).
27
 The L-proline-catalyzed Mannich 
reactions afforded (2S, 3S)-syn-isomers 28 as the major products, while the (3R, 5R)-5-
methyl-3-pyrrolidinecarboxylic acid 29 catalyzed the reactions to yield the (2S, 3R)-anti-
products 30 in good yield with high enantioselectivities. 
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Scheme 13 
Organocatalytic -amination of aldehydes and ketones by addition to the electrophilic 
azodicarboxylates has also been developed. List
 
reported that L-proline-catalyzed reactions 
of aldehydes with dibenzyl azodicarboxylate 31, followed by NaBH4 reduction, can afford -
amino-alcohols 32 in excellent yields and enantioselectivities (Scheme 14).
28
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Scheme 14 
Barbas and co-workers have applied the organocatalytic direct amination of aldehydes in a 
series of reports. For example, this methodology was used to construct the quaternary 
stereocentre in the enantioselective total synthesis of the cell adhesion inhibitor BIRT-377 
(Scheme 15).
29
 The L-proline-derived tetrazole 34 catalyzed the direct -amination of 3-(4-
bromophenyl)-2-methylpropanal 33 with dibenzyl azodicarboxylate 31 to give the amino 
aldehyde 35 in 95% yield and with 80% ee, from which BIRT-377 was prepared. 
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Scheme 15 
Similarly, D-proline catalyzed amination of functionalized indane carboxaldehydes 36 was 
employed for the enantioselective synthesis of the metabotropic glutamate receptor ligands 
(S)-AIDA and (S)-APICA (Scheme 16).
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Scheme 16 
1.2 Asymmetric reduction of prochiral carbon-nitrogen double bonds 
The reduction of a carbon-nitrogen double bond provides one of the most convenient 
methods for the synthesis of amines. When carbon-nitrogen double bond-containing 
compounds (generally imines) derived from unsymmetrical ketones are employed in this 
reaction, a new stereogenic centre is formed at the carbon connected to the nitrogen atom. A 
number of hydrogen sources have been used to perform this operation, including hydrogen 
gas, transfer hydrogenation agents, and hydride transfer agents. When a suitable chiral 
11 
 
catalyst or ligand is used, the reaction can be enantioselective. 
1.2.1 Asymmetric hydrogenation 
Catalytic asymmetric hydrogenation, using chiral ligand-metal complexes as catalysts is a 
prime example of atom economy since both atoms of the hydrogen gas molecule are 
transferred to the product.
31
 In the asymmetric hydrogenation of imines, chiral phosphine 
complexes of rhodium or iridium have frequently been used as catalysts. Zhang et al.
32 
reported the hydrogenation of imine 38 using iridium-ferrocenylphosphane complex 40 as a 
catalyst delivering (S)-1-phenylethanamine 39 in high ee and good yield after deprotection 
with CAN (Scheme 17). 
P
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P
N
MeO
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(i) then (ii)
72%, 98% ee
(i) [Ir(COD)Cl]2-40(1 mol%)
H2 (1000 psi), CH2Cl2, RT.
(ii) CAN, MeOH, H2O
38
(R,R)-ferrocenylphoshane
40
39
 
Scheme 17 
This same group has explored the asymmetric hydrogenation of N-tosylimines with many 
transition-metal-containing catalysts, in particular Rh, Ru, Ir, and Pd complexes.
33
 A Pd-
complex of ligand 42 was the best catalyst tested and for example at 1 mol % catalyst 
loading, the N-tosylamine 41 was obtained in high yield and excellent enantioselectivity 
(Scheme 18). 
P PH
H
t-Bu t-Bu
(S,S,R,R)-TangPhos
N
Ts
HN
Ts
1 mol% Pd(OCOCF3)2-42 complex
H2 (75 atm), CH2Cl2, 40 °C
24 h, > 99% conv.
>99% ee 41 42  
Scheme 18 
Wang and co-workers recently developed a C2-symmetric bis(aminophosphine) ligand 45.
34
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Aryl enamides 43 can be hydrogenated in high enantioselectivity to afford amines 44 by 
Rh(I)-catalyzed hydrogenation with ligand 45. Remarkable enantioselectivity and catalytic 
activity were obtained with 0.5 mol % catalyst loading (Scheme 19). 
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NHPR2
Ar NHAc
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R=3,5-bis(methyl)phenylR=Ph, m/ p-Me-Ph, m/ p-Cl-Ph, m/ p-Br-Ph, m/p--MeOPh,
m/ p-F-Ph, p-CF3-Ph, 2-naphthyl
98.2-99.9% ee100% Conv.
 
Scheme 19 
Recently, Zhou and co-workers reported the direct preparation of chiral tertiary amines in 
high yield and ee by catalytic asymmetric hydrogenation of the N, N-dialkyl enamines using 
an Ir(I) complex with ligand-46.
35
 The natural product crispine A was synthesized in a 97% 
yield and 90% ee exploiting this method (Scheme 20). 
N
R2
R1
N
R2
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Scheme 20 
The Rh-TsDPEN complex (R,R)-47 is a well-known catalyst for the asymmetric transfer 
hydrogenation of ketones and imines.
36
 It was presumed that the corresponding cationic Rh 
(III) species might be more reactive towards hydrogen to form the necessary Rh-H hydride. 
Xiao et al.
 
tested the effect of a range of silver salts on the hydrogenation, aiming to remove 
the chloride from coordination sphere to form the cationic Rh(III) species (Scheme 21).
37
 In 
the presence of AgSbF6, complex 47 was converted in-situ into catalyst 48, the key species 
for hydrogen activation. Using this methodology, a range of isoquinoline-type imines 49 and 
50 can be hydrogenated to afford the tetrahydroisoquinolines 51 and tetrahydro--carbolines 
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52 with excellent ee. 
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Scheme 21 
Bolm et al. developed a chiral sulfoximine-phosphine complex 54 catalyst which facilitated 
the hydrogenation of a variety of N-(4-methoxyaryl) imines 53 to give amines 55 with high 
enantioselectivity and quantitative yield (Scheme 22).
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Scheme 22 
In 2006, Stephan et al. first demonstrated that hydrogen can be activated via heterolytic 
cleavage by frustrated Lewis pairs (bulky Lewis acids and bases), in an intermolecular or 
intramolecular fashion (Scheme 23).
39
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Scheme 23 
Following this discovery of the metal-free hydrogen activation by frustrated Lewis pairs, 
Stephan and coworkers reported the catalytic hydrogenation of imines using 5 mol% Lewis 
pair 56 as a catalyst.
40
 For example, imine 59 was reduced within 1 hour in 98% yield to 
afford amine 60 (Scheme 24). 
56 (5 mol%), H2 (1 atm), 80 °C
toluene, 1 hPh H
N
t -Bu
Ph H
HN
t-Bu
98%59 60  
Scheme 24 
Later, the same group disclosed that electron rich imines can be hydrogenated with a Lewis 
acid B(C6F5)3 without additional Lewis bases. In this case, the imine substrate acted as 
Lewis base to form a frustrated Lewis pair with B(C6F5)3 to activate hydrogen. However, 
additional base was required for the reduction of electron poor imines.
41
 Recently, 
Klankermayer extended these systems for asymmetric hydrogenation of ketimines.
42
  A 
series of amines were obtained in good yield and enantioselectivity by hydrogenation of the 
corresponding imines at 5 mol% catalyst loading using chiral frustrated Lewis pair 61 
(Scheme 25). 
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Scheme 25 
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1.2.2 Asymmetric transfer hydrogenation 
Asymmetric transfer hydrogenation using a stable organic hydrogen donor is a useful 
synthetic method. Although originally focused on ketone substrates, asymmetric transfer 
hydrogenation of imines has also been investigated. Noyori et al. reported that ketimines can 
be reduced with a 5:2 formic acid-triethylamine mixture in the presence of catalyst 
RuCl[(S,S)-Tsdpen](η6-arene) 62.43 For example, (R)-salsolidine and indole derivative 63 
were obtained in 95% ee and 97% ee respectively by reduction of the corresponding imines 
(Scheme 26). 
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Scheme 26 
Asymmetric organocatalytic transfer hydrogenation has also been developed employing a 
Hantzsch ester as the hydride source. Rueping and co-workers investigated the use of chiral 
binaphthyl-derived phosphoric acids for the enantioselective organocatalytic reduction of 
imines.
44
 Chiral phosphoric acid 64 proved to be most enantioselective, allowing the 
reduction of a range of aromatic methyl ketimine substrates in 70-84% ee (Scheme 27).
44b
 
List and co-workers subsequently reported the efficiency and enantioselectivity can be 
improved using phosphoric acid 65 at 1 mol % catalyst loading.
45
 Macmillan and co-workers 
later developed a reductive amination strategy with analogous chiral binaphthyl-derived 
phosphoric acids.
46
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Scheme 27 
Akiyama et al. reported that benzothiazolines were also suitable hydride sources for the 
asymmetric transfer hydrogenation of ketimines and -imino esters using chiral phosphoric 
acids as catalysts,
47
 and more recently reported that trifluoromethylated imines can also be 
reduced in high enantioselectivity using chiral phosphoric acid 64 (Scheme 28).
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Scheme 28 
1.2.3 Reduction of carbon-nitrogen double bonds with boranes 
Asymmetric hydrometallation of ketimines and ketoxime ethers catalyzed by chiral 
transition-metal complexes or metal-free chiral ligands provides an effective route to 
optically active amines. Organoborane reagents, especially oxazaborolidine borane 
complexes, have been widely used for the asymmetric reduction of ketones due to their 
outstanding enantioselectivity and predictable stereochemical control,
49
 and may also be 
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used for the reduction of ketoxime ethers.
50
 In 2004, Field and co-workers reported the 
reduction of imines using a CBS catalyst 66 and a less reactive reducing agent 
catecholborane 67 (Scheme 29).
 51
 Their studies showed that the choice of reducing agent 
can affect the sense of asymmetric reduction, which was attributed to steric factors. 
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Scheme 29 
Ortoz-Marciales and co-workers prepared a spiroborate ester 68 derived from 
diphenylvalinol, which has been successfully used for the asymmetric reduction of ketoxime 
ethers.
52
 The same group found that the (S)-nicotine analogue 70 could be prepared in 97% 
ee from enantiopure 69 with 64% overall yield using the same strategy (Scheme 30).
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Scheme 30 
1.2.4 Reduction of carbon-nitrogen double bonds with silanes 
Several silanes have been used in the enantioselective reduction of nitrones, imines and 
enamines to afford chiral amines. Murahashi et al. reported that the enantioselective 
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hydrosilylation of carbon-nitrogen double bonds of nitrones with diphenylsilane (Ph2SiH2) 
using Ru2Cl4-(S)-Tol-BINAP-NEt3 as catalyst at 0 C afforded the corresponding optically 
active N,N-disubstituted hydroxylamines (Scheme 31).
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Scheme 31 
Polymethylhydrosiloxane (PMHS) is an attractive reducing agent because it is inexpensive, 
non-toxic and insensitive to air and moisture, leading to many applications in organic 
synthesis.
55
 Buchwald et al. reported that a combination of titanocene 72 and PMHS can 
reduce imines to amines with excellent ee and high yields (Scheme 32).
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Scheme 32 
Trichlorosilane
 
(HSiCl3, an inexpensive and relatively easy-to-handle reducing reagent) is 
more Lewis acidic than alkyl- and arylsilanes and can be activated by metal-free organic 
molecules, such as DMF, a discovery which made the organocatalytic asymmetric reduction 
of imines possible.
57
 A series of chiral formamides based on amino acids have been 
developed as the activator by several groups. In 1999, Matsumura reported the first 
enantioselective reduction of ketones using trichlorosilane with proline-derived amides 73, 
74.
58
 In 2001, the same group expanded the scope of their catalysts to reduce ketimines in an 
asymmetric fashion (Scheme 33).
59
 The N-formyl group proved to be crucial for the 
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activation of HSiCl3, as the corresponding N-methoxycarbonyl and acetyl group failed to 
initiate the reaction. 
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Scheme 33 
Although moderate enantioselectivity was obtained, these studies gave impetus to the 
development of chiral activators for asymmetric reduction of imines with trichlorosilane. 
Several groups have been involved with the development of new chiral formamide catalysts. 
Sun and co-workers reported a series of catalysts by replacing the rigid proline core with 
pipecolinic acid and piperazine 2-carboxylic acid derivatives 75-80 (Scheme 34).
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Scheme 34 
Most recently, the same group demonstrated that indoles can be reduced by trichlorosilane in 
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the presence of one equivalent of water and 10 mol% of the novel N-formyl L-
pipecolinamide 81 or the N-formyl L-proline amide 82 (Scheme 35).
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Scheme 35 
Sun and co-workers also reported that catalysts 83-87 based on a chiral sulfinamide instead 
of chiral formamide worked efficiently for the asymmetric reduction of ketimines (Scheme 
36).
62
 A clear positive non-linear effect of the enantiomeric excess of catalyst 83 on the 
product enantioselectivity in the asymmetric reduction of ketimine was observed.
62a
 This 
result suggested more than one molecule of monosulfinamide catalyst 83 was involved in the 
transition state. As expected for the bissulfinamide 84, a linear correlation of catalyst ee on 
product ee was observed, which indicated in this case a single molecule participated in the 
transition state.
62b
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Scheme 36 
The highly enantioselective reduction of N-alkyl -enamino esters with trichlorosilane using 
a chiral sulfinamide derivative of L-proline 88 as catalyst was reported recently by the same 
group (Scheme 37).
63
 The use of one equivalent of water as an additive proved to be crucial 
to achieve high reactivity and enantioselectivity; the HCl generated in situ was proposed to 
accelerate the enamine-imine tautomerization. 
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Scheme 37 
Malkov et al. devised a range of chiral formamide catalysts 89-93, employing acyclic N-
methyl amino acids instead of cyclic amino acids as the core (Scheme 38).
64
 Their studies 
showed that a conformationally restricted core, such as proline, was not necessary to achieve 
high enantioselectivity. Interestingly, despite the same configuration of the parent amino 
acids in catalysts 73-80 and 89-93, the valine-based catalysts 89-93 induced the formation of 
the opposite enantiomer of product. 
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Scheme 38 
A highly active N-formamide catalyst 94 (commercialized as Sigamide) based on (S)-valine 
was also reported by Malkov.
65
 Benchmark imine substrates can be reduced in 92% yield 
and 93% ee by trichlorosilane in the presence of 1 mol% of catalyst 94 (Scheme 39). 
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Scheme 39 
In 2007, Malkov et al. reported the reduction of -chloro-imines using catalyst 94. 66 
Interestingly, -chloro-imines generated in-situ from the corresponding -chloro-ketones 
and aniline derivatives can be reduced directly in high yields and enantioselectivities 
following addition of trichlorosilane and catalyst. After further cyclization, the 
corresponding aziridines were obtained with high enantiopurities (Scheme 40). 
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Scheme 40 
In 2008, catalyst 94 was extended to catalyze the asymmetric reduction of -enamino esters 
with trichlorosilane.
67
 -Substituted -enamino esters were also suitable substrates through a 
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dynamic kinetic resolution process. Since the reaction involved a crucial imine-enamine 
equilibrium, addition of 1 eq. of acetic acid to buffer the reaction medium was important to 
ensure good reproducibility (Scheme 41). 
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Scheme 41 
Malkov and co-workers devised several recyclable catalytic systems of (S)-valine-derived 
organocatalysts by immobilising the catalytic species onto nanoparticles, resins, dendrons 
and fluorous tags.
65,68
 For example, the soluble polymer-supported catalyst 95 exhibited high 
activity even after being reused 5 times (Scheme 42).
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Scheme 42 
In 2006, the same group devised a series of mandelic acid derived oxazoline catalysts 96-100 
(Figure 3).
69
 Catalyst 100 provided the best enantioselectivities for the reduction of aryl 
ketones and was also found to exhibit high efficiency in the reduction of N-aryl imines with 
20% catalyst loading (up to 67%, 87% ee). 
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Figure 3 
In 2006, Matsumura and co-workers developed a new non-formamide catalyst 101 based on 
(S)-α,α-diphenylprolinol and picolinoyl chloride (Scheme 43). 70  The relationship of the 
structure and activity of the catalysts was investigated using a series of structurally related 
catalysts 101-105. Coordination of the silicon atom with both the nitrogen atom of picolinoyl 
group and the carbonyl oxygen was thought to play a significant role since the N-
nicotinoylpyrrolidine 104 and N-(4-pyridylcarbonyl)-pyrrolidine 105 were less efficient 
activators than catalyst 101-103. Furthermore, the fact that catalyst 101 afforded higher 
enantioselectivity than catalyst 102 suggests an important role of the hydroxyl group of 
catalyst 101. According to these results, a transition state model was proposed (Figure 4). It 
is crucial that the formation of a hydrogen bond between the nitrogen of imine and the 
hydroxyl group in the catalyst 101 controls the stereochemistry. 
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Figure 4 
Matsumura demonstrated that both -imino esters and -enamino esters can be reduced with 
trichlorosilane using catalyst 101, but only with moderate enantioselectivity (Scheme 44).  
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Scheme 44 
A series of chiral N-picolinoyl aminoalcohol catalysts were prepared and screened for the 
asymmetric reduction of ketimines by both Benaglia’s and Zhang’s group.71,72 Catalyst 106 
proved to be one of the best catalysts tested by both groups. The structure/activity 
relationship studies carried out by Benaglia indicated that a pyridine ring, free hydroxyl 
group and N-alkyl substituent were necessary structural elements to obtain good 
stereoselectivity and high yield (Scheme 45). These results were similar to Matsumura’s 
work (Scheme 43) and a transition state model proposed similar to this. The effect of 
introducing a substituent on the pyridine ring was also investigated; placement of a chlorine 
or bromine atom on the 4-position of the pyridine improved the catalyst efficiency. With a 
catalyst loading of 1 mol%, 4-chloropicolinic acid derivative 112 still maintained a high 
level of catalytic efficiency yielding the product in 77% yield and 87% ee. 
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Scheme 45 
The reductive amination of acetophenone with aniline and p-anisidine using 10 mol% of 
catalyst 112 was also reported although a long reaction time was necessary for achieving 
high yield by Benaglia et al. (Scheme 46).
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Scheme 46 
Zhang et al. also reported the highly enantioselective reduction of -enamino esters with 
trichlorosilane catalyzed by chiral N-picolinoyl aminoalcohol catalyst 114 as a chiral Lewis 
base activator (Scheme 47).
73
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Scheme 47 
Recently, the asymmetric reduction of -acetoxy -enamino esters with the picolinamide 
115 as catalyst was reported by the same group (Scheme 48).
74
 The use of unpurified solvent 
was necessary to generate HCl in-situ (from water and trichlorosilane) to promote the 
tautomerisation of enamine-imine. 
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Scheme 48 
The same group has reported that the asymmetric reduction of -imino esters can be 
achieved with 10% mol of chiral N-picolinoyl aminoalcohol catalyst 82 (Scheme 49).
75
 
Pentanoic acid (0.5 mol%) was required as an additive to activate the substrates. 
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Scheme 49 
Benaglia et al. recently reported that the asymmetric reduction of imines and -imino esters 
derived from enantiopure 1-phenylethylamine can be achieved in high diastereoisomeric 
excess with catalyst 112.
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Subsequently, this methodology was extended to the reduction of -enamino esters derived 
from enantiopure amines using the same catalyst 112.
77
 Further conversion of the product 
provided a route to -lactams. 
Most recently, the same group demonstrated that a range of chiral bis-phosphinamides 
derived from L-proline were active catalysts for the reduction of -enamino esters.78 The 
best catalyst 116 facilitated the reduction of -enamino esters in up to 99% yield and 85% ee 
(Scheme 51). 
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Scheme 51 
In Jones’ group, a new bifunctional catalyst 117 was developed featuring an imidazole ring, 
which can facilitate the asymmetric reduction of a variety of ketimines within 4 hours at a 
low catalyst loading (1 mol%).
79
 A structure-activity study was carried out by testing the 
activity of catalysts 117-120 (Scheme 52). Two coordination sites are necessary for highly 
catalytic activities, since catalyst 120 exhibited very low catalytic activity and no selectivity. 
This observation was similar to Matsumura’s result (Scheme 43). Using the gem-diphenyl 
and gem--dinaphthyl prolinol derivatives 117 and 118 as catalysts, the product was 
obtained in good yield and ee, while prolinol derivative 119 showed low enantioselectivity 
but high yield. Apparently, the steric hindrance effect of the geminal groups played a key 
role in controlling the enantioselectivity. 
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Scheme 52 
1.3 Project aims 
A number of synthetic strategies to prepare chiral amines have been developed. The 
processes catalysed by a biocatalyst are expensive, require aqueous reaction media, and the 
concentration of substrates is limited to a low level since most organic substrates are poorly 
soluble in the aqueous phase. The reduction of imines by transition metal catalytic 
hydrogenation or transfer hydrogenation has been extensively investigated. However, it can 
suffer from metal-leaching in the product which is a non-negligible issue in the 
pharmaceutical industry. Organic catalysts have emerged as a promising method. Phosphoric 
acid catalysed reduction of imines using Hantzsch esters as hydrogen source has been 
reported by several groups. Clearly, this method is less atom-economical due to the 
stoichiometric pyridine derivative produced as waste, removal of which is not trivial in some 
cases. Trichlorosilane is now well placed to take up the baton as an economic hydrogen 
source. A catalyst 117 developed in Jones’ group proved to be efficient for asymmetric 
reduction of various N-phenyl and N-p-methoxyphenyl ketimines at a very low catalyst 
loading (1% mol). Continuing this research, the main aims of the project are therefore as 
follows: 
 Expand the substrate scope of catalyst 117 
 Develop an asymmetric reductive amination protocol using catalyst 117 
 Investigate the mechanism and devise new catalysts  
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2. Investigation of the scope of asymmetric reduction of imines 
2.1 Optimisation of synthesis of catalyst 
Catalyst 117 was prepared by four steps starting from L-proline and ethyl chloroformate 
(Scheme 53). The key intermediate of α,α-diphenylprolinol 122 was synthesized in 33% 
yield by addition of four equivalents of phenylmagnesium bromide to proline methyl ester 
121, followed by hydrolysis of the carbonate according to a literature procedure. Pure α,α-
diphenylprolinol 122 was obtained after purification by silica chromatography. The 
condensation of α,α-diphenylprolinol 122 with ethyl 1-methylimidazole-2-carboxylate 123 
afforded catalyst 117 in 66% yield after purification by chromatography and 
recrystallization. 
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O
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+ N O
OMe
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EtO
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1) PhMgBr, THF
N
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Ph
Ph
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N
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Ph
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N OEt
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N
N
42% over 3 steps
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70 °C, 72h
117
121
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122 123
33% for 2 steps
66%
 
Scheme 53 
During the preparation of catalyst 117, the main by-product was found to be biphenyl from 
the preparation of α,α-diphenylprolinol 122, formed by homo-coupling during the formation 
of phenylmagnesium bromide. Additionally, catalyst 117 was poorly soluble at room 
temperature in ethyl acetate whereas the impurities were soluble. Therefore, it was possible 
to conduct the final three steps without purification until the last step, followed by 
recrystallisation. In order to reduce the homo-coupling by-product, a solution of proline 
methyl ester in THF was added dropwise to a solution of freshly prepared phenylmagnesium 
bromide (3 eq. instead of 4 eq.) in THF. The following steps were then carried forward 
without purification of the intermediates. Gratifyingly, catalyst 117 was obtained after two 
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crystallizations from ethyl acetate in 42% yield over the final three steps (Scheme 53). This 
process for synthesis of catalyst 117 is scalable with good overall yield without purification 
by chromatography. 
2.3 Evaluation of the influence of N-protecting group on the reduction of imines 
The generality of catalyst 117 has been previously demonstrated by asymmetric reduction of 
an array of acyclic imines bearing a phenyl or p-MeO-phenyl ring on the nitrogen atom. 
Thus, in this project, the effect of varying the electronic and steric properties of imine 
protecting group would be explored in the first instance. 
A series of N-arylimines were prepared as single isomers by the condensation of the 
corresponding ketone and aniline derivative in the presence of 4Å molecular sieves at room 
temperature in toluene, followed by purification by recrystallisation or vacuum distillation 
(Table 1). These imines were assumed to be the more stable trans
i
 isomers. 
Table 1: Preparation N-arylimines
a 
Imine Yield (%) Imine Yield (%) 
Ph
N
124
 
51 
Ph
N
MeO
128
 
44 
Ph
N
OMe
125
 
52 
Ph
N
Me
129
 
48 
Ph
N
Me
126
 
72 
Ph
N
N
130
 
17 
Ph
N
F
127
 
46   
a The mixture of ketone (50 mmol), amine (60 mmol) and 4Å MS (20 g) in toluene (40 mL) stirred at room temperature for 
24 hours. 
                                                 
i In this thesis, the trans isomer of an imine is defined as the isomer in which the bulky groups of imine lie on opposite side 
of the double bond of an imine. In contrast, the cis isomer of imine has the bulky groups on the same side of the double 
bond. 
32 
 
The reductions were performed under the optimized conditions developed in Jones’ group, 
which were imine (1 mmol), trichlorosilane (2 eq.) and catalyst 117 (0.01 mmol) in 
dichloromethane (0.5 mL), stirring for 4 hours at 0 C (Table 2).79 Both electronic rich and 
poor imines were reduced in high yields and good enantioselectivies (amines 131-134). In 
contrast, exceptionally high enantioselectivities were obtained with ortho-substituted N-aryl 
imines but with lower yields (amines 135-136). These results indicated that electronic factors 
had little effect on the activity and enantioselectivity; however, steric interactions close to 
the nitrogen atom played an important role on the activity and enantioselectivity. The 
reduction of N-pyridinyl imine 130 can yield amine 137 in 40% yield and 47% ee; the 
enantioselectivity was slightly improved (60% ee) when increasing the catalyst loading to 10 
mol%. It should be mentioned that a suspension formed upon the addition of trichlorosilane 
for the reduction of imine 130. 
Table 2: The asymmetric reduction of N-arylimines
a 
Amine Yield (%) Ee (%) Amine Yield(%) Ee(%) 
Ph
HN
Ph
131
 
98 85 
Ph
HN
MeO
135
 
35 96 
Ph
HN
PMP
132
 
100 90 
Ph
HN
Me
136
 
64 97 
Ph
HN
Me
133
 
100 87 
Ph
HN
N
137
 
40 (44)
b
 47 (60)
b
 
Ph
HN
F
134
 
96 87    
a A solution of imine (1 mmol) and catalyst 117 (0.01 ~ 0.1 mmol) in CH2Cl2 (0.5 mL) was cooled to 0 ºC and HSiCl3 (2 
mmol) was added, and then the mixture was stirred  for 4 h at 0 ºC; b Reduction was performed for 8 h at 10 mol % catalyst 
for data in parentheses. 
A control experiment was performed in order to rationalise why the N-3-pyridinylimine 130 
was reduced with poor enantioselectivity and low yield (Scheme 54). A mixture of amine 
33 
 
130 and 125 was reduced with 10 mol% catalyst.  Low conversion (25%) for reduction of N-
3-pyridinylimine 130 was observed with 63% ee, while imine 125 was reduced completely 
in 90% ee. Therefore, the poor enantioselectivity obtained when using imine 130 as a 
substrate was not attributable to it acting as a competitive catalyst, although the possibility of 
it reacting in an intramolecular fashion cannot be ruled out. The low yield perhaps could be 
attributable to coordination with trichlorosilane removing it from reaction since it is known 
that pyridine derivatives with trichlorosilane can form low solubility complexes.
80
 
Ph
N
N
Ph
N
PMP
+
Ph
HN
N
Ph
HN
PMP
+
130, 0.5 mmol
10 mol% catalyst, 2eq. HSiCl3
CH2Cl2, 0 °C, 8h
125, 0.5 mmol
137 132
25% conv. 63% ee 100% conv. 90% ee  
Scheme 54 
To determine whether the imine geometry was important, a series of geometrically 
constrained substrates were prepared. Cyclic imine 138 was successfully prepared by 
condensation of 2-aminophenol and 2-bromoacetophenone in reflux acetone with potassium 
carbonate in 60% yield (Scheme 55). 
O
BrNH2
OH
+
N
O
PhK2CO3
Acetone, reflux
60% 138  
Scheme 55 
The seven-membered ring imine 139 was synthesized from o-hydroxy-acetophenone in 4 
steps (Scheme 56). It should be mentioned that the protection of the carbonyl group of o-
hydroxyacetophenone was necessary for the following SNAr reaction with o-
chloronitrobenzene, otherwise a C-arylation product 140 formed through a Smiles-type 
rearrangement (Figure 5).
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Figure 5 
Cyclic imines 141 and 142 were prepared according to known procedures reported in the 
literature (Scheme 57).
82 
N
H
O
1. TMSCl, NEt3, Et2O
2. PhMgBr, Et2O
n
N
n
Ph
141, n=0, 142, n=1   
Scheme 57
 
The asymmetric reduction of these cyclic imines was then tested (Table 3). cis-Imine 139 
was reduced in 86% conversion and 99% ee, however, under the same conditions only 26% 
of trans-imine 138 was reduced in 21% ee. Amines 145 and 146 were isolated in 81% yield, 
82% ee and 53% yield, 73% ee, respectively, after reduction of trans-imines 141 and 142. 
The absolute configuration of amine 144 was assigned to (S) by X-ray crystal analysis of the 
salt with (1S)-(+)-camphor-10-sulfonic acid (see Appendix 1). The configuration of amines 
145 and 146 was confirmed to be (S) by comparison of the specific rotation with compounds 
of known configuration. Amine 143 was confirmed as (S) by comparing the retention time 
on HPLC with the optically pure amine (R)-143 prepared from (R)-2-phenylglycinol 
(Scheme 58). 
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Table 3: Asymmetric reduction of cyclic imines 
Entry Imine Amine Conv. (%) Ee (%) 
1
a
 
N
O
Ph
138  143
H
N
O
Ph
 
26 21 
2
a
 
O
N
139  144
O
NH
 
86 99 
3
b
 
141N
Ph
 145
N
H
Ph
 
81
c
 82 
4
b
 
N Ph
142  
N
H
Ph
146  
53
c
 73 
a 1.2 mL of CH2Cl2, 1 mol% 117, 2 eq. HSiCl3, 4 h 0 C; 
b 1 mL of CH2Cl2, 1 mol% 117, 2 eq. HSiCl3, 12 h 0 C; 
c Isolated 
yield. 
Ph
OH
NH2
I
OH
+Ph
OH
NHBoc
Ph
O
NHBoc
DIAD, Ph3P
THF
61%
TFA
Ph
O
NH2
96% yield
5% Pd2(dba)3, 10%BINAP
1.3eq. NaOtBu, Tol. 95 °C N
H
O
Ph
(R)-14390% yield
CH2Cl2, rt.
Boc2O
NEt3, CH2Cl2
Ph
O
NHBoc
I
I
I
84%
 
Scheme 58 
It was quite interesting that trans cyclic imine 138 resulted in the opposite stereoselectivity 
compared to the trans cyclic imines 141, 142 and acyclic imines 124-130 (attention: Cahn-
Ingold-Prelog priority changes). The opposite selectivity of an analogue of imine 148 
compared to acyclic imines was also observed using catalyst 117 for this process reported by 
Malkov and co-workers, although a wrong configuration was assigned in their paper.
83
 It is 
notable that the reduction of cis cyclic imine 139 also shows the same stereoselectivity as the 
trans cyclic imines 141, 142 and trans acyclic imines 124-130, which could be a result of 
locked conformation of the fused rings. It is therefore likely that the stereoselectivity is 
related to the reactive conformation of the imine. 
The opposite selectivity of trans-imine 148 may have been as a consequence of the fused 
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benzene ring since both trans-imine 141 and 142 have the same selectivity with acyclic 
imines 124-130. Therefore, preparation of imine 148 was attempted by the procedure for 
imines 141 and 142 (Scheme 59). Imine 148 did form according to the 
1
H NMR spectrum of 
the crude product. However, after purification by chromatography, only enamine 149 was 
isolated in 3% yield. This was then used for the reduction and unexpected amide 151 was 
isolated in 66% yield instead of amine 150, with no trace amount of expected product 150 
detected. But it is not clear how amide 151 was formed. 
HSiCl3 (2 eq.), 117 (5 mol%)
N
H
O
Ph N
H
O
Ph
undetected
Ph N
H
O
OH
DCM, 0 °C, 4 h
150 151 66% yield
N
H
O
O N
O
Ph
N
H
O
Ph
3%
1. TMSCl, NEt3, Et2O
2. PhLi, Et2O
148 149
Chromatography
147
149
 
Scheme 59 
Similar to the reduction of N-3-pyridinylimine 130, a suspension was also observed after 
addition of trichlorosilane in the reduction of imine 141 and this suspension disappeared 
after stirring for 9 h at 0 C. The solid was proposed to be an imine-trichlorosilane 
pentacoordinate or hexacoordinate complex (Figure 6).
80
 Sun also explored the reduction of 
imine 141 with trichlorosilane using chiral sulfonamide catalysts, however, imine 141 was 
totally inactive and no explanation was disclosed.
62b 
N Ph
Si
Cl
Cl
Cl
H
NPh
Si
Cl
Cl
NPh
Cl
HSiCl
Cl
NPh
H
Cl
pentacoordinate complex hexacoordinate complex  
Figure 6: Proposed complexes formed from trichlorosilane and imine 151 
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2.4 Asymmetric reduction of N-alkyl ketimines with trichlorosilane 
There are many chiral amines used as therapeutic drugs possessing one or two alkyl groups 
on the nitrogen atom and thus highly enantioselective reduction of N-alkyl ketimines could 
provide a straight-forward pathway to this type of chiral amine, circumventing N-
deprotection and N-alkylation steps. Although reduction of imines with trichlorosilane 
catalysed by an organic Lewis base has been achieved with good to excellent 
enantioselectivities and yields, there are only a few reports exploiting N-alkyl ketimine 
substrates.
64,72
 The first reported example of reduction of N-alkyl ketimines with 
trichlorosilane used formamide (S)-89 as a catalyst by Malkov and coworkers, however, the 
products were obtained with low enantioselectivity (Scheme 60).
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Scheme 60 
In 2008, Sun made a breakthrough with a catalyst 152 that reduced a number of N-benzyl, 
allyl and alkyl imines with high enantioselectivities and yields (Scheme 61).
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Scheme 61 
Benaglia recently disclosed that 4-chloropicolinic acid derivative 112 can also catalyse the 
reduction of the N-butyl ketimine of acetophenone in good yield and enantioselectivity at 
low catalyst loading but only this one substrate was tested (Scheme 62).
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Catalyst 117 has already shown high catalytic efficiency in the reduction of N-aryl ketimines. 
The potential utility of catalyst 117 for the asymmetric reduction of N-alkyl ketimines with 
trichlorosilane was examined. The N-alkyl ketimines were prepared from the corresponding 
ketones and amines using molecular sieves to trap the water (method A) or under Dean-Stark 
conditions with a catalytic amount of p-TsOH (method B) and were isolated as isomeric 
mixtures of trans and cis imines by distillation or crystallization (Table 4). 
Table 4: Preparation of N-alkyl ketimines
a 
Imine 
Isomer 
ratio 
Yield % 
(method) 
Imine 
Isomer 
ratio 
Yield % 
(method) 
Ph
N
Me
153
 
16:1 77(A) 
157 Ph
NPh
 
3:2 61(B) 
154Ph
N
 
10:1 45(A) 
N
MeO
MeO 158  
5:1 100(A) 
155Ph
N
 
2:1 17(A) 
N Ph
159
 
3:1 47(B) 
156
N
 
1:0 47(A)    
a Method A: A mixture of ketone (50 mmol), amine (60 mmol) and 4Å MS (20 g) in toluene (40 mL) stirred at room 
temperature for 24 hours. b Method B:  A mixture of ketone (10 mmol), amine (1.1  1.3 eq.) and p-toluene sulfonic acid 
(0.05 eq.) in toluene (50 mL) was heated at reflux under Dean-Stark condition for 24 hours. 
Most of N-alkyl ketimines were reduced smoothly under the standard conditions (Table 5). 
The N-alkyl ketimines derived from acetophenone were reduced in high yield and reasonable 
enantioselectivity and the ee was slightly improved when increasing catalyst loading from 1 
to 10 mol% (amines 160-162). The amine 163 was isolated in high enantioselectivity (88% 
ee) but only moderate yield, even if the reaction time was prolonged to 24 h at a 10 mol% 
catalyst loading (Table 5). 
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Table 5 : Asymmetric reduction of N-alkyl ketimines
a
 
R1
N
R2 R1
HN
R2
R3117, HSiCl3 (2 eq.)
CH2Cl2, 0 °C
R3
 
Amine 
Cat. 
loading 
Time 
Yield 
(ee)% 
Amine 
Cat. 
loading 
Time 
Yield 
(ee)% 
Ph
HN
Me
160
 
1% 4 h 
93 
(67) 
Ph
HN Ph
164  
1% 8 h 
67 
(56) 
10% 4 h 
89 
(77) 
161Ph
HN
 
1% 4 h 
60 
(90) 
165
NH
MeO
MeO
 
1% 8 h 
77 
(53) 
1% 8 h 
87 
(91) 
10% 8 h 
73 
(49) 
162
Ph
N Ph
 
1% 8 h 
89 
(79) 
166
H
N
Ph
 
1% 8 h 
8
b
 
(23) 
10% 8 h 
94 
(85) 
10% 24 h 
40 
(50) 
163
HN
 
1% 4 h 
9 
(69) 
    
10% 24 h 
44 
(88) 
    
a A solution of imine (1 mmol) and catalyst 117 (0.01 ~ 0.1 mmol) in CH2Cl2 (0.5 mL) was cooled to 0 ºC and HSiCl3 (2 
mmol) was added, and then the mixture was stirred at 0 ºC; b Conversion based on integration of appropriate signals in the 
1H NMR spectrum. 
Amines 164-165 were obtained in moderate enantioselectivity, which could be attributable 
to less steric differences of ketimines 157-158. Imine 159 derived from 1-acetonaphthalene 
was reduced to give amine 166 in both low yield and poor enantioselectivity, which could be 
a result of peri-interaction in naphthalene derivatives. 
2.5 Investigations of the scalability and solvent influence 
After demonstrating catalyst 117 to be an excellent catalyst for the reduction of certain types 
of both N-aryl and N-alkyl imines, attention was then turn to the scalability of the process. 
The reduction of imine 125 can be performed at a 0.02 mol scale in dichloromethane with a 
complete conversion after 10 hours at 1 mol% catalyst loading, which yielded the amine 139 
without any decrease in term of enantioselectivity compared to a 1 mmol scale (Table 6, 
entry 1-2). Toluene was proven to be a suitable solvent, albeit with slightly lower 
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enantioselectivity (entry 3). Finally, it was found that the catalyst loading can be decreased 
to 0.1 mol% with no obvious decrease in term of enantioselectivity (entry 4). Acetonitrile 
was also a suitable solvent although a slightly lower enantioselectivity was observed (entry 
5-7). 
Table 6: Scale-up investigation of the reduction of imine 125 
Ph
N
PMP
Ph
HN
PMP
HSiCl3 (2eq.), 117 (X mol%)
DCM, 0 °C, 4h
125 139  
Entry Solvent (mL) Cat. loading Scale Time  Yield (%) Ee (%) 
1 DCM (0.5) 1 % 1 mmol 4 h 100 90 
2 DCM (10) 1 % 20 mmol 10 h 95 91 
3 Toluene (20) 1 % 20 mmol 8 h 98 85 
4 DCM (5) 0.1 % 10 mmol 4 h 74 86 
5 CH3CN (1) 1 % 1 mmol 4 h 99 84 
6 CH3CN (0.5)/DCM (0.5) 1 % 1 mmol 4 h 96 88 
7 CH3CN (0.5)/toluene (0.5) 1 % 1 mmol 4 h 95 88 
The scalability of reduction of cyclic imine 141 was then explored at a 10 mmol scale (Table 
7). The concentration of substrate had a significant effect on the enantioselectivity. As 
mentioned earlier, a suspension was formed upon addition of trichlorosilane when smaller 
amounts of dichloromethane (<10 mL) were used, but the suspension disappeared after 
stirring for 2-4 hours. When the amount of dichloromethane was increased to 20 mL, no 
suspension was observed. With a more diluted substrate, a higher enantioselectivity was also 
observed (entry 1-3). Improved enantioselectivity was observed when increasing the catalyst 
loading (entry 2 vs 4). Gratifying, the higher enantioselectivity can be also achieved by slow 
addition of a solution of imine 141 (10 mmol in 10 mL dichloromethane) at a rate of 2 mL/h 
using a syringe pump at a 1 mol% catalyst loading. 
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Table 7: Scale-up investigation of the reduction of imine 151 
N
Ph
N
H
Ph117 (X mol%), HSiCl3 (2eq.)
DCM, 0 °C, 20 h
141 145  
Entry DCM (mL) Cat. Loading (%) Conversion (%) Ee % 
1 5 1 >95 65 
2 10 1 >95 72 
3 20 1 >95 80 
4 10 10 >95 86 
5 10+10 1 >95 85 
2.6 Applications toward the synthesis of precursor of Saxagliptin 
Saxagliptin, a new anti-diabetic drug approved as the trade name Onglyza by FDA for 
treatment of type II diabetes mellitus, is produced industrially from N-Boc-3-
hydroxyadamantylglycine and methanoprolineamide, both of these being optically pure 
amino acid derivatives (Scheme 63).
85
 The possibility of preparing the adamantyl -amino 
acid by asymmetric reduction of the corresponding -imino ester with trichlorosilane using 
catalyst 117 was explored. 
NH2
O
N
NC
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H
NHBoc
O
OH HN
HH
H2N
O
+
Saxagliptin
OHOH
 
Scheme 63 
-Imino ester 177 was prepared from the corresponding keto acid in two steps in acceptable 
yield (Scheme 64). Unfortunately the reduction of -imino ester 167 offered the -amino 
ester 168 in a 16% conversion and without any optical activity. 
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Scheme 64 
-Imino ester 169 was also prepared using a similar general procedure as for the preparation 
of -imino ester 167 in good yield (Scheme 65). As in the case of the reduction of -imino 
ester 167, low conversion and no asymmetric induction were observed in the reduction of -
imino ester 169. 
N
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117 (1 mol%), CH2Cl2, 0C, 10h HN
OBn
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OMe
27% yield, 0% ee
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Dean-stark
N
OBn
O
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Scheme 65 
The absence of asymmetric induction in these reductions could be attributable to 
racemisation during basic workup or from the steric hindrance which could impede the 
access to the catalyst-activated trichlorosilane. In order to examine this issue, the bulky 
imine 171 was prepared and used as a substrate (Scheme 66). As expected, the -amino ester 
172 was observed in low enantioselectivity (28% ee). The absolute configuration of 172 was 
presumed to S isomer by analog. Since this is unlikely to undergo racemisation during the 
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basic workup, steric hindrance is probably the main reason behind the low selectivity and 
yield observed. 
O
N
OMe
p-anisidine, 4 Å MS
Tolunene, RT
24% yield
HN
OMe
HSiCl3, 0 °C
CH2Cl2
1 mol% 117, 4h, 22% yield and 28% ee
10 mol% 117, 21h, 74% yield and 33% ee
171 172
 
Scheme 66 
2.7 Conclusions and future work 
A scalable process for the preparation of catalyst 117 was developed in four steps from 
commercially available L-proline without chromatography. Asymmetric reduction of both 
N-aryl and N-alkyl ketimines can be performed using trichlorosilane catalyzed by 117 at low 
catalyst loading. The scalability of this reducing system was demonstrated by the reduction 
of acyclic imine 125 and cyclic imine 141, although the reduction of sterically bulky -
imino esters was inefficient. Future work will focus on employing this methodology to 
develop processes for the preparation of some pharmaceutically important chiral amine 
intermediates. 
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3 Asymmetric reductions of -enamino esters 
3.1 Background 
Optically active -amino acids and their derivatives are common structures in Nature and are 
also widely used as building blocks for the synthesis of -lactams and other biologically 
active compounds.
86
 It is not surprising then that much interest has focused on the 
development of methodologies for the preparation of enantioenriched -amino acids and 
their derivatives.
87
 The catalytic asymmetric synthesis of -amino acids and their derivatives 
using both transition metal catalysts and organocatalysts have been developed in recent 
decades. 
3.1.1 Asymmetric C-C bond-forming reactions 
The asymmetric C-C bond-forming reaction to form the bond between -carbon and -
carbon atoms are important methods to synthesize -amino acids.88 Asymmetric Mannich 
reactions have been widely investigated to prepare chiral -amino carbonyl derivatives.89 
Shibasaki and co-workers reported a catalyst system formed in situ from diethylzinc and 
(S,S)-linked BINOL ligand 173 for the direct addition of -hydroxyl aromatic ketones to N-
diphenylphosphinoyl imines (Scheme 67).
90
 In the presence of 1 mol% of the ligand, a range 
of N-protected -hydroxyl--amino ketones were isolated in excellent yield and 
enantioselectivity with high anti-selectivity. 
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Scheme 67 
The same authors later demonstrated that catalyst 173 produced highly syn-selective 
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products when N-Boc-imines were used (Scheme 68).
91
 Subsequently, Baeyer-Villiger 
oxidation of the products afforded the -hydroxyl--amino esters, which form the basis of 
important targets, such as the Taxotere side-chain. 
O
HO
OMe
Ph
N
+
173 (1 mol%)
ZnEt2 (4 mol%)
3Å MS, THF, -40 °C
OMeO
Ph
OH
NH
Boc
Boc
94% yield, 99% ee (syn)
dr (ant i/syn) 89:11
OMe
O
Ph
OH
NH
Boc
Taxotere side-chain  
Scheme 68 
Shibasaki and co-workers disclosed that the reaction of trichloromethyl alkyl ketones and N-
thienylsulfonyl imines can be promoted by La(OAr)3-pybox 174 complex to produce the 
corresponding -amino trichloromethylketones in excellent yield and stereoselectivity with 
high syn-selectivity (Scheme 69).
92
 The -amino trichloromethylketones can be transformed 
into -amino--substituted esters without epimerization by hydrolysis and subsequent 
protecting group interconversion. 
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S
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S
O
O
S
N
N
OO
N
La(OAr)3 (10 mol%)
174 (10 mol%)
ArOLi (5 mol%)
-40 °C, 3Å MS
THF/toluene
+
1. NaOMe, MeOH
2. Boc2O, DMAP
MeCN, rt
3. Mg, MeOH, rt
Ph
NH O
OMe
Boc
174
syn/ anti = 21:1, 96% yield, 96% ee
 
Scheme 69 
The addition of silyl enol ethers to imines has also been studied.
93
 For example, Wulff and 
co-workers reported the highly stereoselective addition of silyl ketene acetal 175 to a range 
of aromatic imines with 2 mol% catalyst which was pre-generated by the combination of 
Zr(i-PrO)4i-PrOH, R-VAPOL and N-methyl imidazole (Scheme 70).
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Scheme 70 
Proline-type organocatalysts have also been shown to promote Mannich reaction of 
aldehydes and imines, the product of which are the precursors of -amino acids (Scheme 13, 
page 9). Chiral Brønsted acids can be used as catalysts for highly asymmetric Mannich 
reactions. For example, Terada has used the highly steric-hindered phosphoric acid 176 to 
affect the addition of enecarbamates to imines at a very low catalyst loading (Scheme 71).
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NH O
Ph
Ph
O
H3O
2 mol%, 1 h, 85%, 95% ee
0.1 mol%, 5 h, 82%, 95% ee
0.05 mol%, 5 h, 85%, 93% ee  
Scheme 71 
Johnston et al. demonstrated that enantioselective synthesis of -phenyl alanine derivatives 
can be achieved by addition of nitroacetic acid esters to N-Boc imines under the catalysis of 
5 mol% catalyst 177, followed by denitration (Scheme 72).
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Scheme 72 
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The dual activation system consisting of DABCO and thiourea 178 has been used for highly 
enantioselective asymmetric aza-Morita-Baylis-Hillman reaction between N-nosyl imines 
and methyl acrylate albeit in moderate yield by Jacobsen and co-workers (Scheme 73).
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Scheme 73 
3.1.2 Asymmetric reduction of -enamino esters 
Asymmetric catalytic reduction of -enamino esters provides a direct route to access -
amino acid derivatives. Strategies employing transition metal-catalyzed asymmetric 
hydrogenation and organocatalytic hydride-transfer have been extensively investigated for 
the asymmetric catalytic reduction of -enamino esters.87 
Noyori et al. reported the highly enantioselective hydrogenation of N-acyl--enamino esters 
using a catalyst system of Ru(AcO)2 and R-BINAP.
98
 Although high enantioselectivities can 
be achieved in the hydrogenation of (E)-N-acyl--enamino esters, unsatisfactory results were 
obtained in the hydrogenation of (Z)-N-acyl--enamino esters (Scheme 74). Similar results 
were produced using related catalyst systems.
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Ru(OAc)2• R-BINAP (5 mol%)
MeOH, 25 °C Ph
NH
OMe
O
O
(E)-isomer, 90% ee
(Z)-isomer, 9% ee  
Scheme 74 
Zhang et al. reported that highly enantiopure -amino esters can be obtained by asymmetric 
hydrogenation of both (Z)- and (E)-N-acyl--enamino esters or a mixture of these two 
isomers using a Rh-TangPhos catalyst system (Scheme 75).
100
 The same group later 
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extended this catalyst system to the asymmetric hydrogenation of N-aryl -enamino 
esters.
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O
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NH
OMe
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O
P PH
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H
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(E)-substrate, 100%, conv. 99.6% ee
(Z)-substrate, 100%, conv. 98.5% ee
1:1 mixture of (E)/(Z) substrate, 100% conv. 99.5% ee  
Scheme 75 
The Rh-Me-BDPMI complex was also reported to be an effective catalyst for the 
hydrogenation of both (Z)- and (E)-N-acyl--enamino esters by Lee and co-workers (Scheme 
76).
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O
O
NN
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Scheme 76 
Hsiao et al. disclosed that unprotected -enamino esters can also be hydrogenated in high 
yield and enantioselectivity using Josiphos (179)-Rh complex as catalyst.
103
 Recently, this 
catalyst system has been successfully applied to the synthesis of Sitagliptin on a mole scale 
(Scheme 77).
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Scheme 77 
More recently, Zhang and co-workers reported the asymmetric hydrogenation of a variety of 
enamino hydrochloride esters can also be achieved in good to excellent enantioselectivity 
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using the iridium-ferrocenylphoshine 180 catalyst system.
105
 High enantioselectivity still can 
be obtained at 0.01 mol% catalyst loading albeit with slightly lower conversion (Scheme 78). 
Ph
NH3
OMe
O
Ph
NH2
OMe
O[Ir(COD)Cl]2, 180
H2 (100 atm), 12 h
CH2Cl2 / MeOH
P
Fe
P
(S,S)-ferrocenylphoshine
Cl
rt. 0.1 mol%, >99% conv. 95% ee
40 °C, 0.02 mol%, > 99% conv. 94% ee
40 °C, 0.01 mol%, > 87% conv. 94% ee
180  
Scheme 78 
A catalyst system of Cu(OAc)2 and enantiopure (S)-P-phos was used in combination with 
PMHS (polymethylhydrosiloxane) as hydride source for the asymmetric reduction of N-acyl-
-enamino esters. Both (Z)- and (E)-isomers were reduced in good yield and 
enantioselectivity (Scheme 79).
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Scheme 79 
List and co-workers reported that -amino acid precursors can be synthesized by transfer 
hydrogenation of nitroalkenes with a Hantzsch ester catalyzed by thiourea 182.
107
 High 
enantioselectivities were obtained from both (E)-alkene and (Z)-alkene, but with opposite 
stereoselectivity. Hydrogenation of the -nitro ester in the presence of Pd/C directly affords 
the free -amino acid (Scheme 80). 
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74% yield and 94% ee for 2 steps
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Scheme 80 
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3.2 Asymmetric reduction of -enamino esters with trichlorosilane 
Asymmetric reduction of -enamino esters with trichlorosilane catalysed by chiral Lewis 
bases has also been reported (see Chapter 1.24, page 17). In order to examine the activity of 
catalyst 117 in this respect, a range of N-aryl--enamino esters was prepared by 
condensation of the corresponding -ketoester and amine or its acetate salt in the presence of 
a catalytic amount of p-TsOH at reflux in ethanol. Pure products were obtained by 
chromatography or recrystallisation (Table 8). 
Table 8: Synthesis of -enamino esters 
-Enamino esters Yield % -Enamino esters Yield % 
Ph
NH
OEt
O
Ph
183  
37 
191
NH
OEt
O
PMP
Me  
41 
Ph
NH
OEt
O
PMP
184
 
60 
192
NH
OEt
O
PMP
MeO  
50 
185
Ph
NH
OEt
O
Me
 
56 
193
NH
OEt
O
PMP
S  
26 
186
Ph
NH
OEt
O
OMe
 
40 
194
NH
OEt
O
PMP
O2N  
82 
Ph
NH
OEt
O
Me
187
 
41 
NH
OEt
O
PMP
Me
195
 
11 
188
Ph
NH
OEt
O
F
 
59 
196
Bn
NH
OEt
O
PMP
 
56 
189
Ph
NH
OEt
O
Bn
 
42 
Me
NH
OEt
O
PMP
197
 
66 
190
Ph
NH
OEt
O
Me
 
55 
NH
OEt
O
PMP
198  
42 
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The -enamino ester 184 was used as a model substrate for the optimisation of reaction 
conditions (Table 9). The reaction was performed in dichloromethane at 0 C at 10 mol% of 
117. With 1 eq. acetic acid or water as additives, the yields of product 199 were improved, 
but with serious erosion of enantioselectivity (entry 1-3). High yield is observed when 20% 
salicylic acid used as an additive but with low enantioselectivity (entry 4). Using 20% of 
benzoic acid and phenol as independent additives gave good enantioselectivity but 
unsatisfactory yield (entry 5-6). Further increasing the amount of benzoic acid additive to 30 
mol% gave a drop in enantioselectivity (entry 7). Higher enantioselectivity was achieved 
when using 10 mol% of benzoic acid, however, the yield was not acceptable and could not 
be improved by prolonging the reaction time (entry 8-9). The highest enantioselectivity was 
achieved using 5 mol% of benzoic acid as an additive (half amount of catalyst loading), 
albeit in unsatisfactory yield (entry 10). The optimal conditions in term of both 
enantioselectivity and yield obtained were thus use of 20 mol% catalyst 117 and 10 mol% 
benzoic acid as additive. Using these conditions, product 199 was isolated in 76% yield and 
91% ee after 10 h at 0 C (entry 9). This represents the shortest reaction time in the literature 
for the reduction of -enamino esters with trichlorosilane catalysed by Lewis bases. 
Table 9: Optimisation for reduction of -enamino ester 183 
Catalyst 117, HSiCl3 (4 eq.)
DCM. 0 °CPh
NH
PMP
OEt
O
Ph
NH
PMP
OEt
O
184 199  
Entry Additive Reaction time Yield % Ee % 
1 no 10h 55 84 
2 AcOH, 100% 10h 93 42 
3 H2O, 100% 10h 74 51 
4 Salicylic acid, 20% 10h 87 65 
5 PhOH, 20% 10h 68 85 
6 PhCO2H, 20% 10h 70 83 
7 PhCO2H, 30% 10h 83 75 
8 PhCO2H, 10% 10h 60 88 
9 PhCO2H, 10% 24h 62 88 
10 PhCO2H, 5% 10h 58 91 
11
a 
PhCO2H, 10% 10h 76 91 
a
 20 mol% catalyst was used. 
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Under the optimised reaction conditions (Table 9, entry 11), a series of N-aryl phenyl 
enamino esters were used as substrates to evaluate the generality of this methodology (Table 
10). Excellent enantioselectivity was obtained for most substrates, although slightly lower 
enantioselectivity was observed for the -amino ester 202, which has an electron-deficient 
aromatic ring attached to the nitrogen atom (71% ee). The catalyst system was found to be 
very sensitive to the steric properties of the substrates since reduction of N-2-methoxyphenyl 
enamino ester 186 exhibited a low reactivity and enantioselectivity compared to N-2-
methylphenyl enamino 197 ester (-amino ester 203 vs 204). It was notable that N-alkyl -
enamino esters were suitable substrates, the reduction of which showed good reactivity and 
excellent enantioselectivity (-amino esters 205 -206). 
Table 10: Reduction of -enamino esters 
Ph
NH O
OEt
R
Ph
NH O
OEt
R
117 (0.2 eq.), PhCO2H (0.1 eq.)
HSiCl3 (4 eq.), CH2Cl2, 0 °C, 10 h  
Product Yield % Ee % Product Yield % Ee % 
Ph
NH O
OEt
PMP
199  
76 91 203
Ph
NH O
OEt
Me
 
53 86 
200
Ph
NH O
OEt
Ph
 
64 85 204
Ph
NH O
OEt
OMe
 
41 13 
Ph
NH O
OEt
Me
201
 
69 87 
205
Ph
NH O
OEt
Ph
 
57 93 
Ph
NH O
OEt
F
202
 
59 71 
206
Ph
NH O
OEt
Me
 
59 95 
With the same reaction conditions (Table 9, entry 11), the reduction of a series of -
aryl/alkyl N-p-anisidine enamino esters was further explored (Table 11). -Aryl N-p-
anisidine enamino esters bearing an electron-donating group were reduced with excellent 
enantioselectivity, although electron-deficient substrate 194 afforded the product in a slightly 
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lower yield and enantioselectivity (-amino ester 210). Reduction of the -aryl enamino 
ester containing an o-methyl group gave a surprisingly low yield of product with poor 
enantioselectivity (-amino ester 211). Reduction of -alkyl -enamino esters afforded the 
products with low enantioselectivity (-amino esters 212-214). 
Table 11: Reduction of N-p-anisolyl -aryl or -alkyl enamino esters 
R
NH O
OEt
PMP
R
NH O
OEt
PMP117 (0.2 eq.), PhCO2H (0.1 eq.)
HSiCl3 (4 eq.), CH2Cl2, 0 °C, 10 h
 
Product Yield (%) Ee (%) Product Yield (%) Ee (%) 
NH O
OEt
PMP
Me
207
 
75 92 
NH O
OEt
PMP
Me
211
 
27 3 
NH O
OEt
PMP
MeO
208
 
70 91 
NH O
OEt
PMP
Ph
212  
56 30 
NH O
OEt
PMP
S
209
 
66 90 
Me
NH O
OEt
PMP
213  
63 20 
NH O
OEt
PMP
O2N
210
 
50 82 
214
NH O
OEt
PMP
 
44 56 
The mechanism of the process is not clear at present. It is likely that the enamino esters 
tautomerize to the corresponding imines in the acidic reaction environment and then reduced 
to the amino esters by trichlorosilane. The observation of low enantiopurity of -amino ester 
204 cannot be attributable to simple steric effects, since -amino ester 203 was obtained in 
high ee (Table 10). It is perhaps more likely that intramolecular stabilization of the enamine 
occurs through interaction with the oxygen lone pair, limiting the imine/enamine equilibrium 
(Figure 7). In this enamine tautomeric form, unselective reduction then occurs. This proposal 
was in accordance with the observation that -enamino ester 215 existing exclusively in 
enamine tautomeric form, was also reduced in good yield under the optimized conditions, 
but the reduction occurred in a racemic fashion (Scheme 81). 
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Figure 7: Stable tautomer of -enamino ester 204 
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N
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O
117 (20 mol%), HSiCl3 (2 eq.)
benzoic acid (10 mol%)
CH2Cl2, 0 °C, 10 h
62% yield, 0% ee 216215  
Scheme 81 
It seems that the conjugation of aromatic ring and double bond of enamine is required for the 
reduction since -enamino ester 195 was only reduced to give -amino ester 211 in fairly 
low yield and negligible enantioselectivity. In this case, -enamino ester 195 could exist 
mainly in the frustrated conjugated conformation to reduce steric clashes between o-methyl 
group and the hydrogen or aromatic ring attached to the nitrogen atom (Figure 8). 
NH
OEt
O
H
MeO
CH3
NH
OEt
O
H
MeO
CH3
 
Figure 8: Frustrated conjugated confirmations of -enamino ester 195 
-Alkyl -amino esters 212-214 obtained in low enantioselectivity could be a result of the 
smaller steric difference of the two alkyl groups compared to that of aryl and alkyl groups. 
3.3 Conclusion and future work 
In summary, the results obtained so far demonstrate that catalyst 117 can facilitate the 
reduction -enamino esters with trichlorosilane with high enantioselectivity. It is notable that 
both N-aryl and N-alkyl substrates are suitable for the reduction with this catalytic system in 
high enantioselectivity although catalyst activity is not very efficient compared to the 
reduction of imines and high catalyst loading was necessary to achieve good results. Acidic 
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additives can accelerate the reduction, but a negative effect on enantioselectivity was 
observed when a large amount of additives was used. It is also important to note that the 
identification of the additives used depends greatly on the catalyst that is being used. Those 
additives that have been successful in the literature (one equivalent of H2O or AcOH) were 
not very successful with catalyst 117. Thus, although the methodology delivered the desired 
targets, better alternative strategies exist in the literature to access these compounds. 
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4. Asymmetric reductive amination of ketones 
4.1 Background 
Asymmetric reduction of imines has proved to be an efficient route to access chiral amines, 
but can be hampered by the sometimes non-trivial preparation and stability of imine 
precursors, resulting in a low overall yield. Alternatively, asymmetric reductive amination of 
ketones provides a convenient, economical and time-efficient strategy by circumventing this 
problem. It is not surprising that direct asymmetric reductive amination of ketones has been 
investigated using both transition-metal catalytic hydrogenation and organocatalysed transfer 
hydrogenation with Hantzsch esters as hydride source. 
Blaser et al. reported the first example of asymmetric reductive amination using Ir-Xyliphos 
complex as catalyst.
108
 The synthesis of the herbicide (S)-metolachlor was achieved in good 
yield and ee by this process from methoxyacetone and 2-methyl-6-ethyl-aniline (Scheme 82). 
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NH2 MeO
O
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cyclohexane, 50 °C, 16 h
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Fe
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Scheme 82 
Börner reported the highly enantioselective reductive amination of keto-acids with 
benzylamine using Rh(I)-complexes as catalysts.
109
 Three highly efficient P-ligands were 
obtained by high-throughput screening of 96 chiral ligands (Scheme 83). 
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O
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Ph
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MeOH, rt. 24 h
PPh2
PPh2
PPh2
PPh2
BnN
PPh2
PPh2
(R,R)-Norphos (S,S)-Chiraphos (R,R)-Deguphos
99%, 95% ee (S) 99%, 91% ee (R) 98%, 92% ee (S)  
Scheme 83 
Zhang and co-workers reported the highly enantioselective reductive amination of aryl 
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ketones in the presence of Ti(OiPr)4 and iodine using a Ir-f-phosphane complex as catalyst 
(Scheme 84).
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Scheme 84 
Kadyrov reported the asymmetric hydrogen-transfer reductive amination of aryl ketones 
using ammonium formate as the hydrogen donor. Under optimal conditions, highly 
enantiopure primary amines were produced using 1 mol% of catalyst prepared in situ from 
RuCl2 and tol-BINAP 217 (Scheme 85).
111
 
Ph
O
PhNH3/MeOH, 85 °C, 20 - 48h Me
NH2
Me
HCOONH4 (10 eq.)
RuCl2-217 (1 mol%)
92%, 95% ee
PAr2
PAr2
217, Ar = 4-MeC6H4  
Scheme 85 
Wills and co-workers reported an intramolecular reductive amination to prepare cyclic 
amines under transfer hydrogenation conditions.
112
 This process consisted of a sequence of 
deprotection, followed by formation and reduction of the imine (Scheme 86). 
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Scheme 86 
Asymmetric reductive amination of ketones has been investigated using Hantzsch esters as 
the hydrogen donor with chiral phosphoric acid catalysts. List and co-workers reported that 
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reductive amination of -branched aldehydes with p-anisidine can give -branched amines 
in high yield and enantioselectivity via a dynamic kinetic resolution process (Scheme 87).
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Scheme 87 
This process was extended to reductive amination of -branched cyclic ketones with p-
anisidine using the same catalyst 65.
114
 The synthesis of a key intermediate lactam 218 for 
the synthesis of perindopril demonstrated the utility of this transformation (Scheme 88). 
O
NH
CO2
tBu
PMP
1. tBuOK, THF, rt.
HN
H
H
O
p-anisidine (1eq.)
65 (5 mol%)
N
H
CO2EtEtO2C
5Å MS, cyclohexane
42 °C, 72 h
2. CAN
CO2
tBu
1.4 eq.
+
N
CO2H
O
HN
CO2Et
H
H perindopril
218
 
Scheme 88 
The same group recently reported the reductive amination of ketones with benzylamine 
using Dean-Stark conditions by heating at reflux under reduced pressure. For example, 
acetophenone was transformed in 96% yield and 88% ee using Hanztsch ester with 5 mol% 
catalyst 219 (Scheme 89).
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Scheme 89 
Akiyama and co-workers reported that the enantioselective reductive amination of 
trifluoromethyl ketones with p-anisidine using benzothiazolines as the hydride source could 
be achieved with 10 mol% chiral phosphoric acid catalyst 64 (Scheme 90).
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Scheme 90 
Limited examples of directed reductive amination of ketones using trichlorosilane as 
reducing agent catalysed by chiral Lewis bases have been reported by Benaglia (Scheme 46, 
page 26). In Jones’ group, it was found that catalyst 117 only activate trichlorosilane to 
reduce imines but not ketones. Clearly, this has the potential for reductive amination of 
ketones. 
4.2 Results and discussions 
Acetophenone 220 and p-anisidine 221 were used as standard substrates for screening 
optimal conditions with 1 mol% catalyst 117 on a 1 mmol scale (Scheme 91, Table 12). 
Although the product was obtained in good ee, the yield was unsatisfactory (entry 1). 
Increasing the equivalents of acetophenone or p-anisidine increased the yield slightly (entry 
2-3), although increasing the equivalents of trichlorosilane from 2 eq. to 4 eq. gave no 
benefit (entry 3-5). Using toluene as a solvent gave no significant difference to the reaction 
in dichloromethane (entry 3 vs 6). In each case, although good enantioselectivities could be 
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obtained, the yield was unsatisfactory. 
Ph
O
OMe
H2N
+ 117 (1 mol%), 0 °C
24 h Ph
HN
PMP
220 221 132  
Scheme 91 
Table 12: Optimization of the reaction conditions for asymmetric reductive amination of 
ketones 
Entry 
Molar ratio 
Additive (eq.) Solvent (mL) Yield % ee % 
220 : 221  : HSiCl3 
1 1 : 1.2 : 2 - CH2Cl2 (1) 39 85 
2 1 : 2 : 2 - CH2Cl2 (1) 47 84 
3 2 : 1: 2 - CH2Cl2 (1) 53 84 
4 2 : 1: 3 - CH2Cl2 (1) 52 85 
5 2 : 1: 4 - CH2Cl2 (1) 46 86 
6 2 : 1: 2 - Toluene (1) 39 84 
7 2 : 1: 2 TMSOTf (0.1) CH2Cl2 (1) 75 77 
8 2 : 1: 2 TMSOTf (0.05) CH2Cl2 (1) 58 80 
9 2 : 1: 2 TMSOTf (0.1) Toluene (1) 52 76 
10
a
 2 : 1: 2 TMSOTf (0.1) CH2Cl2 (1) 78 77 
11 2 : 1: 2 TMSCl (0.1) CH2Cl2 (1) 52 84 
12 2 : 1: 2 TMSCl (0.1) CH2Cl2 (1) 40 71 
13 2 : 1: 2 - CH2Cl2 (5) 43
b
 79 
14 2 : 1: 2 - CH2Cl2 (0.5) 66 84 
15 1 : 1.5 : 2 - CH2Cl2 (0.5) 71 84 
a 0.05 eq. catalyst used; b refers to conversion, not yield. 
TMSOTf has been successfully used as a catalyst in the three component Strecker reaction 
for the preparation of -aminonitriles,116 and might, in this case, increase the rate of initial 
imine formation and thus improve the yield. This was indeed the case. Using 0.1 eq. of 
TMSOTf as additive increased the yield to 75%, but unfortunately the enantioselectivity 
decreased (entry 7-9), and could not be recovered by increasing catalyst loading from 1 mol% 
to 5 mol% (entry 10). Using 0.1 eq. of TMSCl as additive also failed to offer any 
improvements (entry 11-12). Since it appeared that Lewis acid additives promoted formation 
of the ketimine required for reduction, it was reasoned that increasing the concentration of 
the substrates and reagents may also lead to a similar effect (entry 13-15), which was indeed 
the case. Optimum conditions were thus ketone 220, amine 221 and HSiCl3 in a molar ratio 
61 
 
of 1 : 1.5 : 2, producing the product amine 132 in 71% yield and 84% ee at 1 mol% catalyst 
loading (entry 15). These conditions offer an order of magnitude difference in catalyst 
loading, with considerable time savings (24 h vs. 90 h) to deliver a product with almost 
identical yield and ee to the competitive catalyst system reported by Benaglia (Scheme 46, 
page 26).
72
 Indeed, if one calculates the Asymmetric Catalytic Efficiency (ACE) and 
Asymmetric Catalytic Efficiency Speed (ACES) that have recently been proposed to 
compare efficiency of asymmetric transformations, catalyst 117 provides an ACE of 37.5 
and ACES of 1.6.
117
 These compare very well next to the Benaglia system with an ACE of 
5.2 and ACES of 0.1,
72
 and illustrate the cost and time savings associated with using the 
cheap, low molecular weight catalyst 117. 
With the optimal conditions in hand (Table 12, entry 15), the generality of the process was 
explored (Table 13). Both electronic rich and poor aryl methyl ketones afforded the amine 
products in good enantioselectivity (70-84% ee, entry 1-7), although slightly lower yields 
were obtained when using electron-poor aryl methyl ketones as substrates compared to 
electron-rich ones (entry 4-5). Surprisingly, the asymmetric reductive amination of o-
methylphenyl methyl ketone afforded amine 226 in low yield, but use of o-methoxyphenyl 
methyl ketone led to a good yield despite a small drop in enantioselectivity (entry 6 vs. 7). A 
similar change in the steric requirements of the substrate adjacent to the reaction site can also 
been seen when contrasting the 1-naphthyl methyl ketone with 2-naphthyl methyl ketone 
(entry 8 vs. 9). 2-Acetyl thiophene is reasonably well tolerated, while in contrast the furyl 
analogue is a poor substrate (entry 10 vs. 11). Reductive amination of propiophenone 
afforded the corresponding amine 232 in high enantioselectivity but low yield (entry 12). 
This illustrates the limitations of this methodology, since ketones with further substitution at 
the aliphatic centre failed to afford the amine and return only the starting materials after 
workup (entry 13-14). Dialkyl ketones or cinnamyl methyl ketone provided the products in 
high yield but low enantioselectivity (entry 15-17). 
Reductive amination of -cyanoacetophenone did not work at all and ketone was recovered 
after workup. This result could be attributable to the easy enolization of -
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cyanoacetophenone, disfavoring the formation of imine (Figure 9). 
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O
N
Ph
OH
Nacid
Ph
N
N
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Figure 9 
Table 13: Asymmetric reductive amination of ketone substrates
a 
Entry Amine 
Yield 
(%) 
Ee 
(%) 
Entry Amine 
Yield
 
(%) 
ee 
(%) 
1 
Ph
HN
PMP
132
 
71 84 10 
230
O
H
N PMP
 
72 44 
2 
HN
PMP
MeO 222  
76 81 11 
230
S
H
N PMP
 
61 79 
3 
223
HN
PMP
Me  
66 83 12 
Ph
HN
PMP
232  
15 85 
4 
224
HN
PMP
Cl  
61 83 13 
Ph
HN
PMP
233  
-
b 
N.A 
5 
225
HN
PMP
O2N  
46 83 14 
Ph
HN
234
PMP
 
-
b
 N.A 
6 
226
HN
PMP
Me
 
12 81 15 
Ph
HN
235
PMP
 
82 14 
7 
227
H
N
PMP
OMe
 
71 70 16 
Ph
HN
236
PMP
 
77 <2 
8 
228
HN
PMP
 
11 77 17
c MeO
MeO
NH
237
PMP:
 
81 15 
9 
229
HN
PMP
 
63 85     
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a A mixture of ketone (1 mmol), p-anisidine (1.5 mmol), catalyst 117 (0.01 mmol) and HSiCl3 (2 mmol) in CH2Cl2 (0.5 mL) 
were stirred for 24 h at 0 ºC; b No reaction or < 5% conversion; c Reaction performed in 1 mL of CH2Cl2. 
Various aromatic amines can also be used as the amine counterpart for the reductive 
amination of acetophenone and afforded the product amines in synthetically useful yield and 
good enantioselectivity (Table 14, entry 1-3). However, reductive amination employing 3-
aminopyridine as an amine counterpart gave the product in low enantioselectivity (10% ee), 
albeit good yield (Table 14, entry 4). 
Table 14: Reductive amination of acetophenone 229 with various aromatic amines
a 
Ph
O
X R
H2N
Ph
HN
X
R
117 (1 mol%), HSiCl3 (2eq.)
CH2Cl2, 0 °C, 24 h
+
 
Entry X R Product Yield %
 
ee % 
1 CH H 
Ph
HN
Ph
131
 
56 82 
2 CH Me 
Ph
HN
Me
133
 
64 84 
3 CH F 
134
Ph
HN
F
 
65 81 
4
b 
N H 
Ph
HN
N
137
 
58 10 
a A mixture of acetophenone (1 mmol), amine (1.5 mmol), catalyst 117 (0.01 mmol) and HSiCl3 (2 mmol) in CH2Cl2 (0.5 
mL) were stirred for 24 h at 0 ºC; b Reaction was performed in 2 mL of CH2Cl2. 
Reductive amination of acetophenone with aliphatic amines provided only recovered starting 
materials, presumably due to the formation of an initial amino-silane compound that 
inhibited subsequent reactions. With this in mind, a two-step one-pot procedure was 
developed by microwave-assisted imine formation immediately prior to reduction. Ketone 
and aliphatic amine were heated at 150 C for 40 min in the presence of 4 Å molecular 
sieves under microwave irradiation and the crude product immediately submitted to standard 
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reduction conditions. Using this process, several N-alkyl amines were successfully obtained 
in good yield and enantioselectivity (Table 15). It was notable that sterically hindered 
ketones were also aminated with benzylamine under these conditions (entry 6-7), and that 
the isopropyl phenyl ketone led to a reversal of the sense of stereoselectivity (entry 7). 
Table 15: Reductive amination of ketone with aliphatic amines
a
 
Ph R
O
+
n
Ar NH2
1. Microwave, 4Å MS
150 °C, 40 min
2. 1 mol% 117, HSiCl3
CH2Cl2, 0 °C, 8 h
Ph R
HN Ar
n
R = Me, Et, iPr
Ar = Ph, 2-furyl, thiophen-2-yl
n = 1-3  
Entry Product Yield %
 
ee %
 
1 
Ph
HN Ph
238  
63 80 
2
b 
Ph
HN
Ph
239  
65 86 
3
 
Ph
HN Ph
155
 
76 84 
4
 
Ph
HN
O
240  
65 86 
5 
Ph
HN
S
241  
64 83 
6 
Ph
HN
242
Ph
 
66 73 
7 
Ph
HN
243
Ph
 
62 76 
a A mixture of ketone (1 mmol), amine (1.5 mmol) and 4Å MS (200 mg) was irradiated under microwave for 40 min at 150 
ºC, then cooled to RT. Catalyst 117 (0.01 mmol) and CH2Cl2 (0.5 mL) were added, the reaction cooled to 0 ºC, HSiCl3 (2 
mmol) added and left to stir for 8 h; b Reaction was performed in 2 mL of CH2Cl2. 
The two-step one-pot procedure can also be used for the reductive amination of 
acetophenone with aromatic amine 221. Although the product amine 132 was isolated with 
approximately the same enantioselectivity and yield compared to the one-pot procedure 
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(Scheme 92 vs. Table 2, entry 1), the two-step one-pot procedure offers considerable time 
savings (4 h 40 min vs. 24 h), which increased the ACES from 1.6 to 7.6. This also provided 
amine 132 with a higher yield compared to the standard two-step procedure (52% overall 
yield) albeit with slightly low ee (84% vs. 90%, Table 1 and Table 2). 
Ph
O
OMe
H2N
+
Ph
HN
PMP
220 221 132
1. Microwave, 4Å MS
150 °C, 40 min
2. 1 mol% 117, HSiCl3
CH2Cl2, 0 °C, 4 h
68%, 84% ee  
Scheme 92 
The synthetic utility of this methodology was demonstrated by synthesis of calcimimetic 
(R)-(+)-NPS R-568 via the two-step one-pot procedure from amine 244 and ketone 245 in 67% 
yield and 89% ee with 1 mol% catalyst loading of (R)-117 (Scheme 93). 
Cl
NH2
O
1. Microwave, 4 MS
150 °C, 40 min
2. (R)-117 (1 mol% ), HSiCl3
CH2Cl2, 0 °C, 8 h
HN
Cl
(+)-NPS R-568
67%, 89% ee
+
MeO
OMe
244
245  
Scheme 93 
To determine the origins of the reversal of the sense of stereoselectivity in the reductive 
amination of iso-propyl phenyl ketone, a few sterically bulky imines and trifluoromethyl 
imines were synthesized. Initially, the synthesis of these substrates proved to be difficult 
under the traditional conditions. Gratifyingly, a new microwave-assisted method for the 
preparation of these imine substrates was successfully developed using tetraethoxysilane as a 
dehydrating reagent (method C).
118
 Under optimized conditions, steric bulky and 
trifluoromethyl imines derived from p-anisidine were synthesized in moderate to high yield 
(Scheme 94, Table 16, entry 1-5). However, under the same conditions, the cyclopropyl 
phenyl ketone failed to give the corresponding imine 251, which was prepared under 
standard Dean-Stark conditions (method B), as was imine 252 (Table 16, entry 6-7). 
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Scheme 94 
Most of the imines were isolated as single isomers, but some of them existed as a mixture of 
syn/anti-imines and enamines. Although it has been shown that the anti isomer is the major 
product formed for aromatic ketimines by 
1
H NMR experiments,
83
 the geometry of 
trifluoromethyl imines were clearly syn-favored according to nOe NMR experiments (see 
Appendix 2-3). 
Table 16: Synthesis of sterically bulky imines and trifluoromethyl imines 
Entry Imine Isomer ratio Yield (%) 
1 
Ph CF3
N
246
PMP
 
1:0 85 
2 
CF3
N
247
PMP
Ph
 
1.5:1 (imine/enamine) 78 
3 
CF3
N
248
Ph
PMP
 
1:0 76 
4 
Ph t-Bu
N
249
PMP
 
1:0 56 
5 
Ph
N
250
PMP
 
6:1:1 (ratio of two imine isomers and 
enamine) 
40 
6 
Ph
N
PMP
251  
1.6:1 13 
7 
Ph
N
PMP
252  
1:0 59 
These imines were submitted to the optimized reduction conditions (same conditions as the 
reductions in Table 2, page 32). The trifluoromethyl imines 246-248 were not reduced under 
these conditions, perhaps due to the reduced basicity of the nitrogen lone pair caused by the 
strongly electron-withdrawing trifluoromethyl group (Table 17, entry 1-3). Similarly, the 
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fact that the most sterically bulky imine 249 was unreactive could be due to steric hindrance 
inhibiting the interaction with an activated silane species (Table 17, entry 4). Both the 
isopropyl 250 and cyclopropyl imines 251 were reduced in high yield, albeit with much 
lower enantioselectivity for the reduction of the cyclopropyl imine (Table 17, entry 5-6). 
Similar to the reductive amination of isopropyl phenyl ketone, a reversal sense of 
stereoselectivity in the reduction of isopropyl imine 250 was observed, while the reduction 
of the cyclopropyl imine had a same sense of stereoselectivity. In contrast to trifluoromethyl 
imine 248, the corresponding methyl imine 252 can be quantitatively reduced albeit in a 
racemic fashion (Table 17, entry 7). 
Table 17: Reduction of trifluoromethyl imines and sterically bulky imines
a
 
Entry Imine Product Yield (%) Ee (%) 
1 
Ph CF3
N
246
PMP
 
- - - 
2 
CF3
N
247
PMP
Ph
 
- - - 
3 
CF3
N
248
Ph
PMP
 
- - - 
4 
Ph t-Bu
N
249
PMP
 
- - - 
5 
Ph
N
250
PMP
 
Ph
HN
PMP
233  
85 69 
6 
Ph
N
PMP
251  
Ph
HN
PMP
234  
98 36 
7 
Ph
N
PMP
252  
Ph
HN
PMP
235  
100 3 
a Conditions were same as in Table 2. 
The reasons for the reversal of the sense of stereoselectivity for the reduction of isopropyl 
phenyl imine might be attributable to the selective reduction of only one geometric isomer of 
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imine. This, linked with the ability of the imine substrates to interconverted geometry under 
the reaction conditions can then provide a tentative explanation for these results (Figure 10). 
In the case of methyl phenyl imine 125, the interconversion of the syn and anti imine 
isomers is relatively fast, with reduction of the anti-imine assumed to be faster, affording a 
majority of (S)-isomer as product. In the case of the isopropyl phenyl imine 250, imine 
equilibration is still facile, but now steric interaction of the isopropyl group with the PMP 
group disfavor the anti isomer, leading to preferential reduction of the syn-isomer. In the 
case of the cyclopropyl phenyl imine 251, the imine isomers cannot interconvert, as it would 
lead to highly strained cyclopropyl enamine. Thus in this case, the ratio of stereoisomers 
formed should match that of the initial syn/anti isomers (1.6:1 or 62:38), which does indeed 
correlate well with the observed enantioselectivity (68:32), within experimental error. 
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Figure 10 
4.3 Conclusions and future work 
In conclusion, the asymmetric reductive amination of ketones with both aromatic and 
aliphatic amines was successfully developed employing an organic catalyst at 1 mol% 
catalyst loading. Sterically hindered ketones also undergo reductive amination in good yield 
and enantioselectivity by a two-step one-pot procedure. The asymmetric synthesis of (+)-
NPS R-568 using the two-step one-pot procedure was achieved in good yield and high 
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enantioselectivity. Lewis acidic TMSOTf can improve the yield in the directed reductive 
amination, but showed a negative effect on the enantioselectivity. Future work will perhaps 
focus on improving the efficiency of this process by screening some more Lewis acidic 
additives. An important observation and tentative reaction mechanism has been put forward, 
linking imine geometry and product selectivity to support the results obtained. 
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5. Investigation into the mechanism of reduction of imines 
5.1 Background 
Several models for chiral induction of these Lewis catalysts have been proposed by several 
research groups. In 2004, Malkov and co-workers proposed a bidentate-activation model for 
L-valine-derived catalysts (Figure 11, A).
64a
 In this model, the stacking between the aromatic 
rings of catalyst and imine is crucial for the enantioselectivity. In 2009, the same group 
disclosed that low concentrations of acid in commercial trichlorosilane played an important 
role in the catalytic cycle since proton scavengers were found to slow down the reaction 
dramatically and also erode the enantioselectivity.
83
 According to this observation, a new 
transition model was proposed (Figure 11, B), where the protonated imine coordinated to the 
catalyst and trichlorosilane was activated by formation of pentacoordinated species. 
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Figure 11 
Sun et al. proposed bicoordinate-activation transition state models to explain the chiral 
induction in the reduction of imines based on the structure-activity of catalysts and non-
linear study of catalyst ee and product ee.
60,62
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Matsumura et al. proposed a transition state model for their catalyst 101 in which both imine 
and trichlorosilane coordinated with catalyst 101 through hydrogen bonding and noncovalent 
interactions, respectively (Figure 4, page 25).
70
 In this model, trichlorosilane is proposed to 
be activated by bicoordinate interaction with catalyst 101, with subsequent hydrogen 
bonding interactions between the hydroxyl group and the imine used to control 
stereoselectivity.  Similar transition state models involving hydrogen bonding were also used 
to explain the stereoselectivity of reduction of β-amino esters and imines by Benaglia72 and 
Zhang
73
 (Figure 13). 
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Figure 13 
Since these systems strongly resemble the catalyst 117 developed in the Jones group, it is 
tempting to draw similar transition state models for this system. However, it should be 
pointed out that all the mechanisms or transition states mentioned above did not elucidate the 
catalytic cycle and have little supporting evidence. In order to rationalize the design of new 
catalysts, the focus of this project turned to study the mechanism of reduction of imines with 
trichlorosilane catalyzed by catalyst 117. 
5.2 Results and discussions 
Early studies of the structure and activity of catalysts in Jones’ group delivered a similar 
conclusion to Matsumura’s work. In order to get new insights to the mechanism of imine 
reduction using catalyst 117, a few more catalysts were prepared as structural probes. The 
catalysts 255 and 256 were prepared using the same procedure for catalyst 117 by 
condensation of the corresponding amino alcohols with ethyl 1-methylimidazole-2-
carboxylate 123 in toluene in the presence of sodium hydride (Figure 14, page 72). However, 
72 
 
the same method failed to yield the catalysts 257-259 and the corresponding oxazolidinones 
260-262 were formed instead by loss of the imidazole ring (Figure 15). 
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Figure 15 
In order to evaluate the role of hydroxyl group in catalyst 117, attempts were made to 
synthesize catalysts 263 and 264. Catalyst 263 was successfully prepared by methylation of 
catalyst 117 in 56% yield (Scheme 95). 
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Scheme 95 
Treatment of catalyst 117 with Lawesson’s reagent in a reflux toluene did not deliver the 
desired catalyst 264. Only the dehydrated alkene 265 was isolated in 20% yield (Scheme 96). 
73 
 
N
O
N
N
Ph
SH
Ph
Me
264
N
O
N
N
Ph
OH
Ph
Me
117
Lawesson's reagent
toluene, ref lux
N
O
N
N
Me
Ph
Ph
265
not formed 20%  
Scheme 96 
The synthesis of achiral catalysts 266 and 267 was achieved from the corresponding 
imidazoles by deprotonation and quenching with dimethylcarbamoyl chloride (Scheme 97). 
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Scheme 97 
Another three catalysts 268-270 were synthesized by coupling α,α-diphenylprolinol 122 with 
the corresponding acid chlorides, which were prepared from carboxylic acids and used 
directly (Scheme 98). 
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The evaluation of these catalysts was carried out by the reduction of imine 125 using the 
standard conditions at 1 mol% catalyst loading (Scheme 99). 
Ph
N
PMP
Ph
HN
PMP
HSiCl3 (2eq.), catalyst (1 mol%)
DCM, 0 °C, 4h
125 132  
Scheme 99 
Background reaction studies with no catalyst returned the product amine in about 10% 
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conversion. Given the results discussed earlier with regard to imine/enamine equilibria, it 
was also important to evaluate the background reaction rate of any transient enamine formed. 
Thus, model substrate 271 was prepared and subjected to both catalyzed and uncatalysed 
reaction conditions. The results indicated no difference in conversion of the catalyzed and 
uncatalysed reactions; however the background reaction appeared to be faster and 
unselective when compared to those conducted on the imine. Although the substrate is, of 
course, slightly different to that used in the benchmark reactions, this could mean that any 
substrate and / or reaction conditions that extend the lifetime of the enamine will lead to 
erosion of enantioselectivity through reduction of this intermediate. It also implies that 
reduction of an iminium ion, the proposed reactive intermediate in this reaction, is much 
faster than that of a neutral imine. 
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Scheme 100 
N-Benzylimidazole and N-t-butylimidazole exhibited reasonable activities for the reduction 
of imine 125, while N-methylimidazole had a low activity (Figure 16). This rather 
unexpected result can perhaps be attributed to the immiscibility of the N-methylimidazole (2 
mmol) and trichlorosilane (4 mmol) in chloroform (0.5 mL) preventing interaction of the 
catalyst with the trichlorosilane. In contrast, clear solutions were formed when using N-t-
butylimidazole and N-benzylimidazole. 
N
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N
N
22% conv. 67% conv.
N
N
54% conv.
Ph
 
Figure 16: Evaluation of imidazole catalysts 
Catalyst 266 was very active but the N-t-butyl counterpart 267 showed a low catalytic 
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activity (Figure 17). A possible explanation may come from examination of their reactive 
conformations. For catalyst 266, both conformations 266A and 266B are reasonably stable 
and are available to interact with trichlorosilane. In the case of catalyst 267, severe steric 
interactions between the N-methyl group and the t-butyl group disfavor conformation 267A, 
leading to preferred conformation 267B. If this conformation is the only one available, 
interaction with trichlorosilane is then slow due to the significant steric hindrance around the 
carbonyl group. This results in no significant conversion other than the background reaction 
in the reduction of imine. 
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Figure 17: Evaluation and conformation analysis of catalysts 266 and 267 
Catalyst 268 with a t-butyl group on the imidazole nitrogen atom showed little catalytic 
activity (Figure 18). In this case, considering rotamers around the C-carbonyl bond, a 
similar situation arises as with catalyst 267, this time with steric interactions between the 
pyrrolidine ring and the t-butyl group. 
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Figure 18: Evaluation and conformation analysis of imidazole catalysts 268 
Catalyst 256 likewise exhibited no catalytic activity. In this case, intramolecular hydrogen 
bonding could lock conformation 256B, thus leading again to a conformation where reaction 
with trichlorosilane is unfavorable (Figure 19). 
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Figure 19: Evaluation and conformation analysis of imidazole catalysts 256 
Similar to catalyst 117, new catalysts 263 and 255 exhibited very high activity. It is very 
interesting that catalyst 263 was very active, delivering product with unexpectedly high 
enantioselectivity. This result is surprising given Matsumura’s transition state model, since 
the hydrogen bonding between the hydroxyl group and the nitrogen atom of the imine cannot 
exist in this case (Figure 4, page 25). The origins of the low enantioselectivity of catalyst 
255 are not clear at this time, but fit in well with previous studies
79
 showing a need for steric 
bulk at the alcohol position in order to maximize enantioselectivity. 
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Figure 20: Comparison of activity of catalyst 117 with new catalysts 
Catalyst 270 was highly active but led to poor stereoselectivity and a reversal in the sense of 
absolute stereochemistry (Figure 21). One explanation could be that in this case, steric 
interactions of the N-methyl group with the pyrrolidine ring do not occur, leading to a stable 
reactive conformation with a coplanar imidazole-amide. The reaction is then able to proceed 
via a slightly different transition state to that proposed (Figure 30, page 84). 
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Figure 21: Reversal stereoselectivity of catalyst 270 
The fact that no catalytic activity was observed with catalyst 269 indicates that the nitrogen 
atom in the imidazole ring plays a crucial role in determining the catalyst activity (Figure 22). 
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Some of the catalysts tested showed very high activity for the reduction of imine 125 at 1 
mol% catalyst loading. In order to compare their activity and the limitation of catalyst 
loading, the reduction of imine 125 was then performed at a much lower catalyst loading 
(Table 18). High enantioselectivity still can be obtained at a 0.01 mol% catalyst loading of 
catalyst 117 or 263; however, a dramatic decrease in conversion was observed for catalyst 
117, while catalyst 263 was still very active at such low catalyst loading with only a minor 
decrease in enantioselectivity. Achiral catalyst 266 exhibited a comparable activity with 
catalyst 263, while catalyst 270 was less active and showed reversal of absolute 
stereoselectivity when compared with catalysts 117 and 263. 
Table 18: Evaluation the Limitation of Catalyst Loading 
Catalyst Catalyst loading (%) Conversion (%) Ee (%) 
N
O
N
N
Ph
OH
Ph
Me
117
 
1 100 90 
0.1 88 87 
0.01 60 80 
N
O
N
N
Ph
OMe
Ph
Me
263
 
1 100 91 
0.1 100 89 
0.01 96 84 
N
O
N
N
Me
266  
1 100 N.R. 
0.1 100 N.R. 
0.01 87 N.R. 
N
O
N N
Ph
OH
Ph
Me
270
 
1% 100% 32 (R) 
0.1% 66% 3 (R) 
0.01% 17% Untested 
The reduction of imine 128 using 1 mol% catalyst 117 was highly enantioselective but low 
yielding. With the new most active catalyst 263, similar results were obtained although high 
enantioselectivity still can be achieved at a lower catalyst loading than with catalyst 117 
(Table 19). 
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Table 19: Comparison of Activity of Catalysts 117 and 263 by Reduction of imine 128 
Ph
N
MeO
128
Ph
HN
MeO
135
Catalyst, HSiCl3 (2 eq.)
CH2Cl2, 0 °C, 4 h
 
Catalyst Catalyst loading (%) Conversion (%) Ee (%) 
117 1 35 96 
263 1 39 96 
263 0.1 39 96 
The relationship of product ee and catalyst ee was plotted using imine 125 as a substrate. A 
clear linear relationship was observed using catalyst 117, indicating that one catalyst moiety 
was involved in the catalytically active species. 
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Figure 23 
In order to elucidate the mechanism, the intermediates and catalysts used were studied by 
1
H 
NMR and 
29
Si NMR experiments. Firstly, the reduction of imine 125 was performed with 
trichlorosilane (2 eq.) in CDCl3 with 1 mol% catalyst 117. After 4 hours, 
1
H NMR and 
29
Si 
NMR spectroscopy disclosed that species from the reduction was intermediate 274 and 
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tetrachlorosilane was also produced (Figure 24). Intermediate 274 was formed independently 
by addition of trichlorosilane to the solution of amine 132. 
 
 
Figure 24: 
29
Si NMR and 
1
H NMR study of Active Intermediates 
The interaction of the catalysts with trichlorosilane was then investigated. New signals can 
clearly be observed in the spectra of 
1
H NMR (4.99 ppm) and 
29
Si NMR (-33.2 ppm) upon 
treating catalyst 117 with excess trichlorosilane (1-3 eq.). The signals were attributable to an 
oxosilane species formed by silylating the hydroxyl group of catalyst 117 confirmed by 
SiCl4
HSiCl3
HSiCl3
Ph
HN
PMP
+
132
Reaction before quench Ph
N
PMPCl2HSi
274
HSiCl3
Reaction before quench
Ph
N
PMPCl2HSi
274
HSiCl3
Ph
HN
PMP
+
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comparison of the chemical shifts of related literature signals (Figure 25).
119
 
 
 
Figure 25: 
29
Si NMR and 
1
H NMR of Catalyst 117 with HSiCl3 
It is then not surprising that no new signals were observed in the 
1
H NMR spectrum when 
catalysts 263 and 266 (with no hydroxyl groups) were treated with trichlorosilane (4 eq.), 
although the 
1
H NMR spectrum of catalyst 263 definitely changed when treated with 
trichlorosilane (Figure 26). No hexacoordinated silicon species were observed by any of the 
29
Si NMR experiments, although these cannot rule out the presence in a very low 
concentration of such species. An alternative explanation for the changes observed in the 
1
H 
HSiCl3
117 + HSiCl3
117 + HSiCl3
N
O
N
N
Ph
O
Ph
Me SiHCl2
N
O
N
N
Ph
O
Ph
Me SiHCl2
JSi-H = 354.8 Hz
HSiCl3, JSi-H = 354.8 Hz
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NMR spectrum could therefore be from the impurities of HCl in the trichlorosilane 
protonating the imidazole. 
 
Figure 26: Comparison of 
1
H NMR of Catalyst 263 Treated with HSiCl3 
The catalysts were then studied using in-situ ReactIR experiments. The absorption signal of 
carbonyl group of catalyst 266 in dichloromethane initially appeared at 1635 cm
-1
; after 
addition of one equivalent of trichlorosilane, a new signal immediately appeared at 1668 cm
-
1
, while the original signal at 1635 cm
-1
 simultaneously disappeared (Figure 27). This 
supports the hypothesis that coordination of the trichlorosilane is rapid for this catalyst, 
leading to a relatively high reaction rate. 
 
Figure 27: In-situ IR Spectrum of Catalyst 266 Treated with Trichlorosilane 
263
263 + HSiCl3
Recovered 263
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A similar observation was made when a solution of catalyst 267 in dichloromethane was 
treated with one equivalent of trichlorosilane. In this case, the original signal of the carbonyl 
group was at 1645 cm
-1
 with a smaller new signal at 1671 cm
-1
 once treated with one 
equivalent of trichlorosilane (Figure 28). It is important to note that in this case the change is 
not as fast as with catalyst 168 and after the first addition, significant amounts of the un-
coordinated catalyst is present. This ratio does not change with time, or when a further 
equivalent of trichlorosilane is added. This supports the hypothesis that coordination of this 
catalyst to trichlorosilane is more difficult than in the case of catalyst 266. 
 
Figure 28: In-situ IR Spectrum of Catalyst 267 Treated with Trichlorosilane 
The IR absorption signal of chiral catalyst 263 in dichloromethane was at 1623 cm
-1
 and a 
new signal appeared immediately at 1641 cm
-1
 when being treated with one equivalent of 
trichlorosilane (Figure 29), but again this was not complete complexation.  
 
Figure 29: In-situ IR Spectrum of Catalyst 263 Treated with Trichlorosilane 
These preliminary in-situ IR data provide a very useful tool to be able to monitor the species 
present in the reaction. While insufficient data has been collected at this moment to provide 
conclusive arguments, it does clearly show that these catalysts do indeed interact with 
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trichlorosilane, although the puzzle at the moment is that no evidence for a coordinated 
silane species can be observed in the NMR data. 
From related studies, additives such as water (to form HCl in situ), acetic acid, and benzoic 
acid have been successfully used to improve the catalytic activity. Naturally, HCl is also 
present in commercial unpurified trichlorosilane. Therefore, another possibility that might 
explain the data accrued so far is that the basic imidazole ring could be protonated once 
trichlorosilane was added and the protonated catalyst is the real catalytic species involved in 
the transition state. This would still fit with the proposed conformation models, and also help 
to explain the reactivity difference between the Matsumura catalyst 101 with a pyridine 
moiety (pKa 5.21) and ours with an imidazole species (pKa 6.95). A proposed transition 
state model may well then be as shown in Figure 30. Initial complexation of trichlorosilane 
must occur via oxygen, based on the NMR data. Next, the N-methyl group must be 
orientated away from the pyrrolidine ring to reduce steric interactions, lying orthogonal to 
the carbonyl group. In this conformation, it avoids steric interactions with the large siloxane 
/ gem-diaryl group by placing the methyl group on the opposite face. This places the 
protonated imidazole on the correct face to undergo hydrogen bonding with the imine 
substrate, holding this in the correct position and activating it to reduction from the pendant 
silane group, itself activated by interaction with the amide. The difference in reactivity of the 
hydroxyl catalyst 117 and the methyl ether 263 may then be explained by considering the 
catalyst turnover-step, since the trichlorosilane cannot form a formal covalent bond with the 
methyl ether as in the case of the hydroxyl group. 
 
Figure 30 
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Obviously this model is only tentative at the moment and further experimental mechanistic 
studies are required to validate it. However, at the moment it appears to be a reasonable 
working hypothesis that fits much of the data. 
5.3 Conclusions and future work 
A new highly active catalyst 263 was successfully developed by methylation of the hydroxyl 
group of the original catalyst 117. This unexpected discovery has put the Matsumura 
transition state model into doubt. No evidence was found to support the coordinated silane 
species by NMR experiments. The preliminary in-situ IR experiment did indicate that there 
are some interactions between the catalyst and trichlorosilane led a red-shift of the 
absorption of the carbonyl group, although it is yet not clear what they are at the moment. A 
tentative transition state model was proposed. 
Future work will investigate the generality of the new catalyst 263 and validate the tentative 
transition state model by kinetic study of the reduction employing the advantage of the in-
situ ReactIR. 
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6. Conclusions and future work 
A chromatography-free process for the synthesis of catalyst 117 has been developed. 
Asymmetric reduction of both N-aryl and N-alkyl ketimines can be performed using 
trichlorosilane catalyzed by 117 at low catalyst loading. The scalability of this process was 
demonstrated by the reduction of acyclic imine 125 and cyclic imine 141. These results 
make the methodology potentially useful to the pharmaceutical industry. 
This catalyst can also facilitate the reduction of -enamino esters with trichlorosilane with 
good yield and high enantioselectivity albeit with the necessity of high catalyst loading and 
benzoic acid additive. It is notable that both N-aryl and N-alkyl substrates are suitable for the 
reduction with this catalytic system in high enantioselectivity. The results obtained using 
several different acidic additives identify that the exact additives depend on the catalyst used. 
A directed asymmetric reductive amination of ketones with aniline derivatives was 
demonstrated employing an organic catalyst 117. For reductive amination of aliphatic 
amines, a two-step one-pot procedure was developed by microwave-assisted imine formation 
immediately prior to reduction. Synthetically useful yield and good enantioselectivity were 
achieved at 1 mol% catalyst loading. Sterically hindered ketones also undergo reductive 
amination in good yield and enantioselectivity by the two-step one-pot procedure. The 
asymmetric synthesis of (+)-NPS R-568 was demonstrated in good yield and high 
enantioselectivity using the two-step one-pot procedure. Lewis acidic TMSOTf can improve 
the yield in the directed reductive amination, but showed a negative effect on the 
enantioselectivity. 
Initial investigations into the mechanism have resulted in unprecedented discoveries. Both 
the NMR study of catalyst 117 and the discovery of the new high active catalyst 263 place 
the Matsumura transition state model into doubt. A new tentative transition state model was 
proposed according to the study of structure/activity of catalysts and the preliminary in-situ 
IR data. 
Considering all the results obtained so far, the generality of the new highly active catalyst 
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will be investigated in the future. In order to elucidate the mechanism, more structurally 
related catalysts need be prepared and evaluated. A detailed kinetic study of the reaction is 
also a good method to justify the tentative transition state model. In this respect, ReactIR 
provides a powerful tool to accrue this data and as well as identify reactive intermediates. It 
is very likely that controlling the geometry of imine is crucial to obtaining high selectivity 
and new experiments will be designed to further confirm this. 
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7. Experimental 
7.1 General information 
Unless stated otherwise, all solvents were obtained from a Grubbs dry solvent system and 
glassware was flame dried and cooled under vacuum before use. All chemicals were used as 
received without further purification unless otherwise stated. Analytical thin layer 
chromatography (TLC) was performed using Merck 60 F254 precoated silica gel plates. 
Subsequent to elution, plates were visualized using UV radiation (254 nm); further 
visualization was possible by staining with a basic solution of potassium permanganate or 
silica supported iodine. Flash chromatography was performed using silica gel 40-63μ 60Å 
(Fluorochem Limited). Columns were typically packed as slurry and equilibrated with the 
appropriate solvent system prior to use. 
1
H and 
13
C NMR spectra were recorded on Bruker 
500 MHz, 400 MHz or 250 MHz spectrometer at ambient temperature unless otherwise 
stated. Chemical shifts for 
1H NMR spectra are reported as δ in units of parts per million 
(ppm) downfield from SiMe4 (δ 0.0) and relative to the signal of chloroform-d (δ 7.26, 
singlet) or DMSO-d6 (2.50 ppm, quintet). Coupling constants are reported as a J value in. 
Data for 
13
C NMR are reported as δ in ppm downfield from SiMe4 (δ 0.0) and relative to the 
signal of chloroform-d (δ 77.0, triplet) or DMSO-d6 (39.7 ppm, quintet). Mass spectra (m/z) 
were recorded on a ‘VG’-Autospec for Electron Ionisation (EI) and on a ‘Waters’-LCT for 
Electrospray (ES). Infrared spectra were recorded on a Perkin-Elmer 1600 FT-IR as thin film 
from a solution in dichloromethane or chloroform. Specific rotations were performed at 
room temperature on an Optical Activity Ltd. AA-10 automatic polarimeter at 589 nm (Na 
D-line) and [α]D values are given in 10
-1
 deg cm
2
 g
-1
. Melting points were measured on a 
Gallenkamp apparatus and uncorrected. Elemental analysis was performed on a Perkin-
Elmer 2400 CHNS/O Series II apparatus. Enantioselectivities were determined by high 
performance liquid chromatography (HPLC) analysis employing a Gilson HPLC chain with 
an ABI Analytical Spectroflow 783 UV detector at λ 254 nm unless specified otherwise, 
using a mixture of hexane and propan-2-ol as mobile phase and Chiralcel OD-H, Chiralcel 
OJ, Kromasil 3-Cellucoat OD, Phenomenex Lux 3u amylase-2 or Phenomenex Lux 3u 
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cellulose-1 column as the stationary phase. Mobile phase flow, unless specified otherwise, 
was 1.0 mL/min. GC was performed using a Perkin Elmer Autosystem XL gas 
chromatograph fitted with a Supleco fused silica capillary column (Astec Chiraldex B-DM) 
(30 m × 0.25 mm × 0.12 μm film thickness) using nitrogen as the carrier gas and detection 
by standard FID. Absolute configuration of the products was determined by comparison with 
compounds previously published. 
7.2 Procedures for catalyst synthesis 
Ethyl 1-methylimidazole-2-carboxylate 123
79
 
N
N
OEt
O
 
A solution of 1-methylimidazole (100 mmol, 8.21 g) and triethylamine (25 mL) in 
acetonitrile (50 mL) was cooled to -30 ºC. A solution of ethyl chloroformate (160 mmol, 
15.3 mL) in acetonitrile (25 mL) was added, while maintaining the temperature lower than 
10 ºC. The mixture was warmed up to room temperature slowly and stirred overnight. The 
solid was filtered off and the filtrate was concentrated. The residue was dissolved in water 
(150 mL), extracted with CHCl3 (2 × 100 mL). The combined organic phases were dried 
over MgSO4 and filtrated. The filtrate was evaporated under reduced pressure. The resulting 
yellow oil was purified by chromatography column on silica gel using AcOEt as eluent, 
yielding a yellow oil (10 g, 65% yield) which crystallised almost immediately upon cooling 
in fridge, m.p. 43-44 °C (lit.
79 
43-45 ºC); δH (250 MHz, CDCl3) 1.42 (t, 3H, J 7.2, 
OCH2CH3), 4.00 (s, 3H, NCH3), 4.39 (q, 2H, J 7.2, OCH2CH3), 7.02 (app. d, 1H, J 1.1, 
ArCH), 7.12 (app. d, 1H, J 1.1, ArCH); Data was in accordance with the literature. 
(S)-N-Ethoxycarbonylproline methyl ester 121
79
 
N
CO2Me
CO2Et  
Preparation by the same procedure reported in literature,
79
 obtained in quantitative yield as a 
colourless oil; δH (250 MHz, CDCl3, 1:1 mixture of rotamers) 1.20 (t, 3H, rotamer A, J 6.9, 
C2HCH3), 1.28 (t, 3H, J 6.8, rotamer B, CH2CH3), 1.85 - 2.33 (m, 4H, rotamer A, 4 × CH2), 
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1.85 - 2.33 (m, 4H, rotamer B, 4 × CH2), 3.39 - 3.66 (m, 2H, rotamer A, CH2N), 3.39 - 3.66 
(m, 2H, rotamer B, CH2N),3.73 (s, 3H, rotamer A, OCH3), 3.75 (s, 3H, rotamer B, OCH3), 
4.04 - 4.23 (m, 2H, rotamer A, CH2CH3), 4.04 - 4.23 (m, 2H, rotamer B, CH2CH3), 4.31 (dd, 
1H, J 8.2, 3.5, rotamer A, CHN), 4.38 (dd, 1H, J 8.5, 3.5, rotamer B, CHN); Data was in 
accordance with the literature. 
(R)-N-Ethoxycarbonylproline methyl ester 121
120
 was prepared by same procedure starting 
from D-proline. 
(R)-α,α-Diphenylprolinol 12279 
N
H
OH
Ph
Ph
 
Magnesium turnings (2.74 g, 114 mmol), a catalytic amount of iodine and THF (42 mL) 
were added into a 250 mL two-necked flask fitted with a dropping funnel under a N2 
atmosphere. Bromobenzene (8.96 g, 57 mmol) and THF (22mL) were introduced into the 
dropping funnel. The reaction was initiated by heating after addition of ca. 5 mL of the 
solution of bromobenzene in THF, which then was added dropwise at a rate to keep the 
reaction heated at reflux. After addition was completed, the reaction mixture was stirred at 
room temperature for 40 mins. This new prepared phenylmagnesium bromide solution was 
slowly added to an ice cold solution of (R)-N-ethoxycarbonylproline methyl ester 121 (2.87 
g, 14.3 mmol) in THF (40 mL) via cannula. The resulting reaction mixture was warmed to 
room temperature and stirred overnight. After being cooled to 0 C, the reaction was 
quenched with saturated aqueous ammonium chloride solution (20 mL). The insoluble solid 
was filtered off and washed with dichloromethane (100 mL). After the filtrate was 
concentrated under reduced pressure, the residue was dissolved in water (100 mL) and 
extracted with chloroform (3  60 mL). The combined organic phases were washed with 
brine (50 mL) and dried over magnesium sulfate. After filtration and evaporation of the 
solvent, the residue was dissolved in methanol (30 mL) with potassium hydroxide (8.0 g) 
and refluxed for overnight. After cooling to ambient temperature, the methanol was removed 
in vacuo and the residue was treated with water (50 mL) and extracted with dichloromethane 
(3  50 mL). The combined organic phases were dried over MgSO4. After filtration and 
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concentration under reduced pressure, the residue was purified by chromatography on silica 
gel (1 : 1 petroleum ether / ethyl acetate  ethyl acetate) to yield the product (1.8 g, 49%) as 
white solid; m.p. 74-75 C (lit.79 63-65 C for S isomer); [α]D +58 (c 2.0 in MeOH, lit.
121
 
+59, c 2.0 in MeOH); δH (250 MHz, CDCl3) 1.55 - 1.82 (m, 4H, 4 × CH2), 2.91 - 3.10 (m, 
2H, CH2N), 4.28 (t, 1H, J 7.5, CHN), 7.15 - 7.22 (m, 2H, ArCH), 7.28 - 7.35 (m, 4H, 
ArCH), 7.50 - 7.62 (m, 4H, ArCH); δC (63 MHz, CDCl3) 25.6 (CH2), 26.3 (CH2), 46.8 
(CH2N), 64.5 (CHN), 77.1 (CPh2OH) 125.6 (2 × ArCH), 125.9 (2 × ArCH), 126.4 (ArCH), 
126.5 (ArCH), 128.0 (2 × ArCH), 128.3 (2 × ArCH), 145.5 (ArC), 148.3 (ArC). Data was in 
accordance with the literature. 
(S)-α,α-Diphenylprolinol 12279 was prepared by same procedure starting from (S)-N-
ethoxycarbonylproline methyl ester 121; white solid, m.p. 65-68 C (lit.79 63-65 C); [α]D -
57.3 (c 2 in MeOH, lit.
121
 +59, c 2 in MeOH for R isomer); Data was in accordance with the 
literature. 
[(2R)-2-(Hydroxydiphenylmethyl)-1-pyrrolidinyl](1-methyl-1H-imidazol-2-yl)-
methanone 117
79
 
N
HO
Ph
PhO
N
N
 
(R)-α,α-Diphenylprolinol 122 (1.8 g, 7.1 mmol) was dissolved in toluene (8 mL) and NaH 
(60% dispersion in mineral oil, 371 mg, 9.2 mmol) was added at room temperature. After 
stirring for 30 mins, ethyl 1-methylimidazole-2-carboxylate 123 (1.31 g, 8.5 mmol) was 
added. The resulting reaction mixture was slowly warm to 70 C and stirred for 40 h at the 
same temperature. The reaction was cooled to room temperature, quenched by addition of 
water (10 mL) and extracted with dichloromethane (4  20 mL). The combined organic 
extracts were washed with brine (20 mL) and dried over magnesium sulfate. After filtration, 
the filtrate was evaporated and purified by chromatography on silica gel (50% ethyl acetate 
in petroleum ether  ethyl acetate) to yield the product (1.2 g, 47%) as white solid, m.p. 146-
149 C (from ethyl acetate and petroleum, lit.79 143-145 ºC from dichloromethane and 
petroleum ether 40-60 ºC); (Found: C, 73.07; H, 6.40, N, 11.71. C22H23N3O2 requires C, 
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73.11; H, 6.41, N, 11.63); [α]D +127 (c 0.44 in CHCl3, lit.
79
 -88, c 0.5 in CHCl3 for S 
isomer); δH (500 MHz, d6-DMSO, 102.5 ºC) 1.67 - 1.83 (m, 2H, CH2), 1.94 - 1.99 (m, 1H, 1 
× CH2), 2.07 - 2.15 (m, 1H, 1 × CH2), 3.36 (s, 3H, NCH3), 3.49 (ddd, 1H, J 11.5, 8.9, 6.9, 
CH2N), 3.93 (ddd, 1H, J 11.5, 9.2, 5.2, CH2N), 5.84 (s, 1H, CHN), 6.16 (br, s, 1H, OH), 6.86 
(app. t, 1H, J 0.6, ArCH), 6.98 (s, 1H, ArCH), 7.05-7.09 (m, 3H, ArCH), 7.14 (br, app. d, 
2H, J 11.0, ArCH), 7.21 - 7.25 (m, 1H, ArCH), 7.30 - 7.33 (m, 2H, ArCH), 7.45 - 7.47 (m, 
2H, ArCH); δC (126 MHz, d6-DMSO, 102.5 ºC) 22.2 (CH2), 27.2 (CH2), 33.7 (CH2), 47.5 
(NCH3), 63.6 (NCH), 80.8 (Ph2COH), 123.2 (ArCH), 125.2 (ArCH), 125.5 (ArCH), 126.08 
(2 ×ArCH), 126.1 (3 ×ArCH), 126.5 (2 ×ArCH), 127.1 (2 ×ArCH), 140.1 (ArC), 145.3 (2  × 
ArC), 158.9 (CO); m/z (TOF ES+) 384.1678 (M
+
+ Na, C22H23N3O2Na requires 384.1688). 
Column free procedure for the synthesis of (S)-catalyst 117
79
 
N OH
Ph
Ph
O
N
N  
Magnesium turnings (4.32 g, 180 mmol), a catalytic amount of iodine and THF (30 mL) 
were added into a 250 mL three-necked flask fitted with a dropping funnel under a N2 
atmosphere. Bromobenzene (14.13 g, 90 mmol) and THF (100 mL) were introduced into the 
dropping funnel. The reaction was initiated by heating after addition of ca.10 mL of the 
solution of bromobenzene in THF, which then was added dropwise at a rate to keep the 
reaction heating at reflux. After complete addition, the reaction mixture was heated to reflux 
for 30 mins and then cooled to 0 C. A solution of (S)-N-ethoxycarbonylproline methyl ester 
121 (6.03 g, 30 mmol) in THF (30 mL) was added dropwise. The resulting reaction mixture 
was warmed to room temperature and stirred overnight. After cooling to 0 C, the reaction 
was quenched with saturated aqueous ammonium chloride solution (10 mL). After stirring 
for 30 mins, the insoluble solid was filtered off and washed with dichloromethane (100 mL). 
The filtrate was concentrated under reduced pressure, the residue re-dissolved in 
dichloromethane (200 mL), washed with brine (50 mL) and dried over magnesium sulfate. 
After filtration and evaporation, the residue was dissolved in methanol (100 mL) with 
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potassium hydroxide (16.8 g) and refluxed for overnight. After cooling to ambient 
temperature, methanol was removed in vacuo and the residue was treated with water (100 
mL). This was extracted with dichloromethane (3  100 mL) and the combined organic 
phases were washed with brine (50 mL) and dried over magnesium sulfate. After filtration, 
the filtrate was concentrated under reduced pressure to afford mainly prolinol 122 which was 
used directly for next step. This crude product was dissolved in toluene (30 mL) and NaH 
(60% dispersion in mineral oil, 1.56 g, 39 mmol) was added at room temperature. After 
stirring for 30 mins, ethyl 1-methylimidazole-2-carboxylate 123 (5.08 g, 33 mmol) was 
added. The resulting reaction mixture was slowly warm to 70 C and stirred for 30 h at the 
same temperature. After cooling to room temperature, water (30 mL) was added and the 
mixture was extracted with dichloromethane (4  50 mL). The combined organic phases 
were washed with brine (50 mL) and dried over magnesium sulfate. After filtration, the 
filtrate was evaporated to give a brown solid that was washed with a mixture of petroleum 
ether and ethyl acetate. The crude product was purified by recrystallisation from ethyl 
acetate (2-3 times) to afford the pure product (4.6 g, 42% over 3 steps) as white solid, m.p. 
144-146 C (from ethyl acetate, lit.79 143-145 ºC); [α]D -104 (c 0.6 in CHCl3, lit.
79
 -88, c 0.5 
in CHCl3); Data was in accordance with the literature. 
(S)-[2-(Methoxydiphenylmethyl)pyrrolidin-1-yl](1-methyl-1H-imidazol-2-yl)methanone 
263 
N OMe
Ph
Ph
O
N
N  
NaH (60% dispersion in mineral oil, 44 mg, 1.1 mmol) was added to a solution of (R)-117 
(0.361g, 1 mmol) in THF (10 mL). After stirring for 20 min at room temperature, MeI (156 
mg, 1.1 mmol) was added dropwise at the same temperature and was then stirred overnight. 
The resulting mixture was quenched by saturated aqueous NH4Cl (10 mL). The organic 
phase was separated and the aqueous phase was extracted with dichloromethane (3  10 mL). 
The combined organic phases were dried over MgSO4. After filtration and concentration, the 
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residue was purified by chromatography on silica gel (20%  50% ethyl acetate in petroleum 
ether) to yield the product as white foam-like solid (0.21 g, 56%); m.p. 93-95 C; []D -68 (c 
0.5 in CHCl3); max (thin film, cm
-1
) 2927, 1624, 1463; δH (400 MHz, CDCl3, as a 4.6:1 
mixture of two rotamers A and B) 1.03 - 1.16 (m, 1H, rotamer A, 1 × CH2), 1.03 - 1.16 (m, 
1H, rotamer B, 1 × CH2), 1.45 - 1.53 (m, 1H, rotamer B, 1 × CH2), 1.57 - 1.68 (m, 1H, 
rotamer A, 1 × CH2), 1.98 - 2.05 (m, 1H, rotamer A, 1 × CH2) 1.98 - 2.05 (m, 2H, rotamer B, 
CH2), 2.25 - 2.48 (m, 2H, rotamer A, CH2), 2.38 (s, 3H, rotamer A, CH3), 2.95 - 3.02 (m, 1H, 
rotamer B, 1 × CH2), 3.00 (s, 3H, rotamer B, CH3), 3.54 - 3.61 (m, 1H, rotamer A, NCH), 
3.70 - 3.76 (m, 1H, rotamer B, NCH), 3.79 (s, rotamer A, NCH3), 3.86 (s, rotamer B, NCH3), 
5.72 (dd, J 8.7, 3.1, 1H, rotamer B, NCH), 6.31 (d, J 8.9, 1H, rotamer A, NCH), 6.79 (d, J 
0.9, 1H, rotamer A, ArH), 6.89 (s, 1H, rotamer B, ArH), 6.95 (d, J 0.9, 1H, rotamer A, ArH), 
7.07 (s, 1H, rotamer B, ArH), 7.26 - 7.36 (m, 9H, rotamer A, ArH), 7.26 - 7.36 (m, 10H, 
rotamer B, ArH), 7.46-7.52 (m, 1H, rotamer A, ArH); δC (100 MHz, CDCl3) 21.8 (rotamer A, 
CH2), 23.9 (rotamer B, CH2), 26.6 (rotamer B, CH2), 29.7 (rotamer A, CH2), 34.2 (rotamer A, 
NCH3), 35.4 (rotamer B, NCH3), 47.4 (rotamer A, NCH2), 50.7 (rotamer B, NCH2), 51.8 
(rotamer A, OCH3), 52.5 (rotamer B, OCH3), 60.4 (rotamer B, NCH), 63.5 (rotamer A, 
NCH), 68.8 (rotamer A, COMe), 122.4 (rotamer A, ArCH), 123.9 (rotamer B, ArCH), 126.6 
(rotamer A, ArCH), 127.4 (rotamer B, ArCH), 127.5 (rotamer B, ArCH), 127.6 (rotamer A, 
ArCH), 127.7 (rotamer A, ArCH), 127.8 (rotamer B, ArCH), 129.4 (rotamer A, ArCH), 
129.6 (rotamer B, ArCH ), 130.0 (rotamer A, ArCH), 138.8 (rotamer A, ArC), 139.7 
(rotamer A, ArC), 140.1 (rotamer B, ArC), 141.2 (rotamer B, ArC), 142.6 (rotamer A, ArC), 
161.2 (rotamer A, CO); m/z (TOF ES+) 376.2023 (MH
+
, C23H26N3O2 requires 376.2025). 
[2-(Diphenylmethylene)pyrrolidin-1-yl](1-methyl-1H-imidazol-2-yl)methanone 265 
N
O
N
N
Ph
Ph
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Lawesson’s reagent (0.7 mmol) was added to a solution of (S)-117 (1 mmol) in toluene (5 
mL) at room temperature and the resulting mixture was heated at 100 ºC for 15 h. The 
reaction mixture was then cooled to room temperature and quenched with aqueous NaOH (1 
N, 20mL). The aqueous phase was extracted with dichloromethane (3 × 30 mL) and the 
combined organic phases were washed with brine (20 mL) and dried over MgSO4. The 
desiccant was filtered off and the filtrate was concentrated. The residue was purified by 
chromatography on silica (50% petroleum in ethyl acetate to 100% ethyl acetate) to afford 
the product as a light yellow solid (23%); m.p. 169-171 ºC; max (thin film, cm
-1
) 2954, 1633, 
1442, 1369; δH (500 MHz, 100 ºC, CDCl3) 1.94-2.00 (m, 2H, CH2), 2.53 (t, 2H, J 7.6, CH2), 
3.04 (s, 3H, NCH3), 3.74 (t, 2H, J 7.5, CH2), 6.69 - 6.71 (m, 2H, ArH), 6.85 - 6.87 (m, 2H, 
ArH), 7.08 - 7.15 (m, 5H, ArH), 7.19 - 7.22 (m, 1H, ArH), 7.26 - 7.29 (m, 2H, ArH); δC (126 
MHz, 100 ºC, CDCl3) 20.0 (CH2), 28.9 (CH2), 32.4 (CH3), 45.9 (CH2), 123.1 (ArCH), 125.6 
(ArCH), 126.1 (ArCH), 126.3 (ArCH), 126.4 (C), 127.1 (2 × ArCH), 127.3 (2 × ArCH), 
128.3 (2 × ArCH), 128.9 (2 × ArCH), 137.2 (ArC), 139.7 (C), 140.7 (ArC), 141.4 (ArC), 
158.6 (CO); m/z (TOF ES+) 344.1748 (MH
+
, C22H22N3O requires 344.1763). 
(S)-,-Dimethyl-2-pyrrolinol122 
N
H
Me
OH
Me
 
Mg (1.92g, 80 mmol), iodine (one granule) and diethyl ether (20 mL) was added into an 
oven-dry 3-neck N2-filled flask. A solution of MeI (4.98 g, 80 mmol) in THF (80 mL) was 
added dropwise (initiated by heat after about 5-10 mL addition). The mixture was stirred at 
room temperature for 2 hours and then cooled to 0 C. A solution of (S)-N-
ethoxycarbonylproline methyl ester 121 (4.02 g, 20 mmol) in diethyl ether (20 mL) was 
added dropwise. The resulting mixture was stirred at room temperature overnight, cooled to 
0 C and quenched with sat. aqueous ammonium chloride (50 mL). The organic layer was 
separated and the aqueous layer extracted with diethyl ether (2  50 mL). The combined 
organic extracts were concentrated to afford yellow oil (3.36 g). This residue was treated 
with KOH (9.3 g), water (60 mL) and ethanol (40 mL), and heated as reflux overnight. The 
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mixture was cooled to room temperature and ethanol was removed under reduced pressure. 
The resulting aqueous phase extracted with dichloromethane (2  50 mL), the combined 
extracts were washed with brine (30 mL) and dried over MgSO4. After filtration, the filtrate 
was concentrated under reduced pressure to afford the title compound as brown low melting 
solid (1.87 g, 72%); []D -28 (c 2 in MeOH, lit.
122
 -32.3, c 1.84 in MeOH); δH (400 MHz, 
CDCl3) 1.14 (s, 3H, CH3), 1.18 (s, 3H, CH3), 1.60 - 1.82 (m, 4H, 2 × CH2), 2.84 (br s, 2H, 
NH and OH), 2.90 - 3.05 (m, 3H, NCH2, and NCH); δC (100 MHz, CDCl3) 25.2 (CH3), 26.1 
(CH2), 26.3 (CH2), 28.6 (CH3), 47.0 (NCH2), 67.0 (NCH), 70.3 [C(OH)Me2); Data was in 
accordance with the literature.  
(S)-[2-(2-Hydroxypropan-2-yl)pyrrolidin-1-yl](1-methyl-1H-imidazol-2-yl)methanone 
256 
N
Me
OH
Me
O
N
N
Me
 
(S)-,-Dimethyl-2-pyrrolinol (1.29 g, 10 mmol) was dissolved in toluene (10 mL) and NaH 
(60% dispersion in mineral oil, 600 mg, 15 mmol) was added at room temperature. After 
stirring for 30 mins, ethyl 1-methylimidazole-2-carboxylate 123 (1.69 g, 11 mmol) was 
added. The resulting reaction mixture was slowly warmed to 70 C and stirred for 40 h at 
this temperature. The reaction was cooled to room temperature, quenched by addition of 
water (20 mL) and extracted with ethyl acetate (3  30 mL). The combined organic phases 
were dried over MgSO4. After filtration, the filtrate was evaporated and purified by 
chromatography on silica gel (50% ethyl acetate in petroleum ether  ethyl acetate) to yield 
the product (0.896 g, 39%) as white solid, m.p. 84-86 C; (Found: C, 60.70; H, 7.98, N, 
17.70. C12H19N3O2 requires C, 60.74; H, 8.07, N, 17.71); max (thin film, cm
-1
) 3353, 2974, 
1607, 1455; [α]D -124 (c 1.1 in CHCl3); δH (500 MHz, d6-DMSO, 100 ºC) 1.07 (s, 6H, 2  
CH3), 1.65 - 1.70 (m, 1H, 1  CH2), 1.89 - 1.95 (m, 3H, 3  CH2), 3.54 (br, 1H, 1  NCH2), 
3.79 (s, 3H, NCH3), 4.03 (br, 1H, 1  CH2N), 4.48 (br, 1H, OH), 4.71 (br, 1H, NCH), 6.95 
(s, 1H, ArCH), 7.19 (s, 1H, ArCH); δC (126 MHz, d6-DMSO, 100 ºC) 23.4 (CH2), 25.6 
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(CH2), 25.7 (CH3), 26.9 (CH3), 33.8 (NCH3), 48.7 (NCH2), 65.2 (NCH), 72.4 (Me2COH), 
123.5 (ArCH), 126.1 (ArCH), 140.4 (ArC), 160.4 (CO); m/z (TOF ES+) 238.1556 (100%, 
MH
+
,  C12H20N3O2 requires 238.1550), 220.1455 (8). 
(S)-Methyl 2-(ethoxycarbonylamino)-3-methylbutanoate
123
 
NH O
OMe
EtO
O
 
The title compound was prepared using the same procedure for the synthesis of (S)-N-
ethoxycarbonylproline methyl ester (121). The crude product was obtained colourless oil and 
used for next step directly without further purification (quantitative yield); δH (400 MHz, 
CDCl3, as a 3.7:1 mixture of two rotamers), major rotamer: 0.91 (d, 3H, J 7.8, major rotamer, 
CH3), 0.99 (d, 3H, J 6.8, major rotamer, CH3), 1.27 (t, 3H, J 7.1, major rotamer, CH3), 1.33 
(t, 3H, minor rotamer, J 7.1, CH3), 2.13 - 2.23 (m, 1H, major rotamer, CH), 2.13 - 2.23 (m, 
1H, minor rotamer, CH), 3.76 (s, 3H, major rotamer, OCH3), 3.80 (s, 3H, minor rotamer, 
OCH3), 4.14 (q, 2H, J 7.1, major rotamer, OCH2), 4.23 (q, 2H, J 7.1, minor rotamer, OCH2), 
4.31 (dd, 1H, J 8.8, 4.8, major rotamer, NCH), 4.57 (dd, 1H, J 9.1, 4.8, minor rotamer, 
NCH), 5.17 (d, 1H, J 9.2, major rotamer, NH), 5.26 (d, 1H, J 8.2, minor rotamer, NH); 
1
H 
NMR data was generally in accordance with the literature, although the minor isomer was 
not characterised. 
 (S)-Ethyl 1-hydroxy-3-methyl-1,1-diphenylbutan-2-yl carbamate 
EtO
O
HN
Ph
OH
Ph
 
Magnesium (4.32 g, 180 mmol), catalytic amount of I2 (1 granule) and THF (10 mL) was 
added into a 3-neck flask fitted with a dropping funnel under nitrogen. A solution of 
bromobenzene (18.84 g, 120 mmol) in THF (110 mL) was introduced into the dropping 
funnel and added dropwise to keep the reaction mixture heated at gentle reflux (after 
addition of c.a. 10 mL of this solution, if the colour of iodine did not disappear, the reaction 
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was heated gently to be initiated before addition of the rest bromobenzene solution). The 
mixture was stirred for 2 h after addition and then cooled to 0 C. A solution of (S)-methyl 2-
(ethoxycarbonylamino)-3-methylbutanoate (6.09 g, 30 mmol) in THF (30 mL) was added 
dropwise, and the resulting mixture was stirred at room temperature for 2 hr. The reaction 
was cooled to 0 C and quenched with aqueous saturated ammonium chloride (100 mL). The 
organic layer was separated and aqueous layer extracted with dichloromethane (2  50 mL). 
The combined organic phase was dried over MgSO4 and filtered. The filtrate was 
concentrated to afford a solid residue, which was washed with petroleum ether to give pure 
product (5.4 g, 55 %) as a white solid; m.p. 196-198 C; (Found: C, 73.27; H, 7.82, N, 4.25. 
C20H25NO3 requires C, 73.37; H, 7.70, N, 4.28); max (thin film, cm
-1
) 3483, 3359, 1605, 
1670, 1545; [α]D -75.4 (c 0.35 in CHCl3); δH (400 MHz, CDCl3) 0.89 (d, 3H, J 6.8, CH3), 
0.91 (d, 3H, J 6.9, CH3), 1.15 (t, 3H, J 6.9, OCH2CH3), 1.82 - 1.87 (m, 1H, CHMe2), 2.64 
(br, s, 1H, OH), 4.05 (q, 2H, J 6.9, OCH2CH3), 4.67 (d, 1H, J 10.3, NCH), 7.18 - 7.36 (m, 
6H, ArH), 7.46 - 7.53 (m, 4H, ArH); δC (100 MHz, CDCl3) 14.6 (CH3), 17.4 (CH3), 22.7 
(CH3), 28.9 (CHMe2), 59.6 (NCH), 60.8 (OCH2), 82.3 (CPh2OH), 125.4 (2 × ArCH), 125.7 
(2 × ArCH), 126.8 (ArCH), 126.9 (ArCH), 128.3 (2 × ArCH), 128.4 (2 × ArCH), 145.5 
(ArC), 146.3 (ArC), 157.1 (CO); m/z (ES+), 310 (100%, MH
+
), 282 (10). 
(S)-2-Amino-3-methyl-1,1-diphenyl-1-butanol
124
 
H2N
Ph
OH
Ph
 
A solution of (S)-ethyl 1-hydroxy-3-methyl-1,1-diphenylbutan-2-yl carbamate (4.3 g, 13.1 
mmol) and KOH (7.3 g, 131 mmol) in aqueous 40% EtOH (100 mL) was heated at reflux 
overnight. The reaction mixture was cooled to room temperature, and a white precipitate 
formed. Water (40 mL) was added and the solid was collected by filtration to afford the pure 
product (2.9 g, 85%) as white solid; m.p. 105-107 C (lit.124 96 C); [α]D -135 (c 0.7 in 
CHCl3, lit.
124
 -127.1, c 0.7 in CHCl3); δH (250 MHz, CDCl3) 0.91 (d, 3H, J 6.8, CH3), 0.95 
(d, 3H, J 7.0, CH3), 1.72 - 1.81 (m, 1H, CH), 3.87 (d, 1H, J 2.1, NCH), 7.17 - 7.24 (m, 2H, 
ArH), 7.27 - 7.36 (m, 4H, ArH), 7.50 - 7.54 (m, 2H, ArH), 7.61 - 7.66 (m, 2H, ArH); δC (63 
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MHz, CDCl3) 16.1 (CH3), 23.0 (CH3), 28.0 (CH), 60.2 (NCH), 79.7 (COH), 125.5 (2 × 
ArCH), 125.9 (2 × ArCH), 126.3 (ArCH), 126.6 (ArCH), 128.0 (2 × ArCH), 128.4 (2 × 
ArCH), 144.9 (ArC), 148.1 (ArC); Data was in accordance with the literature.  
 (S)-3-Methyl-2-(methylamino)-1,1-diphenyl-1-butanol
125
 
MeHN
Ph
OH
Ph
 
A solution of (S)-ethyl 1-hydroxy-3-methyl-1,1-diphenylbutan-2-yl carbamate (3.27 g, 10 
mmol) in THF (20 mL) was added dropwise into a suspension of LiAlH4 (1.52 g, 40 mmol) 
in THF (20 mL) at 0 C. The mixture was heated at reflux for 15 h and then cooled to 0 C. 
The reaction was carefully quenched with brine (20 mL) and diluted with ethyl acetate (100 
mL). The solid was filtered and the filtrate washed with brine (20 mL) and dried over 
MgSO4. Filtration and evaporation of the solvent afforded the crude product, which was 
triturated with petroleum ether and filtered. The filtrate was concentrated to afford the pure 
product as white solid (2.13 g, 79%); m.p. 59-61 C (lit.125 69-71 C); []D -37.7 (c 2.1 in 
CHCl3, lit.
125
 -50.4, c 2.1, CHCl3); δH (250 MHz, CDCl3) 0.71 (d, 3H, J 6.9, CH3), 1.07 (d, 
3H, J 7.1, CH3), 1.95 - 2.08 (m, 1H, CH), 2.22 (s, NCH3), 3.46 (d, 1H, J 2.0, NCH), 5.19 (br, 
s, NH), 7.16 - 7.36 (m, 6H, ArH), 7.57 - 7.60 (m, 2H, ArH), 7.71 - 7.75 (m, 2H, ArH); δC (63 
MHz, CDCl3) 15.8 (CH3), 22.9 (CH3), 28.8 (CH), 38.1 (NCH3), 70.6 (NCH), 78.6 (COH), 
125.9 (2 × ArCH), 126.1 (ArCH), 126.2 (2 × ArCH), 126.4 (ArCH), 127.9 (2 × ArCH), 
128.0 (2 × ArCH), 145.5 (ArC), 148.9 (ArC); Data was in accordance with the literature. 
(S)-N-(1-Hydroxy-3-methyl-1,1-diphenylbutan-2-yl)-1-methyl-1H-imidazole-2-carboxa-
mide 256 
H
N
HO
Ph
Ph
O
N
N
 
(S)-2-Amino-3-methyl-1,1-diphenyl-1-butanol (1.27 g, 5 mmol) was dissolved in toluene (10 
mL) and NaH (60% dispersion in mineral oil, 0.26 g, 6.5 mmol) was added at room 
temperature. After stirring for 30 mins, ester 123 (0.847 g, 5.5 mmol) was added. The 
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resulting reaction mixture was slowly warm to 70 C and stirred for 48 h at the same 
temperature. The reaction was cooled to room temperature, quenched by addition of water 
(10 mL) and extracted with ethyl acetate (3  10 mL). The combined organic extracts were 
washed with brine (10 mL) and dried over MgSO4. After filtration, the filtrate was 
evaporated and the residue was purified by recrystallisation from ethyl acetate/petroleum 
ether to yield the product (0.7 g, 38%) as white solid, m.p. 199-201 C; (Found: C, 72.58; H, 
6.81, N, 11.50. C22H25N3O2 requires C, 72.70; H, 6.93, N, 11.56); max (thin film, cm
-1
) 
3396, 2960, 1659, 1538, 1503; [α]D -117.7 (c 0.62 in CHCl3); δH (400 MHz, CDCl3) 0.91 (d, 
3H, J 6.9, CH3), 1.07 (d, 3H, J 6.8, CH3), 1.95 – 2.03 (m, 1H, CH), 4.04 (s, 3H, NCH3), 4.47 
(s, 1H, OH), 5.03 (dd, 1H, J 10.2, 2.4, NCH), 6.91 (d, 1H, J 1.2, ArH), 6.93 (d, 1H, J 1.2, 
ArH), 7.08 - 7.12 (m, 1H, ArH), 7.18 - 7.24 (m, 3H, ArH), 7.32 - 7.35 (m, 2H, ArH), 7.58 - 
7.61 (m, 4H, ArH), 8.32 (d, 1H, J 10.2, NH); δC (100 MHz, CDCl3) 18.0 (CH3), 23.0 (CH3), 
29.2 (CH), 36.4 (NCH3), 59.2 (NCH), 82.0 (Ph2COH), 124.4 (ArCH), 125.3 (ArCH), 125.6 
(2 × ArCH), 125.7 (2 × ArCH), 126.6 (ArCH), 126.7 (ArCH), 128.1 (2 × ArCH), 128.2 (2 × 
ArCH), 138.6 (ArC), 146.0 (ArC), 146.8 (ArC), 158.6 (CO); m/z (TOF ES+) 364.2029 
(100%, MH
+
,  C22H26N3O2 requires 364.2029), 346.1904 (98). 
(S)-4-Isopropyl-3-methyl-5,5-diphenyloxazolidin-2-one 
N
O
O
Ph Ph
 
(S)-3-Methyl-2-(methylamino)-1,1-diphenyl-1-butanol (1.28 g, 4.76 mmol) was dissolved in 
toluene (10 mL) and NaH (60% dispersion in mineral oil, 0.247 g, 6.12 mmol) was added at 
room temperature. After stirring for 30 mins, ester 123 (0.806 g, 5.23 mmol) was added. The 
resulting reaction mixture was slowly warm to 70 C and stirred for 48 h at this temperature. 
The reaction was cooled to room temperature, quenched by addition of water (30 mL) and 
extracted with ethyl acetate (3  40 mL). The combined organic layers were washed with 
brine (30 mL) and dried over magnesium sulfate. After filtration, the filtrate was evaporated 
and the residue was purified by recrystallisation from ethyl acetate/petroleum ether to yield 
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the product (0.71 g, 50%) as white solid, m.p. 208-209 C; max (thin film, cm
-1
) 1740; [α]D -
275 (c 0.57 in CHCl3); δH (500 MHz, d6-DMSO, 100 ºC) 0.61 (d, 3H, J 6.8, CH3), 1.08 (d, 
3H, J 6.3, CH3), 1.92 - 1.97 (m, 1H, CH), 2.91 (s, 1H, NCH3), 4.48 (s, 1H, NCH), 7.26 - 7.43 
(m, 8H, ArH), 7.60 (d, 2H, J 8.4, ArH); δC (126 MHz, d6-DMSO, 100 ºC) 14.5 (CH3), 21.0 
(CH3), 28.8 (CH), 31.6 (NCH3), 68.5 (NCH), 86.4 (Ph2COH), 124.9 (2 × ArCH), 125.5 (2 × 
ArCH), 126.8 (ArCH), 127.3 (ArCH), 127.4 (2 × ArCH), 127.8 (2 × ArCH), 140.0 (ArC), 
144.3 (ArC), 155.7 (CO); m/z (TOF ES+) 296.1662 (MH
+
, C19H22NO2 requires 296.1651). 
1-t-Butylimidazole
126
 
N N
 
The title compound was prepared using a modified procedure in literature.
126
 A 250 mL 
three-necked flask was equipped with two dropping funnels and a condenser.  Distilled water 
(50 mL) was added to this flask. One dropping funnel was filled with a mixture of 40% 
aqueous glyoxal (11.5 mL, 0.1 mol) and 37% aqueous formaldehyde (8.1g, 0.1 mol), the 
other tert-butylamine (10.6 mL, 0.1 mol) and 35% aqueous ammonia (4.86 g, 0.1 mol). The 
water was heated until boiling, and then both solutions were added simultaneously. The 
resulting mixture turned brown and was stirred for 30 min at reflux after complete addition, 
and then cooled to room temperature. The mixture was extracted with dichloromethane (3  
150 mL), the combined organic phases were washed with brine (50 mL) and dried over 
MgSO4. The desiccant was filtered off and the filtrate was concentrated. The brown residue 
was purified by via vacuum distillation to give the product as a colourless oil (4.8 g, 39%); 
δH (400 MHz, CDCl3) 1.55 [s, 9H, C(CH3)3], 7.03 (s, 1H, ArH), 7.04 (s, 1H, ArH), 7.60 (s, 
1H, ArH); δC (100 MHz, CDCl3) 30.6 [C(CH)3], 54.7 [C(CH)3], 116.3 (ArCH), 129.1 
(ArCH), 134.3 (ArCH); Data was in accordance with the literature. 
Ethyl 1-t-butyl-1H-imidazole-2-carboxylate 
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N
N O
O
 
t-Butylimidazole (4.34 g, 35 mmol) was dissolved in THF (30 mL) and cooled to -78 C. 
nBuLi (20 mL, 2 M in hexane) was added dropwise by syringe. The resulting mixture was 
stirred at -78 C for 2 hours. This solution was added to a solution of ethyl chloroformate 
(7.56 g, 70 mmol) in THF (20 mL) by cannula at -78 C and stirred for 1 hour at the same 
temperature. The reaction mixture was then warmed to room temperature and quenched with 
saturated aqueous ammonium chloride (50 mL). The resulting mixture was extracted with 
ethyl acetate (4  100 mL), and the combined organic layers were washed with brine (100 
mL) and dried over MgSO4. The desiccant was filtered off and the filtrate was concentrated. 
The residue was purified by chromatography on silica gel (20%  30% ethyl acetate in 
petroleum ether) to yield the product as a colourless oil (2.50 g, 37%); max (thin film, cm
-1
) 
2980, 1721, 1403; δH (400 MHz, CDCl3) 1.41 (t, 3H, J 7.1, CH3), 1.50 [s, 9H, C(CH3)3], 
4.38 (q, 2H, J 7.1, CH2), 7.06 (s, 1H, ArH), 7.23 (s, 1H, ArH); δC (100 MHz, CDCl3) 14.2 
(CH3), 30.1 [C(CH)3], 58.7 [C(CH)3], 61.6 (CH2), 122.2 (ArCH), 127.8 (ArCH), 137.4 
(ArC), 160.0 (CO); m/z (TOF ES+) 197.1299 (MH
+
, C10H17N2O2 requires 197.1290). 
1-t-Butyl-1H-imidazole-2-carboxylic acid 
N
N O
OH  
Aqueous KOH (20 mL, 2.5 N) was added to a solution of ethyl 1-t-butyl-1H-imidazole-2-
carboxylate (1.29 g, 6.6 mmol) in methanol (20 mL) at room temperature. The reaction 
mixture was stirred overnight at the same temperature, the methanol was evaporated and the 
mixture carefully acidified to pH 2 with conc. hydrochloric acid. The resulting mixture was 
evaporated to give a white solid residue. This residue was treated with methanol (30 mL) 
and filtered. The filtrate was evaporated to give the crude product in the form of HCl salt as 
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white solid. The crude product was contaminated a small amount of decarboxylated 
imidazole (~9%) and was used for next step without further purification; δH (400 MHz, 
MeOD) 1.86 [s, 9H, C(CH3)3], 7.71 (d, 1H, J 1.8, ArH), 8.02 (d, 1H, J 1.8, ArH); δC (100 
MHz, MeOD) 28.3 [C(CH3)3], 63.9 [C(CH3)3], 119.1 (ArCH), 124.3 (ArCH), 134.8 (ArC), 
154.8 (COOH); m/z (TOF ES+) 169.0978 (100%, MH
+
, C8H13N2O2 requires 169.0977), 
126.1151 (90); Data for the contaminant N-t-butylimidazole HCl salt, δH (400 MHz, MeOD), 
1.72  [s, 9H, C(CH3)3], 7.63 (s, 1H, ArH), 7.91 (s, 1H, ArH), 9.10 (s, 1H, ArH). 
1-Methyl-2-pyrrolecarboxylic acid
127
 
N
O
OH
 
Aqueous KOH (20 mL, 2.5 N) was added to a solution of methyl 1-methylpyrrole-2-
carboxylate (2.1 g, 6.6 mmol) dissolved in methanol (20 mL) at room temperature and the 
resulting reaction mixture was stirred overnight at the same temperature. Methanol was 
evaporated and then carefully acidified to pH 2 with hydrochloric acid (6 N). The white 
precipitate was collected by filtration and washed by water. The precipitate was dissolved in 
dichloromethane (50 mL) and dried over MgSO4. The desiccant was filtered off and the 
filtrate was concentrated to give the product as white solid (1.1 g, 57%); m.p.136-138 C 
(lit.
127
 135-136 C); δH (400 MHz, CDCl3) 3.96 (s, 3H, CH3), 6.18 (dd, 1H, J 4.0, 2.1, ArH), 
6.87 (t, 1H, J 2.1, ArH), 7.13 (dd, 1H, J 4.0, 2.1, ArH), 12.2 (br, s, 1H, COOH); δC (63 MHz, 
CDCl3) 37.0 (CH3), 108.4 (ArCH), 120.1 (ArCH), 121.8 (ArC), 130.8 (ArCH), 166.6 
(COOH); Known compound but NMR data was not reported in the literature. 
(S)-[2-(Hydroxydiphenylmethyl)pyrrolidin-1-yl](1-methyl-1H-pyrrol-2-yl)methanone 
269 
N
O
N
Ph
OH
Ph
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Oxalyl chloride (0.18 mL, 2.1 mmol) was added to a solution of 1-methyl-2-
pyrrolecarboxylic acid (131 mg, 1.05 mmol) in dichloromethane (5 mL) at room temperature. 
One drop of DMF was added and then the reaction mixture was stirred at room temperature 
for 2 hours. The excess oxalyl chloride and dichloromethane were removed by evaporation 
under reduced pressure. The residue was dissolved in dichloromethane (5 mL) and this 
solution was added to a solution of amino alcohol 122 (253 mg, 1 mmol) and triethylamine 
(0.2 mL, 1.4 mmol) in dichloromethane (5 mL) by pipette. The resulting mixture was stirred 
at room temperature for 2 hours and then quenched with aqueous saturated NaHCO3 (15 
mL). The aqueous phase was extracted with dichloromethane (3 15 mL), and the combined 
organic extracts washed with brine (15 mL) and dried over MgSO4. The desiccant was 
filtered off and the filtrate was concentrated. The residue was purified by chromatography on 
silica gel (15% ethyl acetate in petroleum ether) to yield the product as a white solid (195 mg, 
54%); m.p. 184-186 C; (Found: C, 76.28; H, 6.64, N, 7.69. C23H24N2O2 requires C, 76.64; 
H, 6.71, N, 7.77); max (thin film, cm
-1
) 3246, 2958, 1588, 1435; [α]D -83.7 (c 0.86 in 
CHCl3); δH (400 MHz, CDCl3) 1.37 - 1.45 (m, 1H, 1 × CH2),  1.55 - 1.67 (m, 1H, 1 × CH2), 
1.94 - 2.03 (m, 1H, 1 × CH2), 2.14 - 2.22 (m, 1H, 1 × CH2), 2.89 - 2.96 (m, 1H, 1 × NCH2), 
3.76 - 3.79 (m, 1H, 1 × NCH2), 3.81 (s, 3H, CH3), 5.50 (dd, 1H, J 8.4, 7.4, NCH), 6.08 (dd, 
1H, J 3.9, 2.0, ArH), 6.23 (dd, 1H, J 3.9, 2.0, ArH), 6.70 (app. t, 1H, J 2.0, ArH), 6.75 (br, s, 
OH), 7.27 - 7.39 (m, 6H, ArH), 7.48 - 7.50 (m, 2H, ArH), 7.55 - 7.58 (m, 2H, ArH); δC (100 
MHz, CDCl3) 24.5 (CH2), 29.3 (CH2), 36.3 (NCH3), 51.6 (CH2), 66.8 (NCH), 82.7 
[CPh2(OH)], 107.1 (ArCH), 114.6 (ArCH), 125.5 (ArC), 127.1 (ArCH), 127.2 (ArCH), 
127.3 (ArCH), 127.4 (2 × ArCH), 127.9 (2 × ArCH), 128.0 (2 × ArCH), 128.2 (2 × ArCH), 
143.1 (ArC), 145.7 (ArC), 165.5 (CO); m/z (TOF ES+) 361.1913 (90%, MH
+
, C23H25N2O2 
requires 361.1916), 343.1794 (100). 
(S)-(1-t-Butyl-1H-imidazol-2-yl)[2-(hydroxydiphenylmethyl)pyrrolidin-1-yl[methanone 
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N
O
N
N
tBu
Ph
OH
Ph
 
The title compound was prepared from the 1-t-butyl-1H-imidazole-2-carboxylic acid and 
amino alcohol 122 using the same procedure for catalyst 269 and purified by 
chromatography on silica gel (diethyl ether to flush off excess amino alcohol then 50% ethyl 
acetate in petroleum ether) to yield the product white solid (26%); m.p. 157-159 C; max 
(thin film, cm
-1
) 2979, 1618, 1449; [α]D -153.7 (c 0.8 in CHCl3); δH (500 MHz, 100 C, 
DMSO-d6) 1.40 (br, s, 1H, 1 × CH2), 1.45 [s, 9H, C(CH3)3], 1.53 - 1.62 (m, 1H, 1 × CH2), 
1.93 - 1.99 (m, 1H, 1 × CH2), 2.01 - 2.08 (m, 1H, 1 × CH2), 3.19 - 3.24 (m, 1H, 1 × CH2), 
3.46 (br, s, 1H, 1 × CH2), 5.41 (dd, 1H, J 8.3, 3.3, CH), 6.22 (br, s, 1H, OH), 6.86 (s, 1H, 
ArH), 7.13 - 7.16 (m, 1H, ArH), 7.20 - 7.25 (m, 4H, ArH), 7.29 - 7.32 (m, 2H, ArH), 7.42 (d, 
2H, J 7.5, ArH), 7.48 (d, 2H, J 7.7, ArH); δC (126 MHz, 100 C, DMSO-d6) 22.2 (CH2), 
27.6 (CH2), 29.5 [C(CH3)3], 48.6 [C(CH3)3] 56.4 (NCH2), 64.5 (NCH), 80.4 [CPh2(OH)], 
118.4 (ArCH), 125.4 (ArCH), 125.8 (ArCH), 126.1 (ArCH), 126.6 (2 × ArCH), 126.7 (4 × 
ArCH), 126.9 (ArCH), 140.4 (ArC), 144.9 (ArC), 145.8 (ArC), 163.7 (CO); m/z (TOF ES+) 
404.2348 (MH
+
, C25H30N3O2 requires 404.2338). 
(S)-[2-(Hydroxydiphenylmethyl)pyrrolidin-1-yl](1-methyl-1H-imidazol-4-yl)methanone 
N
O
N N
Ph
OH
Ph
 
The title compound was prepared from the 1-t-butyl-1H-imidazole-2-carboxylic acid and 
amino alcohol 122 using the same procedure for catalyst 269 and purified by 
chromatography on silica gel (diethyl ether to flush off excess amino alcohol then 2% 
methanol in ethyl acetate) to yield the product white solid (25%); m.p. 68-70 C; max (thin 
film, cm
-1
) 2924, 2854, 1587, 1556, 1446, 1434; [α]D -116.3 (c 0.94 in CHCl3); δH (500 MHz, 
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100 C, DMSO-d6) 1.30 - 1.39 (m, 1H, 1 × CH2), 1.51 - 1.60 (m, 1H, 1 × CH2), 1.88 - 1.94 
(m, 1H, 1 × CH2), 1.99 - 2.07 (m, 1H, 1 × CH2), 3.28 - 3.34 (m, 1H, 1 × CH2), 3.63 (s, 3H, 
NCH3), 4.08 - 4.13 (m, 1H, 1 × CH2), 5.67 (s, br, 1H, NCH), 6.63 (s, 1H, OH), 7.15 - 7.20 
(m, 3H, ArH), 7.22 - 7.25 (m, 1H, ArH), 7.28 - 7.36 (m, 5H, ArH), 7.43 - 7.45 (m, 2H, ArH), 
7.50 (s, 1H, ArH); δC (126 MHz, 100 C, DMSO-d6) 22.4 (CH2), 27.6 (CH2), 32.4 (NCH3), 
48.3 (NCH2), 64.3 (NCH), 80.8 [CPh2(OH)], 125.1 (ArCH), 125.7 (ArCH), 126.0 (ArCH), 
126.5 (2 × ArCH), 126.7 (2 × ArCH), 126.8 (2 × ArCH), 127.1 (2 × ArCH), 136.4 (ArCH), 
136.9 (ArC), 144.6 (ArC), 146.1 (ArC), 163.6 (CO); m/z (TOF ES+) 384.1676 (38%, 
M+Na
+
), 362.1876 (100, M
+
+1, C22H24N3O2 requires 362.1869), 344.1771 (50). 
1-t-Butyl-N,N-dimethyl-1H-imidazole-2-carboxamide 267 
N
N O
N
 
t-Butylimidazole (2.48 g, 20 mmol) was dissolved in THF (20 mL) and cooled to -78 C. 
nBuLi (12.5 mL, 2 M in hexane) was added dropwise by syringe. The resulting mixture was 
stirred at -78 C for 2 hours. This solution was added dropwise to a solution of 
dimethylcarbamoyl chloride (2.99 g, 28 mmol) in diethyl ether (20 mL) at -78 C and stirred 
for 1 hour at the same temperature. The reaction mixture was then warmed to room 
temperature and quenched with water (50 mL). The organic layer was evaporated and the 
aqueous was extracted with dichloromethane (3  100 mL) and dried over MgSO4. The 
desiccant was filtered off and the filtrate was concentrated to give the crude residue. Pure 
product was obtained as white solid after recrystallisation from ethyl acetate; m.p. 146-148 
C; max (thin film, cm
-1
) 3157, 2931, 1638, 1524; δH (400 MHz, CDCl3) 1.60 [s, 9H, 
C(CH3)3], 2.96 (s, 3H, CH3), 3.09 (s, 3H, CH3), 6.97 (d, 1H, J 1.2, ArH), 7.05 (d, 1H, J 1.2, 
ArH); δC (100 MHz, CDCl3) 30.4 [C(CH)3], 35.0 (CH3), 38.6 (CH3), 57.0 [C(CH)3], 117.9 
(ArCH), 126.8 (ArCH), 140.3 (ArC), 164.5 (CO); m/z (TOF ES+) 196.1442 (MH
+
, 
C10H18N3O requires 196.1450). 
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1-Methyl-N,N-dimethyl-1H-imidazole-2-carboxamide 266
128
 
N
N O
N
 
The title compound was prepared using the same procedure for compound 267 and 
purification by chromatography on silica gel (50% ethyl acetate in petroleum ether  ethyl 
acetate) to yield the product (1.1g, 36%) as colourless oil; δH (400 MHz, CDCl3) 3.12 (s, 3H, 
CH3), 3.41 (s, 3H, CH3), 3.89 (s, 3H, CH3), 6.94 (d, 1H, J 1.0, ArH), 7.05 (d, 1H, J 1.0, ArH); 
δC (100 MHz, CDCl3) 35.0 (CH3), 35.7 (CH3), 39.3  (CH3), 123.6 (ArCH), 127.3 (ArCH), 
140.1 (ArC), 160.9 (CO); Data was in accordance with the literature. 
7.3 Preparation of imines from their ketone precursor 
General procedure A: 
Activated 4 Å molecular sieves (20 g), toluene (40 mL), ketone (50 mmol) and amine (60 
mmol) were introduced into a 100 mL flask. The mixture was stirred at RT for 24 h and 
filtered. The imines were purified by distillation or recrystallisation from petroleum ether 40-
60 ºC and diethyl ether. 
General procedure B: 
Ketone (10 mmol), amine (1.11.3 eq.), p-toluene sulfonic acid (0.05 eq.) and toluene (50 
mL) were introduced in a round-bottom flask and heated for 24 hours under Dean-Stark 
conditions. After cooling to room temperature, K2CO3 (0.1 eq) was added and then filtered 
to remove any insoluble solid. The filtrate was concentrated in vacuo and the residue was 
purified by recrystallisation or distillation to afford the imine. 
General procedure C: 
The mixture of ketone (10 mmol), amine (15 mmol), Si(OEt)4 and p-toluene sulfonic acid (1 
mmol) was heated at 180 ºC for 5 to 60 mins under microwave irradiation. The resulting 
mixture was then cooled to room temperature and diluted with diethyl ether (15 mL). After 
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filtering off the insoluble solid, the filtrate was evaporated and the residue was purified by 
chromatography on silica gel (the silica gel pre-treated overnight with 10% triethylamine in 
petroleum ether) to afford the product. 
N-(1-Phenylethylidene)benzenamine 124
79 
Ph
N
 
Prepared according to general procedure A and purified by distillation under reduced 
pressure as pale yellow crystals (52%), m.p. 40-41°C (lit.
79 
42-43 ºC from petroleum ether 
40-60 °C); δH (250 MHz, CDCl3) 2.26 (3H, s, CH3), 6.81 - 6.84 (m, 2H, ArH), 7.08 - 7.15 
(m, 1H, ArH), 7.35 - 7.51 (m, 5H, ArH), 7.98-8.01 (m, 2H, ArH); δC (63 MHz, CDCl3) 17.4 
(CH3), 119.4 (2 × ArCH), 123.3 (ArCH), 127.3 (2 × ArCH), 128.4 (2 × ArCH), 129.0 (2 × 
ArCH), 130.5 (ArCH), 139.6 (ArC), 151.8 (ArC), 164.4 (C=N); Data was in accordance with 
the literature. 
4-Methoxy-N-(1-phenylethylidene)benzenamine 125
79 
Ph
N
OMe
 
Prepared according to general procedure A and purified by recrystallisation from diethyl 
ether/petroleum ether as yellow crystals (52%), m.p. 85-86 °C (lit.
79
 86 °C from petroleum 
60-80 ºC); δH (250 MHz, CDCl3) 2.28 (s, 3H, CH3), 3.84 (s, 3H, CH3), 6.77 - 6.81 (m, 2H, 
ArH), 6.91 - 6.96 (m, 2H, ArH), 7.44 - 7.49 (m, 3H, ArH), 7.97 - 8.01 (m, 2H, ArH); δC (63 
MHz, CDCl3) 17.3 (CH3), 55.5 (OCH3), 114.3 (2 × ArCH), 120.8 (2 × ArCH), 127.2 (2 × 
ArCH), 128.4 (2 × ArCH), 130.4 (ArCH), 139.9 (ArC), 144.9 (ArC), 156.0 (ArC), 165.7 
(C=N). Data was in accordance with the literature. 
4-Methyl-N-(1-phenylethylidene)benzenamine 126
129
 
109 
 
Ph
N
Me
 
Prepared according to general procedure A and purified by distillation under reduced 
pressure (72%) as a brown oil; δH (400 MHz, CDCl3) 2.27 (3H, s, CH3), 2.38 (3H, s, CH3), 
6.73 (d, 2H, J 8.3, ArH), 7.18 (d, 2H, J 8.3, ArH), 7.47 - 7.49 (m, 3H, ArH), 7.89 - 8.00 (m, 
2H, ArH); δC (100 MHz, CDCl3) 17.3 (CH3), 20.9 (CH3), 119.4 (2 × ArCH), 127.2 (2 × 
ArCH), 128.4 (2 × ArCH), 129.5 (2 × ArCH), 130.4 (ArCH), 132.6 (ArC), 139.7 (ArC), 
149.1 (ArC), 165.5 (C=N); Data was in accordance with the literature. 
4-Fluoro-N-(1-phenylethylidene)benzenamine 127
130 
Ph
N
F
 
Prepared according to general procedure A and purified by recrystallisation (46%) as a 
yellow solid, m.p. 88-89 °C (lit.
130
 86-87 °C); δH (400 MHz, CDCl3) 2.27 (s, 3H, CH3), 6.75 
- 6.80 (m, 2H, ArH), 7.05 - 7.11 (m, 2H, ArH), 7.45 - 7.52 (m, 3H, ArH), 7.97 - 8.01 (m, 2H, 
ArH); δC (100 MHz, CDCl3) 17.4 (CH3), 115.6 (d, 
2
JC-F 23.0, 2 × ArCH), 120.7 (d, 
3
JC-F 7.6, 
2 × ArCH), 127.2 (2 × ArCH), 128.4 (2 × ArCH), 130.6 (ArCH), 139.4 (ArC), 147.7 (ArC), 
159.2 (d, 
1
JC-F 240.8, ArCF), 166.3 (C=N); δF (235 MHz, CDCl3) -121.3. Data was in 
accordance with the literature. 
2-Methoxy-N-(1-phenylethylidene)benzenamine 128
131
 
Ph
N
MeO
 
Prepared according to general procedure A and purified by distillation under reduced 
pressure as a yellow oil (44%); δH (250 MHz, CDCl3) 2.20 (s, 3H, CH3), 3.81 (s, 3H, OCH3), 
6.80 (dd, 1H, J 7.5, 1.7, ArCH), 6.94 - 7.01 (m, 2H, ArCH), 7.07 - 7.14 (m, 1H, ArCH), 7.44 
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- 7.49 (m, 3H, ArCH), 8.01 - 8.05 (m, 2H, ArCH); δC (63 MHz, CDCl3) 17.8 (CH3), 55.7 
(OCH3), 111.8 (ArCH), 120.7 (ArCH), 121.1 (ArCH), 124.3 (ArCH), 127.4 (2 × ArCH), 
128.4 (2 × ArCH), 130.5 (ArCH), 139.6 (ArC), 140.8 (ArC), 149.1 (ArC), 167.0 (C=N). 
Data was in accordance with the literature. 
2-Methyl-N-(1-phenylethylidene)benzenamine 129
132
 
Ph
N
Me
 
Prepared according to general procedure A and purified by distillation under reduced 
pressure as a yellow solid (48%), m.p. 49-50 °C (not reported in literature); δH (400 MHz, 
CDCl3) 2.13 (3H, s, CH3), 2.20 (3H, s, CH3), 6.88 (dd, 1H, J 7.8, 1.0, ArH), 7.03 (ddd, 1H, J 
8.7, 7.6, 1.2, ArH), 7.19 - 7.25 (m, 2H, ArH), 7.46 - 7.51 (m, 3H, ArH), 8.02 - 8.05 (m, 2H, 
ArH); δC (63 MHz, CDCl3) 17.5 (CH3), 17.8 (CH3), 118.5 (ArCH), 123.3 (ArCH), 126.4 
(ArCH), 127.2 (2 × ArCH), 128.4 (2 × ArCH), 130.4 (ArCH), 130.5 (ArCH), 139.5 (2 × 
ArC), 150.4 (ArC), 164.9 (C=N). Data was in accordance with the literature. 
N-(1-Phenylethylidene)pyridin-3-amine 130 
Ph
N
N
 
Prepared according to general procedure B, purified by distillation (17%), yellow solid, m.p. 
46-48 °C; (Found: C 79.32; H 6.02; N 14.25; C13H12N2 requires C 79.56; H 6.16, N 14.27); 
vmax (thin film, cm
-1
) 3406, 3055, 1630, 1578; δH (400 MHz, CDCl3) 2.29 (s, 3H, CH3), 7.17 
- 7.20 (m, 1H, ArH), 7.20 - 7.34 (m, 1H, ArH), 7.46 - 7.53 (m, 3H, ArH), 7.99 - 8.02 (m, 2H, 
ArH), 8.17 (dd, 1H, J 2.7, 0.7, ArH), 8.38 (dd, 1H, J 4.9, 1.5, ArH); δC (100 MHz, CDCl3) 
17.6 (CH3), 123.6 (ArCH), 126.9 (ArCH), 127.3 (2 × ArCH), 128.5 (2 × ArCH), 131.0 
(ArCH), 138.7 (ArC), 141.0 (ArCH), 144.7 (ArCH), 147.4 (ArC), 167.3 (C=N); m/z (EI) 
196.0999 (85%, M
+
, C13H12N2 requires 196.1000), 181 (100), 119 (20), 78 (75). 
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4-Methoxy-N-(4-phenylbutan-2-ylidene)aniline 252 
N
Ph
OMe
 
Prepared according to general procedure B, purified by distillation (isolated as a 3.6:1 isomer 
mixture, 59%), yellow oil; vmax (thin film, cm
-1
) 3361, 3027, 1716, 1657, 1512, 1503; δH 
(400 MHz, CDCl3) 1.82 (s, 3H, CH3, major isomer), 2.22 (s, 3H, CH3, minor isomer), 2.47-
2.51 (m, 2H, CH2, minor isomer), 2.72-2.76 (m, 2H, CH2, major isomer), 2.79-2.83 (m, 2H, 
CH2, minor isomer), 3.02-3.06 (m, 2H, CH2, major isomer), 3.81 (s, 3H, OCH3, minor 
isomer), 3.82 (s, 3H, OCH3, major isomer), 6.51 - 6.55 (m, 2H, ArH, minor isomer), 6.62 - 
6.66 (m, 2H, ArH, major isomer), 6.81 - 6.84 (m, 2H, ArH, minor isomer), 6.85 - 6.89 (m, 
2H, ArH, major isomer), 7.05 - 7.07 (m, 2H, ArH, minor isomer), 7.19 - 7.35 (m, 5H, ArH, 
major isomer), 7.19 - 7.35 (m, 3H, ArH, minor isomer); δC (100 MHz, CDCl3) 19.9 (CH3, 
major isomer), 24.2 (CH3, minor isomer), 32.5 (CH2, major isomer), 33.0 (CH2, minor 
isomer), 35.7 (CH2, minor isomer), 43.0 (CH2, major isomer), 55.4 (OCH3, major isomer), 
55.4 (OCH3, minor isomer), 114.2 (2 × ArCH, minor), 114.3 (2 × ArCH, major), 120.4 (2 × 
ArCH, minor), 120.6 (2 × ArCH, major), 126.0 (ArCH, major), 126.3 (ArCH, minor), 128.2 
(ArCH, minor), 128.4 (2 × ArCH, major), 128.5 (2 × ArCH, major), 128.5 (2 × ArCH, 
minor),140.6 (ArC, minor), 141.6 (ArC, major), 144.2 (ArC, minor), 144.8 (ArC, major), 
155.7 (ArC, minor), 155.8 (ArC, major), 171.1 (C=N, major), 171.7 (C=N, minor); m/z 
(TOF ES+) 254.1557 (MH
+
 C17H20N requires 154.1545). 
N-[Cyclopropyl(phenyl)methylene]-4-methoxyaniline 251
83
 
Ph
N
MeO
 
Prepared according to general procedure B, purified by chromatograph on silica (the silica 
gel pre-treated overnight with 10% triethylamine in petroleum ether) and further purified by 
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distillation to give the yellow oil product as a 1.6:1 mixture of cis and trans imines (13%); 
δH (400 MHz, CDCl3) 0.58 - 0.62 (m, 2H, CH2, minor isomer), 0.82 - 0.87 (m, 2H, CH2, 
minor isomer), 0.98 - 1.03 (m, 2H, CH2, major isomer), 1.15 - 1.19 (m, 2H, CH2, major 
isomer), 1.86 - 1.93 (m, 2H, CH, minor isomer), 1.97 - 1.19 (m, 2H, CH2, major isomer), 
3.72 (s, 3H, OCH3, major isomer), 3.85 (s, 3H, OCH3, minor isomer), 6.54 [2H, (AX)2, ArH, 
major isomer], 6.66 [2H, (AX)2, ArH, major isomer], 6.93 [2H, (AX)2, ArH, minor isomer], 
6.96 [2H, (AX)2, ArH, minor isomer], 7.16 - 7.18 (m, 2H, ArH, major isomer), 7.23 - 7.25 
(m, 3H, ArH, major isomer), 7.41 - 7.43 (m, 3H, ArH, minor isomer), 7.75 - 7.77 (m, 2H, 
ArH, minor isomer); δC (100 MHz, CDCl3) 7.98 (2 × CH2, minor isomer), 9.37 (2 × CH2, 
major isomer),  13.9 (CH, minor isomer), 20.2 (CH, major isomer), 55.3 (OCH3, major 
isomer), 55.4 (OCH3, minor isomer), 113.8 (2 × ArCH, major), 114.0 (2 × ArCH, minor), 
121.6 (2 × ArCH, minor), 122.2 (2 × ArCH, major), 127.9 (2 × ArCH, minor),  127.97 (2 × 
ArCH, major), 128.03 (2 × ArCH, minor), 128.1 (2 × ArCH, major), 128.2 (ArCH, major), 
129.3 (ArCH, minor), 138.1 (ArC, major), 138.8 (ArC, minor), 144.0 (ArC, minor), 144.2 
(ArC, major), 155.4 (ArC, major), 156.0 (ArC, minor), 170.7 (C=N, minor), 172.6 (C=N, 
minor). Data was in accordance with the literature. 
4-Methoxy-N-(2,2,2-trifluoro-1-phenylethylidene)aniline 246
133
 
Ph CF3
N
MeO
 
Prepared according to general procedure C heated at 180 ºC for one hour, purified by 
chromatograph on silica gel (0%~3% diethyl ether in petroleum ether) to afford the product 
as light yellow oil (85%); δH (400 MHz, CDCl3) 3.77 (s, 3H, CH3), 6.72 - 6.78 (m, 4H, ArH), 
7.25 - 7.28 (m, 2H, ArH), 7.34 - 7.43 (m, 3H, ArH); δC (100 MHz, CDCl3) 55.2 (CH3), 114.0 
(2 × ArCH), 120.2 (q, J 278.7, CF3), 123.4 (2 × ArCH), 128.6 (2 × ArCH), 128.8 (2 × 
ArCH), 130.2 (ArCH), 130.7 (ArC), 139.7 (ArC), 155.4 (q, J 33.6, C=N), 157.9  (ArC); δF 
(235 MHz, CDCl3) -69.93. Data was in accordance with the literature. 
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4-Methoxy-N-(1,1,1-trifluoro-3-phenylpropan-2-ylidene)aniline 247 
CF3
N
MeO
Ph
 
Prepared according to general procedure C heated at 180 ºC for 5 mins, purified by 
chromatography on silica gel (0%~5% diethyl ether in petroleum ether) to afford the yellow 
oil product as a 1.5:1 mixture of imine and enamine (78%); vmax (thin film, cm
-1
) 3386, 2983, 
1731, 1514; δH (400 MHz, CDCl3) 3.74 (s, 3H, OCH3, enamine), 3.83 (s, 3H, OCH3, imine), 
3.91 (s, 2H, CH2, imine), 5.20 (s, br, 1H, NH, enamine), 6.67 [2H, (AX)2, ArH, enamine], 
6.72 (s, 1H, CH, enamine), 6.73 [2H, (AX)2, ArH, enamine], 6.86 [2H, (AX)2, ArH, imine], 
6.94 [2H, (AX)2, ArH, imine], 7.09 (d, 2H, J 6.84, ArH, imine), 7.23 - 7.34 (m, 3H, ArH, 
enamine), 7.23 - 7.34 (m, 3H, ArH, imine), 7.41 - 7.43 (m, 2H, ArH, enamine); δC (100 
MHz, CDCl3) 34.4 (CH2, imine), 55.4 (OCH3, imine), 55.5 (OCH3, enamine), 114.46 (CH), 
114.50 (CH), 117.5 (CH), 120.1 [q, J 4.0, enamine, CH=C(CF3)NH], 120.5 (CH), 122.7 (q, J 
234.8, CF3), 127.1 (CH), 128.3 (CH), 128.4 (CH), 128.7 (CH), 128.8 (CH), 129.5 (CH), 
133.0 (C), 134.1 (C), 135.4 (C), 140.3 (C), 154.1 (C), 157.5 (C), 158.2 (q, J 32.3, CCF3); δF 
(378 MHz, CDCl3) -69.9 (enamine), -70.3 (imine); m/z (TOF ES+) 294.1092 (MH
+
 
C16H15NOF3 requires 294.1106). 
4-Methoxy-N-(1,1,1-trifluoro-4-phenylbutan-2-ylidene)aniline 248 
CF3
N
MeO
Ph  
Prepared according to general procedure C heated at 180 ºC for 5 mins, purified by 
chromatography on silica gel (4%~9% diethyl ether in petroleum ether) to afford the yellow 
oil product as a single isomer (76%); vmax (thin film, cm
-1
) 3030, 2949,  1678, 1505; δH (400 
MHz, CDCl3) 2.77 - 2.82 (m, 2H, CH2), 2.85 - 2.91 (m, 2H, CH2), 3.86 (s, OCH3), 6.66 [2H, 
(AX)2, ArH], 6.93 [2H, (AX)2, ArH], 7.06-7.08 (m, 2H, ArH), 7.23 - 7.32 (m, 2H, ArH); δC 
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(100 MHz, CDCl3) 30.5 (CH2), 32.5 (CH2), 55.5 (OCH3), 114.4 (2 × ArCH), 121.5 (2 × 
ArCH), 122.1 (q, J 297.7, CF3), 126.7 (ArCH), 128.2 (2 × ArCH), 128.7 (2 × ArCH), 139.6 
(ArC), 140.5 (ArC), 157.2 (ArC), 159.9 (q, J 32.2, C=N); δF (235 MHz, CDCl3) -71.4; m/z 
(TOF ES+) 308.1258 (MH
+
 C17H17NOF3 requires 308.1262). 
N-(2,2-Dimethyl-1-phenylpropylidene)-4-methoxyaniline 249
83
 
Ph tBu
N
MeO
 
Prepared according to general procedure C heated at 180 ºC for one hour, purified by 
chromatograph on silica gel (0%~5% diethyl ether in petroleum ether) to afford the product 
as white solid (56%); m.p. 54-56 ºC (lit.
83
 53-54 ºC); δH (400 MHz, CDCl3) 1.29 [s, 9H, 
C(CH3)3], 3.68 (s, 3H, OCH3), 6.50 [2H, (AX)2, ArH], 6.60 [2H, (AX)2, ArH], 6.93 - 6.95 
(m, 2H, ArH), 7.14 - 7.22 (m, 2H, ArH); δC (100 MHz, CDCl3) 28.6 [C(CH3)3], 40.4 
[C(CH3)3], 55.2 (OCH3), 113.4 (2 × ArCH), 121.5 (2 × ArCH), 127.1 (ArCH), 127.4 (2 × 
ArCH), 128.0 (2 × ArCH), 137.5 (ArC), 144.6 (ArC), 155.2 (ArC), 180.1  (C=N). Data was 
in accordance with the literature. 
4-Methoxy-N-(2-methyl-1-phenylpropylidene)aniline 250
83
 
Ph
N
MeO
 
Prepared according to general procedure C heated at 180 ºC for 80 min, purified by 
chromatograph on silica gel (petroleum ether) and followed by distillation purification to 
afford the yellow oil product as a 6:1:1 mixture of two imine isomers and one enamine 
isomer (40%); δH (400 MHz, CDCl3) 1.19 [d, 6H, J 7.1, CH(CH3)2, minor imine isomer], 
1.24 [d, 6H, J 6.8, CH(CH3)2, major imine isomer], 1.84 (s, 3H, CH3, enamine isomer), 1.86 
(s, 3H, CH3, enamine isomer), 2.98 - 3.08 (m, 1H, CH, major imine isomer), 3.15 - 3.26 (m, 
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1H, CH, minor imine isomer), 3.71 (s, 3H, OCH3, major imine isomer), 3.73 (s, 3H, OCH3, 
minor imine isomer), 3.84 (s, 3H, OCH3, enamine isomer), 4.98 (s, br, 1H, NH, enamine 
isomer), 6.56 [2H, (AX)2, ArH, major imine isomer], 6.66 [2H, (AX)2, ArH, major imine 
isomer], 6.72 [2H, (AX)2, ArH, minor imine isomer], 6.78[2 H, (AX)2, ArH, enamine 
isomer], 6.93 [2H, (AX)2, ArH, enamine isomer], 7.02 - 7.04 (m, 2H, ArH, major imine 
isomer), 7.22 - 7.25 (m, 3H, ArH, major imine isomer), 7.28 - 7.32 (m, 3H, ArH, minor 
imine isomer), 7.36 - 7.39 (m, 2H, ArH, minor imine isomer), 7.42 - 7.44 (m, 3H, ArH, 
enamine isomer), 7.66 - 7.68 (m, 2H, ArH, major imine isomer); δC (100 MHz, CDCl3) 
major isomer: 20.2 [C(CH3)2], 38.6 (CH), 5.3 (OCH3), 113.7 (2 × ArCH), 122.0 (2 × ArCH), 
127.8 (ArCH), 127.86 (2 × ArCH), 127.90 (2 × ArCH), 138.3 (ArC), 144.3 (ArC), 155.5 
(ArC), 176.6 (C=N); other remaining observable signals: 21.0 [CH(CH3)2, minor imine 
isomer], 23.4 (CH3, enamine isomer), 28.0 (CH3, enamine isomer), 31.7 (CH, minor imine 
isomer), 55.5 (OCH3, minor imine isomer), 55.7 (OCH3, enamine isomer), 114.3 (ArCH), 
114.6 (ArCH), 115.8 (ArCH), 120.0 (ArCH), 122.7 (ArCH), 128.9 (ArCH), 127.0 (ArCH), 
129.4 (ArCH). Data was in general accordance with the literature – the enamine isomer was 
not assigned in literature 83. 
General procedure D: 
The procedure of preparations of imines 122, 123 and 130 was same with the procedure 
reported by Coindet et al.
82
 
2-Phenyl-1-pyrroline 141
134
 
N  
Prepared by general procedure D in a 22% yield as a white melting solid; δH (400 MHz, 
CDCl3) 1.97 - 2.06 (m, 2H, CH2), 2.90 - 2.95 (m, 2H, CH2), 4.04 - 4.09 (m, 2H, CH2), 7.37 - 
7.42 (m, 3H, ArH), 7.83 - 7.86 (m, 2H, ArH); δC (100 MHz, CDCl3) 22.7 (CH2), 34.9 (CH2), 
61.5 (CH2), 127.6 (2 × ArCH), 128.4 (2 × ArCH), 130.3 (ArCH), 134.6 (ArC), 173.2 (C=N). 
Data was in accordance with the literature. 
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2,3,4,5-Tetrahydro-6-phenylpyridine 142
134 
N Ph  
Prepared by general procedure D in a 20% yield as a light yellow oil; δH (250 MHz, CDCl3) 
1.65 - 1.74 (m, 2H, CH2), 1.81 - 1.91 (m, 2H, CH2), 2.62 - 2.69 (m, 2H, CH2), 3.82 - 3.89 
(m, 2H, CH2), 7.37 - 7.41 (m, 3H, ArCH), 7.76 - 7.80 (m, 2H, ArCH); δC (63 MHz, CDCl3) 
19.8 (CH2), 21.9 (CH2), 27.0 (CH2), 49.9 (CH2), 125.9 (2 × ArCH), 128.2 (2 × ArCH), 129.5 
(ArCH), 140.2 (ArC), 165.6 (C=N). Data was in accordance with the literature. 
5-Phenyl-3,4-dihydro-2H-1,4-oxazine 149 
N
H
O
Ph
 
Prepared by general procedure D in a 3% yield as a yellow solid, m.p. 54-56 ºC; δH (250 
MHz, CDCl3) 3.69 - 3.76 (m, NCH2), 4.35 (app. t, 2H, J 5.3, OCH2), 6.88 (br, s, 1H, NH), 
7.28 - 7.52 (m, 3H, ArH), 7.76 - 7.80 (m, 2H, ArH), 8.06 (s, 1H, C=CH); δC (100 MHz, 
CDCl3) 39.1 (NCH2), 62.8 (OCH2), 127.0 (2 × ArCH), 128.6 (2 × ArCH), 131.6 (ArCH), 
134.1 (ArC), 161.0 (NC=CHO), 167.8 (NC=CHO). Further analysis could not be performed 
due to quantity of available material. 
3-Phenyl-2H-benzo[b][1,4]oxazine 138
135
 
N
O
Ph  
A mixture of 2-hydroxyaniline (2.18 g, 20 mmol), 2-bromoacetophenone (3.98 g, 20 mmol) 
and K2CO3 (3.6 g, 26 mmol) in toluene (80 mL) was refluxed for 10 h. The reaction mixture 
was cooled to room temperature, and the solid was filtered. The filtrate was concentrated 
under reduced pressure, and the residue was purified by chromatography (petroleum 
ether/ethyl acetate, 50:1). Further purification by recrystallisation from petroleum and ether 
117 
 
afforded the product as colorless needle-like crystals (2.5g, 60% yield), m.p. 111-112 °C 
(lit.
135
 113 ºC from ethanol); δH (250 MHz, CDCl3) 5.10 (s, 2H), 6.94 (dd, 1H, J 7.9, 1.3, 
ArH), 7.05 (dt, 1H, J 7.5, 1.3, ArH), 7.18 (dt, 1H, J 7.5, 1.6, ArH), 7.45-7.54 (m, 4H, ArH), 
7.93-7.97 (m, 2H, ArH); δC (63 MHz, CDCl3) 62.9 (CH2), 115.6 (ArCH), 122.4 (ArCH), 
126.5 (2 × ArCH), 127.9 (ArCH), 128.7 (ArCH), 128.8 (2 × ArCH), 131.2 (ArCH), 133.9 
(ArC), 135.5 (ArC), 146.4 (ArC), 158.7 (C=N). Data was in accordance with the literature. 
2-(2-Methyl-1,3-dioxolan-2-yl)phenol
136
 
OH
OO
 
2′-Hydroxyacetophenone (6.12 g, 45 mmol), glycol (5.58 g, 90 mmol), p-TsOHH2O (100 
mg) and benzene (60 mL) were introduced into a single-necked round bottom flask (100 
mL). The mixture was heated at reflux under Dean-Stark conditions for 40 h. After the 
mixture was cooled to RT and the solvent was evaporated in vacuo. The residue was purified 
by recrystallisation from petroleum to afford the product (4.0g, 49 % yield) as white solid,  
m.p. 66-69 ºC (lit.
136
135 61.5-63.5 ºC); (Found: C 66.60, H 6.73; C10H12O3 requires C 66.65, 
H 6.71); vmax (thin film, cm
-1
) 3324, 2996, 2899, 1613, 1579, 1482; δH (250 MHz, CDCl3) 
1.71 (s, 3H, CH3), 3.83 - 3.97 (m, 2H, CH2), 4.06-4.20 (m, 2H, CH2), 6.85-6.92 (m, 2H, 
ArH), 7.19 - 7.26 (m, 1H, ArH), 7.32 (dd, 1H, J 7.9, 1.9, ArH); δC (63 MHz, CDCl3) 26.6 
(CH3), 64.4 (2  CH2), 110.0 (CCH3), 117.1 (ArCH), 120.0 (ArCH), 126.2 (ArC), 126.5 
(ArCH), 129.9 (ArCH), 154.4 (ArCOH); m/z (EI) 180 (M
+
, 50), 165 (68), 121 (100). Data 
was in accordance with the literature. 
2-Methyl-2-[2-(2-nitrophenoxy)phenyl]-1,3-dioxolane 
O
O2N
OO
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Sodium hydride (60 % dispersion in mineral oil, 788mg, 19.6 mmol) was added to a solution 
of 2-(2-methyl-1,3-dioxolan-2-yl)phenol (3.54 g, 19.6 mmol) in DMF (30 mL) at RT. The 
mixture was stirred for 20 min at RT and a precipitate formed. A solution of 2-
chloronitrobenzene (2.82 g, 17.8 mmol) in DMF (10 mL) was added at RT. The resulting 
mixture was stirred for 30 min at RT and for 20 h at 105 °C. After cooling to RT, water (50 
mL) was added and extracted with ethyl acetate (3  50 mL). The combined organic phases 
were dried over MgSO4 and filtered. The filtrate was concentrated and purified by 
chromatography (petroleum/ethyl acetate, 20:110:1) to afford the desired product (4.5 g, 
yield 84%) as white solid, mp 103-105 ºC; vmax (thin film, cm
-1
) 2936, 2890, 1610, 1578, 
1531; δH (250 MHz, CDCl3) 1.84 (s, 3H, CH3), 3.68 - 3.82 (m, 2H, CH2), 3.90-4.00 (m, 2H, 
CH2), 6.81 (dd, 1H, J 8.5, 1.3, ArH), 6.98 (dd, 1H, J 7.9, 1.3, ArH), 7.13 (ddd, 1H, J 8.2, 7.5, 
1.3, ArH), 7.22 (dt, 1H, J 7.5, 1.3, ArH), 7.35 (dt, 1H, J 7.5, 1.6, ArH), 7.45 (ddd, 1H, J 8.2, 
7.5, 1.6, ArH), 7.66 (dd, 1H, J 7.5, 1.6, ArH), 7.99 (dd, 1H, J 8.2, 1.6, ArH); δC (63 MHz, 
CDCl3) 25.9 (CH3), 64.5 (2  CH2), 108.0 (CCH3), 118.7 (ArCH), 121.6 (ArCH), 121.9 
(ArCH), 124.9 (ArCH), 125.7 (ArCH), 127.8 (ArCH), 129.9 (ArCH), 133.9 (ArCH), 134.8 
(ArC), 140.4 (ArC), 152.1 (ArC), 152.2 (ArC); m/z (EI) 301.0940 (<5%, M
+
, C16H15NO5 
requires 301.0950), 286 (100), 196 (33). 
2-Methyl-2-[2-(2-aminophenoxy)phenyl]-1,3-dioxolane 
O
H2N
OO
 
A solution of 2-methyl-2-[2-(2-nitrophenoxy)phenyl]-1,3-dioxolane (3.22 g, 13.3 mmol) in 
EtOAc (120 mL) was passed through a Pd/C Catcart on H-cube apparatus (30 bar H2, 40 °C). 
The solvent was evaporated under reduced pressure to afford the product as white solid (2.87 
g, 99%), m.p. 71-73 °C; (Found: C 70.54, H 6.30, N 5.08; C16H15NO5 requires C 70.83, H 
6.32, N 5.16); vmax (thin film, cm
-1
) 3456, 3354, 2983, 2886; 1622, 1501; δH (250 MHz, 
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CDCl3) 1.92 (s, 3H, CH3), 3.88 - 3.94 (m, 2H, 2 × CH2), 4.04 (br, s, 2H, NH2), 4.08 - 4.10 
(m, 2H, 2 × CH2), 6.71 - 6.78 (m, 1H, ArH), 6.82 - 6.85 (m, 2H, ArH), 6.94 - 7.06 (m, 3H, 
ArH), 7.21 (ddd, 1H, J 9.4, 7.5, 1.9, ArH), 7.59 (dd, 1H, J 7.5, 1.6, ArH); δC (63 MHz, 
CDCl3) 25.8 (CH3), 64.7 (2  CH2), 108.7 (CCH3), 116.4 (ArCH), 116. 5 (ArCH), 118.2 
(ArCH), 121.2 (ArCH), 122.0 (ArCH), 125.1 (ArCH), 126.9 (ArCH), 129.5 (ArCH), 131.5 
(ArC), 139.4 (ArC), 142.8 (ArC), 155.1 (ArC); m/z (EI) 271.1215 (55%, M
+
, C16H17NO3 
requires 271.1208), 210 (100), 209 (92). 
11-Methyldibenz[b,f][1,4]oxazepine 139 
O
N
 
The solution of 2-methyl-2-[2-(2-aminophenoxy)phenyl]-1,3-dioxolane (4.1 g, 15.1 mmol) 
and p-TsOHH2O (143 mg, 0.75 mmol) in toluene (60 mL) and water (1 mL) was stirred for 
4 h at 100 °C. The reaction mixture was cooled to room temperature, diluted with ethyl 
acetate (100 mL) and washed with brine (60 mL). The organic layer was dried over 
magnesium sulfate. After filtration, the solvent was evaporated to afford the crude product. 
Pure product (3.1 g, 98%) was obtained by recrystallisation from ethyl acetate and petroleum 
ether as a light yellow solid, m.p. 84-85 °C; vmax (thin film, cm
-1
) 3051, 1618, 1599, 1474, 
1440; δH (250 MHz, CDCl3) 2.67 (s, 3H, CH3), 7.16-7.33 (m, 6H, ArH), 7.42-7.49 (m, 2H, 
ArH); δC (63 MHz, CDCl3) 27.6 (CH3), 120.7 (ArCH), 120.8 (ArCH), 126.1 (ArCH), 125.6 
(ArCH), 127.2 (ArCH), 127.7 (ArCH), 128.5 (ArCH), 129.1 (ArC), 133.0 (ArCH), 140.7 
(ArC), 152.5 (ArC), 160.9 (ArC), 167.3 (C=N); m/z (EI) 209.0837 (100%, M
+
 C14H11NO 
requires 209.0841), 194 (15), 180 (54). 
N-(1-Phenylethylidene)methanamine 153
137
 
Ph Me
N
Me
 
120 
 
The mixture of acetophenone (2.4 g, 20 mmol), 4Å molecular sieves (4 g) and methylamine 
(33% wt in ethanol, 15 mL) was stirred for 48 h at room temperature. After filtration, the 
solvent was evaporated and the residue was purified by distillation (2.05 g, 77%, isomer 
ratio=16:1), colourless oil; δH (400 MHz, CDCl3, isomer ratio, 16:1) 2.27 (q, 3H, J 0.7, CH3, 
major), 2.32 (q, 3H, J 1.4, CH3, minor), 3.09 (q, 3H, J 1.4, NCH3, minor), 3.38 (q, 3H, J 
0.72, NCH3, major), 7.39 - 7.42 (m, 3H, ArH, major), 7.76 - 7.78 (m, 2H, ArH, major); δC 
(100 MHz, CDCl3, major isomer) 15.1 (CH3), 39.5 (CH3), 126.4 (2 × ArCH), 128.2 (2 × 
ArCH), 129.4 (ArCH), 141.2 (ArC), 167.0 (C=N). Data was in accordance with the 
literature. 
N-(1-Phenylethylidene)prop-2-yn-1-amine 154 
Ph Me
N
 
Prepared according to general procedure A and purified by distillation (45%, isomer ratio 
3:1) as a yellow oil; vmax (thin film, cm
-1
) 3293, 3058, 2219, 1683, 1631, 1447; δH (400 MHz, 
CDCl3, isomer ratio, 10:1) 2.30 (t, 1H, J 2.5, CCH, major), 2.35 (app. t, 3H, J 0.6, CH3, 
major), 2.39 (app. t, 4H, J 1.3, CCH and CH3, minor), 3.99-4.01 (m, 2H, NCH2, minor), 4.33 
(app. dd, 2H, J 2.5, 0.6, NCH2, major), 7.38 - 7.44 (m, 3H, ArH), 7.83 - 7.85 (m, 2H, ArH); 
δC (100 MHz, CDCl3) 16.4 (CH3, major), 29.6 (CH3, minor), 41.4 (CH2, major), 43.0 (CH2, 
minor), 71.3 (CCH, major), 71.5 (CCH, minor), 81.8 (CCH, major), 126.3 (2 × ArCH, 
minor), 127.2 (2 × ArCH, major), 128.7 (2 × ArCH, major), 129.2 (2 × ArCH, minor), 130.4 
(ArCH, major), 140.9 (ArC, major), 169.4 (C=N, major); m/z (EI) 157.0884 (70%,  M
+
, 
C11H11N requires 157.0891), 156 (100) 142 (96), 115 (52), 77 (50). 
3-Phenyl-N-(1-phenylethylidene)propan-1-amine 155 
Ph
N Ph
 
Prepared according to general procedure B and purified by distillation (17 %, isomer 
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ratio=15:1) as a brown oil; vmax (thin film, cm
-1
) 3024, 2934, 2858, 1634; 1495, 1446; δH 
(400 MHz, CDCl3, major isomer) 2.14-2.21 (m, 2H, CH2), 2.25 (s, 3H, CH3), 2.87 (t, 2H, J 
7.4, CH2), 3.55 (t, 2H, J 6.8, CH2), 7.15 - 7.46 (m, 8H, ArCH), 7.85 - 7.87 (m, 2H, ArCH); 
δC (63 MHz, CDCl3, major isomer) 15.6 (CH3), 32.5 (CH2), 33.8 (CH2), 51.4 (CH2), 125.8 
(ArCH), 126.6 (2 × ArCH), 128.3 (2 × ArCH), 128.4 (2 × ArCH), 128.6 (2 × ArCH), 129.4 
(ArCH), 141.5 (ArC), 143.4 (ArC), 165.2 (C=N); δH (400 MHz, CDCl3, selected signals of 
minor isomer): 2.36 (s, 3H, CH3), 2.66 (t, 2H, J 7.8, CH2), 3.32 (t, 2H, J 7.1, CH2); δC (63 
MHz, CDCl3, minor isomer)  29.2 (CH3, minor), 32.7 (CH2, minor), 33.7 (CH2, minor), 52.8 
(CH2, minor); m/z (EI) 237.1522 (5%, M
+
, C17H19N, requires 237.1517), 132 (100), 91 (86), 
77 (26). 
N-(2,3-Dihydro-1H-inden-1-ylidene)prop-2-yn-1-amine 156 
N
 
Prepared according to general procedure A and purified by recrystallization from 
ether/petroleum (47 %), obtained as a single isomer of an off-white solid, m.p. 82-83 ºC; vmax 
(thin film, cm
-1) 3266, 3220, 2924, 1652, 1604; δH (250 MHz, CDCl3) 2.30 (t, 1H, J 2.5, 
CCH), 2.80 - 2.82 (m, 2H, CH2), 3.11 - 3.16 (m, 2H, CH2), 4.28 (app. 2H, J 2.5, 1.3, NCH2), 
7.28 - 7.46 (m, 3H, ArH), 7.88 (d, 1H, J 7.6, ArH); δC (63 MHz, CDCl3) 28.1 (CH), 28.2 
(CH2), 42.1 (CH2), 70.9 (CCH), 81.3 (CCH), 122.6 (ArCH), 125.6 (ArCH), 127.0 (ArCH), 
131.6 (ArCH), 139.3 (ArC), 149.9 (ArC), 177.7 (C=N); m/z (EI) 169.0886 (83%, M
+
, 
C12H11N, requires 169.0891),  168 (100), 115 (52), 77 (30). 
2-Cyclopropyl-1-phenyl-ethanone
138
 
 
Magnesium (1.92g, 80 mmol), catalytic amount iodine and diethyl ether (30 mL) was placed 
into a oven-dried 2-necked flask under N2 atmosphere. Bromobenzene (12.56 g, 80 mmol) in 
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diethyl ether (60 mL) was added dropwise at a rate to keep the reaction mixture at gently 
reflux. After addition was complete, the reaction mixture was heated at reflux for another 30 
mins. A solution of cyclopropylacetonitrile (6.4 g, 79 mmol) in diethyl ether (60 mL) was 
added dropwise. At the end of addition, a precipitate was formed and after addition complete, 
the mixture was heated at reflux for another 1 h. The reaction mixture was allowed to stand 
at room temperature overnight. The ice-cooled reaction mixture was decomposed carefully 
by a mixture of water (40 mL) and conc. HCl (25 mL). The ether was removed by rotary 
evaporation. The aqueous phase was heated for 1 h to ensure hydrolysis of ketimine. This 
was extracted with diethyl ether (3  60mL), and the combined ether layers were washed 
with brine (50 mL) and dried over magnesium sulfate. After filtration, the filtrate was 
concentrated and the residue was purified by chromatography (petroleum ether/ethyl acetate, 
20:1) to give the ketone as light oil (8.85 g, 70% yield). δH (400 MHz, CDCl3) 0.20 - 0.23 (m, 
2H, CH2), 0.60 - 0.65 (m, 2H, CH2), 1.14-1.24 (m, 1H, CH), 2.91 (d, 2H, J 6.8, CH2), 7.46 - 
7.51 (m, 2H, ArCH), 7.56 - 7.60 (m, 1H, ArCH), 7.96 - 7.99 (m, 2H, ArCH); δC (100 MHz, 
CDCl3) 4.6 (CH2), 6.7 (CH), 43.8 (CH2), 128.1 (2 × ArCH), 128.5 (2 ×ArCH), 132.9 (ArCH), 
137.0 (ArC), 200.0 (C=O). Data was in accordance with the literature. 
N-(2-Cyclopropyl-1-phenylethylidene)-3-phenylpropan-1-amine 157 
N Ph
 
Prepared according to general procedure A and purified by distillation under reduced 
pressure as a yellow oil (25%); vmax (thin film, cm
-1
) 3025, 2936, 1686, 1631, 1495, 1453; δH 
(250 MHz, CDCl3, isomer ratio 2:1) 0.08 - 0.16 (m, 2H, CH2), 0.36 - 0.49 (m, 2H, CH2), 
0.74 - 0.88 (m, 1H, CH), 1.87 - 1.99 (m, 2H, CH2, minor), 2.05 - 2.17 (m, 2H, CH2, major), 
2.48 (d, 2H, J 6.9, o-PrCH2, minor), (d, 2H, J 6.6, o-PrCH2, major), 2.62 (app. t, 2H, J 7.9, 
CH2, minor), 2.82 (app. t, 2H, J 7.7, CH2, major), 3.25 (t, 2H, J 6.9, CH2, minor), 3.57 (t, 2H, 
J 6.9, CH2, major), 7.10 - 7.43 (m, 13H, ArH, major and minor), 7.77 - 7.81 (m, 2H, ArH, 
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major); δC (63 MHz, CDCl3) 4.6 (CH2, minor), 5.2 (CH2, major), 8.6 (CH, minor), 8.7 (CH, 
major), 32.8 (CH2), 33.7 (CH2, minor), 38.8 (CH2, major), 47.2 (CH2), 51.1 (CH2), 52.5 
(CH2), 125.7 (ArCH), 126.5 (ArCH), 127.1 (ArCH), 127.9 (ArCH), 128.3 (ArCH), 128.5 
(ArCH), 128.6 (ArCH), 129.2 (ArCH), 139.0 (ArC), 141.1 (ArC), 142.4 (2 × ArC), 168.5 
(C=N, major), 172.2 (C=N, minor); m/z (EI) 277.1821 (4%, M
+
 C20H23N requires 277.1830), 
222 (45), 105 (100), 91 (75), 77 (68). 
N-[1-(3,4-Dimethoxyphenyl)propan-2-ylidene]prop-2-yn-1-amine 158 
NMeO
MeO  
Prepared according to general procedure A and purified by distillation (100 %, isomer ratio 
= 5:1) as a brown oil; vmax (thin film, cm
-1
) 2936, 2835, 1708; 1655, 1516; δH (400 MHz, 
CDCl3) 1.86 (s, 3H, CH3), 2.18 (s, 3H, CH3, minor), 2.02 (t, 1H, J 1.2, CCH, minor), 2.27 (t, 
1H, J 2.7, CCH), 3.56 (s, 2H, CH2), 3.88 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 4.09-4.10 (m, 
2H, NCH2), 4.22-4.23 (m, 2H, NCH2, minor), 6.72-6.87 (m, 3H, ArH); δC (100 MHz, CDCl3) 
16.8 (CH3, major), 27.3 (CH3, minor), 38.0 (CH2, minor), 40.3 (CH2, major), 48.9 (CH2, 
major), 50.5 (CH2, minor), 55.8 (OCH3, major), 70.6 (CCH, major), 81.3 (CCH, major), 
111.2 (ArCH, major), 112.0 (ArCH, major), 121.2 (ArCH, major), 129.4 (ArC, major), 147.9 
(ArC, major), 149.0 (ArC, major), 172.3 (C=N, minor), 173.1 (C=N, major); m.z (EI) 
231.1257 (15%, M
+
, C14H17NO2, requires 231.1259), 194 (40), 151 (100). 
3-Phenyl-N-(1-naphthylethylidene)propan-1-amine 159 
Me
N Ph
 
Prepared according to general procedure B and purified by distillation (47 %, isomer ratio = 
3:1) to give a yellow sticky oil; vmax (thin film, cm
-1
) 3024, 2934, 2858, 1634; 1495, 1446; δH 
(400 MHz, CDCl3) 1.89 - 1.97 (m, 2H, CH2, major), 2.18 - 2.26 (m, 2H, CH2, minor), 2.33 (s, 
3H, CH3, minor), 2.46 (s, 3H, CH3, major), 2.57 (t, 2H, J 7.9, CH2, major), 2.88 (t, 2H, J 7.7, 
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CH2, minor), 3.03 - 3.17 (m, 2H, CH2, major), 3.63 (t, 2H, J 7.0, CH2, minor), 7.10-8.09 (m, 
12H, ArCH); δC (63 MHz, CDCl3) 29.6 (CH3, major), 31.3 (CH3, minor), 32.4 (CH2, minor), 
32.6 (CH2, major), 33.8 (CH2, major), 34.1 (CH2, minor), 51.8 (CH2, minor), 53.3 (CH2, 
major), 123.1 (ArCH), 124.7 (ArCH), 124.9 (ArCH), 125.4 (ArCH), 125.5 (ArCH), 125.7 
(ArCH), 125.9 (ArCH), 126.4  (ArCH), 126.9 (ArCH), 128.2 (ArCH), 128.3 (ArCH), 128.7 
(ArCH), 128.8 (ArCH), 133.6 (ArC, major), 134.1 (ArC, minor), 138.3 (ArC, major), 141.6 
(ArC, minor), 142.3 (ArC, major), 168.3 (C=N, minor), 168.8 (C=N, major); m/z (EI) 
287.1686 (45%, M
+
, C21H21N, requires 287.1674), 272 (25), 182 (100), 127 (60). 
Benzyl tricyclo[3.3.1.13,7]decane-1-oxoacetate 
OH
O
O
OBn
 
The mixture of hydroxyadamantane keto-acid (6.72 g, 30 mmol), benzyl bromide (5.64 g, 33 
mmol), KI (150 mg) and K2CO3 (4.55 g, 33 mmol) in acetone (100 mL) was heated at reflux 
for 24 h. The solvent was evaporated, the residue dissolved in water (50 mL) and extracted 
with diethyl ether (3  50 mL). The combined organic phases were washed with brine (50 
mL) and dried over magnesium sulfate. Filtration and concentration afforded the crude 
product (5.0 g, 53%) as a light yellow solid, which was used directly without further 
purification. An analytically pure sample was obtained after purification by chromatography 
column on silica gel as white solid, mp 52-54 ºC; (Found: C 72.60, H 6.95; C19H22O4 
requires C 72.59, H 7.05); vmax (thin film, cm
-1
) 3385, 2921, 1734, 1711, 1455; δH (400 MHz, 
CDCl3) 1.60 (s, 2H), 1.66 - 1.85 (m, 11H), 1.97 (s, br, 1H, OH), 2.29 (s, 2H), 5.38 (s, 2H, 
OCH2Ph), 7.37 - 7.40 (m, 5H, ArH); δC (100 MHz, CDCl3) 30.0 (CH), 34.8 (CH2), 36.1 
(CH2), 44.2 (CH2), 44.5 (CH2), 48.4 (CH2), 67.3 (OCH2Ph), 68.1 (COH), 128.6 (2 × ArCH), 
128.7 (ArCH), 128.8 (2 × ArCH), 134.5 (ArC), 163.5 (CO), 199.6 (COOBn); m/z (ES) 
337.1404 (MNa
+
 C19H22O4Na requires 337.1416), 251 (100). 
3,3-Dimethyl-2-oxobutanoic Acid
139
 
125 
 
O
O
OH
 
Preparation by the same procedure reported in the literature,
139
 gave a light yellow oil (75% 
yield); δH (400 MHz, CDCl3) 1.36 (s, 9H); Data was in accordance with the literature. 
Benzyl 3,3-dimethyl-2-oxobutanoate 
O
O
O Ph
 
The mixture of keto-acid (5.0 g, 38 mmol), benzyl bromide (6.6 g, 38 mmol) and K2CO3 (5.8 
g, 42 mmol) in acetone (80 mL) was refluxed for 48 h. The solid was filtered off and the 
filtrate was concentrated under reduced pressure to give the crude product (5.0 g, 60%) as a 
colorless oil, which was used directly for next step without further purification; δH (400 MHz, 
CDCl3) 1.25 [s, 9H, C(CH3)3], 5.30 (s, 2H, CH2), 7.36-7.40 (m, 5H, ArH). 
Benzyl tricyclo[3.3.1.13,7]decane-1-(4-methoxyphenylimino)acetate 167 
OH
N
O
OBn
OMe  
Prepared by general procedure B and purified by chromatography on silica gel (29%) to 
provide colorless crystals (isomer ratio, 9:1); m.p. 82-85 ºC; (Found: C 74.42, H 6.87, N 
3.21; C26H29O4 requires C 74.44, H 6.97, N 3.34); vmax (thin film, cm
-1
) 3376, 2911, 2854, 
1727, 1643, 1503; δH (400 MHz, CDCl3, major isomer) 1.63 (t, 2H J 2.7Hz, 2 × CH2), 1.70 - 
1.90 (m, 12H, 12 × CH2), 2.32 (s, 2H, 2 × CH2), 3.79 (s, 3H, OCH3), 4.98 (s, 2H, OCH2), 
6.74 - 6.77 (m, 4H, ArH), 7.01 - 7.03 (m, 2H, ArH), 7.25 - 7.12 (m, 3H, ArH); δH (400 MHz, 
CDCl3, selected peaks for minor isomer) 5.30 (s, 2H, OCH2), 6.82 [2 H, (AX)2, ArH], 6.94 
[2 H, (AX)2, ArH]; δC (100 MHz, CDCl3, major isomer) 30.0 (CH), 35.0 (CH2), 38.2 (CH2), 
43.8 (CH2), 44.3 (CH2), 46.8 (CH2), 55.3 (OCH3), 66.6 (OCH2), 68.6 (COH), 114.0 (2 × 
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ArCH), 120.8 (2 × ArCH), 128.3 (ArCH), 128.4 (ArCH), 128.6 (ArCH), 134.6 (ArC), 143.0 
(ArC), 156.7 (ArC), 165.1 (CO), 169.7 (COOBn); m/z (EI) 419 (M
+
, 56), 284 (100). 
Benzyl 2-(4-methoxyphenylimino)-3,3-dimethylbutanoate 169 
N
O
O Ph
OMe
 
Prepared by general procedure B and purified by chromatography on silica gel (petroleum 
ether/ethyl acetate, 50:120:1) and further by recrystallisation from petroleum ether and 
diethyl ether to afford the product as a white solid (82%, isomer ratio, 11.5: 1); m.p. 53-55 
ºC; (Found: C 73.91, H 7.16, N 4.20; C20H23NO3 requires C 73.82, H 7.12, N 4.30); v (thin 
film, cm
-1
) 2951, 1730, 1641, 1501; δH (400 MHz, CDCl3, isomer ratio, 11.5:1) 1.25 [s, 9H, 
C(CH3)3, minor)], 1.30 [s, 9H, C(CH3)3, major)], 3.79 (s, 3H, OCH3, major), 3.81 (s, 3H, 
OCH3, minor), 4.98 (s, 2H, OCH2Ph, major), 5.30 (s, 3H, OCH2Ph, minor), 6.73 - 6.78 (m, 
4H, ArH), 7.02 - 7.05 (m, 2H, ArH), 7.25 - 7.31 (m, 3H, ArH); m/z (EI) 325 (M
+
, 50%), 192 
(98), 130 (100). 
N-(3,3-Dimethylbutan-2-ylidene)-4-methoxybenzenamine 171
83
 
N
O
 
Prepared according to general procedure A, purified by distillation to give the product as a 
yellow oil (24%); δH (250 MHz, CDCl3) 1.24 [s, 9H, C(CH3)], 1.78 (s, 3H, CH3), 3.80 (s, 
3H, OCH3), 6.59 - 6.62 (m, 2H, ArCH), 6.84 - 6.89 (m, 2H, ArCH);
 δC (63 MHz, CDCl3) 
15.1 (CH3), 27.9 [C(CH3)], 40.2 [C(CH3)], 55.4 (OCH3), 114.2 (2 × ArCH), 120.1 (2 × 
ArCH), 145.5 (ArC), 155.5 (ArC), 177.8 (C=N). Data was in accordance with the literature. 
1-(1-Phenylvinyl)piperidine 271
140
 
127 
 
N
Ph  
The reactions were carried out under argon. A three-necked flask containing a magnetic 
stirrer was charged with anhydrous pentane (150 mL), acetophenone (3 g, 24.9 mmol) and 
piperidine (6.38 g, 74.9 mmol). The mixture was stirred at r.t. for 1 h, then was cooled to 
0 °C, TiCl4 (2.37 g, 12.5 mmol) was added dropwise over 5 min. The mixture was stirred for 
1 h, then allowed to warm to r.t. and stirred for another 5 h. After filtration, the filtrate was 
concentrated and the residue was purified by distillation to afford the desired product as light 
yellow oil (1 g, 21%); δH (250 MHz, CDCl3) 1.55 - 1.70 (m, 6H, 6 × CH2), 2.82-2.86 (m, 4H, 
4 × CH2), 4.19 (s, 1H, 1 × C=CH2), 4.29 (s, 1H, 1 × C=CH2), 7.31-7.40 (m, 3H, ArH), 7.48 - 
7.53  (m, 2H, ArH); δC (63 MHz, CDCl3) 24.6 (CH2), 26.0 (2 × CH2), 50.5 (2 × CH2), 90.1 
(C=CH2), 127.7 (ArCH), 127.8 (ArCH), 128.1 (ArCH), 140.4 (ArC), 158.1 (C=CH2). Data 
was in accordance with the literature. 
7.4 Asymmetric reduction of imines 
General procedure E 
Imine (1 mmol), catalyst and dry CH2Cl2 (0.5 mL or 1mL) were introduced into an oven-
dried 25 mL two-necked flask or an oven-dried carousel tube. The mixture was stirred until 
complete dissolution, then cooled to 0 ºC and trichlorosilane (2 mmol, 0.2 mL) was added by 
syringe over five to ten seconds. The reaction was left to stir for the desired time. 
Hydrochloric acid (1 M, ca. 2 mL) was added, which led to gas evolution and precipitation, 
followed by CH2Cl2 (20 mL) and aqueous sodium hydroxide (1 M, 20 mL). This mixture 
was stirred until the precipitate was completely dissolved. The organic phases were 
separated and the aqueous phase was extracted with CH2Cl2 (2  20mL). The combined 
organic phases were washed with brine (20mL) and dried over MgSO4. Filtration and 
concentration gave the product that could be purified by chromatography column on silica 
gel using 2%  10% solution of diethyl ether or ethyl acetate in petroleum ether. Racemic 
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samples of compound were obtained by this procedure, using N-formylpyrrolidine (10%) as 
catalyst.  
(S)-N-(1-Phenylethyl)-aniline 131
79
 
Ph
HN
Ph
 
Prepared according to general procedure E (96%, 85% ee) as a yellow oil; []D +16 (85% ee 
from HPLC, c 1.0 in MeOH, lit.
79
 []D
 
+13.9, c 1.0 in MeOH，86% ee); δH (250 MHz, 
CDCl3) 1.55 (d, 3H, J 6.6, CH3), 4.05 (br, 1H, NH), 4.51 (q, 1H, J 6.6, CH), 6.51 - 6.55 (m, 
2H, ArH), 6.63 - 6.70 (m, 1H, ArH), 7.08 - 7.14 (m, 2H, ArH), 7.21 - 7.42 (m, 5H, ArH), C 
(CDCl3, 63MHz) 25.1 (CH3), 53.5 (NCH), 113.4 (2 × ArCH), 117.4 (ArCH), 126.0 (2 × 
ArCH), 127.0 (ArCH), 128.8 (2 × ArCH), 129.2 (2 × ArCH), 145.4 (ArC), 147.4 (ArC); 
Enantiomeric excess was determined by chiral phase HPLC (Kromasil 3-Cellucoat OD-H), 5% 
ipa in hexane @ 1 mL min
-1
, tR = 5.0 min (major), 5.9 min (minor). Data was in accordance 
with the literature. 
(S)-4-Methoxy-N-(1-phenylethyl)aniline 132
79
 
Ph
HN
OMe
 
Prepared according to general procedure E (100%, 90% ee) as a brown oil; []D -2.65 (88% 
ee from HPLC, c 3.4 in CHCl3, Lit.
79
 []D -5.6, c 0.54 in CHCl3, 87% ee); δH (400 MHz, 
CDCl3) 1.52 (d, 3H, J 6.8, CH3), 3.72 (s, 3H, OCH3), 3.81 (br, 1H, NH), 4.43 (q, 1H, J 6.8, 
NCH), 6.49 [2H, (AX)2, ArH], 6.71 [2H, (AX)2, ArH], 7.23 - 7.40 (m, 5H, ArH); C (CDCl3, 
100 MHz) 25.2 (CH3), 54.3 (NCH), 55.8 (CH3O), 114.6 (2 × ArCH), 114.8 (2 × ArCH), 
125.9 (2 × ArCH), 126.9 (ArCH), 128.6 (2 × ArCH), 141.6 (ArC), 145.5 (ArC), 151.9 (ArC); 
Enantiomeric excess was determined by chiral phase HPLC (Phenomenex Lux 3 µm 
Cellulose-1) 2 % ipa in hexane @ 1 mL min
-1
, tR= 16.5 min (minor), 19.2 min (major). Data 
was in accordance with the literature. 
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(S)-4-Methyl-N-(1-phenylethyl)aniline 133
62a
 
Ph
HN
Me
 
Prepared according to general procedure E (100 %, 87% ee) as a yellow solid, mp 75-76 °C 
(lit.
141
 70 °C); []D
 
+31.6 (87% ee from HPLC, c 1.25 in ethyl acetate, lit.
62a
 []D +27.3, c 
0.7 in ethyl acetate, 91% ee); δH (400 MHz, CDCl3) 1.54 (d, 3H, J 6.6, CH3), 2.22 (s, 3H, 
ArCH3), 3.95 (s, br, 1H, NH), 4.49 (q, 1H, J 6.6, NCH), 6.47 [2H, (AX)2, ArH], 6.94 [2H, 
(AX)2, ArH], 7.24 - 7.42 (m, 5H, ArH); C (100 MHz, CDCl3) 20.5 (ArCH3), 25.2 (CH3), 
53.8 (NCH), 111.5 (2 × ArCH), 126.0 (2 × ArCH), 126.4 (ArC), 126.9 (ArCH), 128.7 (2 × 
ArCH), 129.7 (2 × ArCH), 145.1 (ArC), 145.6 (ArC); Enantiomeric excess was determined 
by chiral phase HPLC (Kromasil 3-Cellucoat OD-H), 1% ipa in hexane @ 1 mL min
-1
, tR = 
7.2 min (minor), 8.0 min (major). Data was in accordance with the literature. 
(S)-4-Fluoro-N-(1-phenylethyl)aniline 134
130 
Ph
HN
F
 
Prepared according to general procedure E (95%, 88% ee) as a yellow oil; []D +23.8 (88% 
ee from HPLC, c 1.05 in CHCl3, lit.
130
 []D -16.8, c 1.0 CHCl3, 84% ee R isomer); δH (400 
MHz, CDCl3) 1.53 (d, 3H, J 6.6, CH3), 3.95 (br, 1H, NH), 4.44 (q, 1H, J 6.6, CH), 6.43 - 
6.47 (m, 2H, ArH), 6.79 - 6.84 (m, 2H, ArH), 7.23 - 7.28 (m, 1H, ArH), 7.32 - 7.38 (m, 4H, 
ArH); C (100 MHz, CDCl3) 25.1 (CH3), 54.1 (CH), 114.1 (d, 
3
JC-F 6.9, 2 × ArCH), 115.5 (d, 
2
JC-F 22.2, 2 × ArCH), 125.9 (2 × ArCH), 127.0 (ArCH), 128.8 (2 × ArCH), 143.7 (ArC), 
145.1 (ArC), 155.5 (
1
JC-F 234.6, ArCF); F (235 MHz, CDCl3) -128.4; Enantiomeric excess 
was determined by chiral phase HPLC (Kromasil 3-Cellucoat OD-H), 2% ipa in hexane @ 1 
mL min
-1
, tR = 6.9 min (minor), 7.8 min (major). Data was in accordance with the literature. 
(S)-2-Methoxy-N-(1-phenylethyl)aniline 135
62a 
130 
 
Ph
HN
MeO
 
Prepared according to general procedure E (35%, 95% ee) as a white solid, mp 78-80 ºC (not 
reported in literature); []D +78.3 (95% ee from HPLC, c 0.6 in ethyl acetate, lit.
62a
 +76.4, c 
0.5 in ethyl acetate 88% ee); δH (400 MHz, CDCl3) 1.57 (d, 3H, J 6.8, CH3), 3.91 (s, 3H, 
OCH3), 4.49 (q, 1H, J 6.8, NCH), 4.68 (br, 1H, NH), 6.36 (dd, 1H, J 7.6, 1.6, ArH), 6.63 (dt, 
1H, J 7.6, 1.9, ArH), 6.70 (dt, 1H, J 7.5, 1.6, ArH), 6.77 (dd, 1H, J 7.8, 1.9, ArH), 7.20 - 
7.41 (m, 5H, ArH); C (CDCl3, 100 MHz) 25.3(CH3), 54.3 (NCH), 55.5(CH3O), 109.4 
(ArCH), 111.2 (ArCH), 116.4 (ArCH), 121.3 (ArCH), 126.0 (2 × ArCH), 126.9 (ArCH), 
128.7 (2 × ArCH), 137.3 (ArC), 145.6 (ArC), 1146.7 (ArC); Enantiomeric excess was 
determined by chiral phase HPLC (Kromasil 3-Cellucoat OD-H), 0.2% ipa in hexane @ 1 
mL min
-1
, tR = 7.5 min (major), 10.6 min (minor). Data was in accordance with the literature. 
(S)-2-Methyl-N-(1-phenylethyl)aniline 136
142
 
Ph
HN
Me
 
Prepared according to general procedure E (64%, 97% ee) as a white solid, mp 42-44 ºC (not 
reported in literature); []D
 
+60.8 (97% ee from HPLC, c 1.09 in CHCl3, lit.
142
 []D +14, c 
0.5 in CHCl3, 16% ee); δH (400 MHz, CDCl3) 1.59 (d, 3H, J 6.7, CH3), 2.26 (s, 3H, ArCH3), 
3.88 (s, br, 1H, NH), 4.56 (q, 1H, J 6.7, NCH), 6.39 (d, 1H, J 8.1, ArH), 6.33 (t, 1H, J 7.2, 
ArH), 6.98 (t, 1H, J 7.7, ArH), 7.01 (d, 1H, J 7.2, ArH), 7.25 (t, 1H, J 7.1, ArH), 7.33 - 7.40 
(m, 4H, ArH); C (100MHz, CDCl3) 17.7(ArCH3), 25.1 (CH3), 53.4 (NCH), 111.1 (ArCH), 
116.9 (ArCH), 121.6 (ArC), 125.9 (2 × ArCH), 126.9 (ArCH), 127.1 (ArCH), 128.7 (2 × 
ArCH), 130.1 (ArCH), 145.2 (ArC), 145.4 (ArC); Enantiomeric excess was determined by 
chiral phase HPLC (Kromasil 3-Cellucoat OD-H), 3% ipa in hexane @ 1 mL min
-1
, tR = 4.1 
min (major), 7.0 min (minor). Data was in accordance with the literature. 
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(S)-N-(1-Phenylethyl)pyridin-3-amine 137
143
 
Ph
HN
N
 
Prepared according to the general procedure E (44%, 60% ee) as a white solid; m.p. 88-90 
ºC (not reported in literature); []D +0.9 (c 1.05 in CHCl3, 60% ee from HPLC, not reported 
in literature); δH (400 MHz, CDCl3) 1.55 (d, 3H, J 6.6, CH3), 4.33 (s, br, 1H, NH), 4.49 (q, 
1H, J 6.6, CH), 6.72 (ddd, 1H, J 8.3, 2.7, 1.2, ArCH), 6.97 (dd, 1H, J 8.3, 1.2, ArCH), 7.23 - 
7.38 (m, 5H, ArCH), 7.91 (d, 1H, J 4.2, ArCH), 8.02 (d, 1H, J 2.2, ArCH); δC (100 MHz, 
CDCl3) 24.9 (CH3), 53.3 (CH), 119.0 (ArCH), 123.6 (ArCH), 125.8 (ArCH), 127.2 (ArCH), 
128.8 (2 × ArCH), 136.6 (ArCH), 138.5 (2 × ArCH), 143.3 (ArC), 144.3 (ArC); 
Enantiomeric excess was determined by chiral phase HPLC (Phenomenex Lux 3 um 
Cellulose-1), 8% ipa in hexane @ 1 mL min
-1
, tR = 21.4 min (major), 48.3 min (minor). Data 
was in accordance with the literature. 
(S)-10, 11-Dihydro-11-methyl-dibenz[b, f]oxazepine 143 
O
NH
Me
 
Prepared according to general procedure E (86% conversion, 99% ee) as a yellow oil; []D = 
-21 (c 1.05 in MeOH, 99% ee from HPLC); (Found: C 79.50; H 6.15; N 6.70; C14H13NO 
requires C 79.59; H 6.20; N 6.63); vmax (thin film, cm
-1
) 3386, 3058, 2970, 1609, 1494; δH 
(400 MHz, CDCl3) 1.66 (d, 3H, J 6.7, CH3), 3.25 (s, br, 1H, NH), 5.10 (q, 1H, J 6.7, NCH), 
6.60 (dd, 1H, J 7.8, 1.6, ArH), 6.71 (ddd, 1H, J 8.4, 7.2, 5.6, ArH), 6.88 (dt, 1H, J 8.4, 1.5, 
ArH), 7.10-7.31 (m, 5H, ArH); δC (100 MHz, CDCl3) 20.0 (CH3), 50.5 (NCH), 119.1 
(ArCH), 120.0 (ArCH), 120.9 (ArCH), 121.8 (ArCH), 124.5 (ArCH), 124.6 (ArCH), 125.7 
(ArCH), 128.9 (ArCH), 134.4 (ArC), 137.0 (ArC), 145.0 (ArC), 157.3 (ArC); m/z (EI) 
211.1006 (45%, M
+
 C14H13NO requires 211.0997), 196(100); Enantiomeric excess was 
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determined by chiral phase HPLC (Kromasil 3-cellucoat OD-H), 1% ipa in hexane @ 1 
mLmin
-1
, tR = 12.6 min (minor), 13.4 min (major). 
(R)-t-Butyl 2-hydroxy-1-phenylethylcarbamate
144
 
OH
NH
O
O
 
A solution of (Boc)2O (2.4 g, 11 mmol) in THF (5mL) was added dropwise to a solution of 
triethylamine (1.1 g, 11 mmol) and (R)-2-phenylglycinol (1.37 g, 10 mmol) in THF (15 mL) 
at 0 C. The reaction mixture was stirred at room temperature overnight. Diethyl ether (40 
mL) was added and the resulting mixture was washed by brine (2 × 30 mL). The organic 
layer was dried over MgSO4, filtrated and evaporated to afford the desired product as a white 
solid (2.0 g, 84 % yield), m.p. 136-137 ºC (lit.
144
 136-137 ºC); []D -40 (c 1.0 in CHCl3, 
lit.
144
 +38.7, c 1.0 in CHCl3, S isomer); δH (CDCl3, 400 MHz) 1.46 [s, 9H, C(CH3)3], 1.87 
(br, 1H, OH), 3.87 (d, 2H, J 4.4, OCH2), 4.80 (br s, 1H), 5.25 (br s, 1H), 7.28 - 7.40 (m, 5H, 
ArCH). Data was in accordance with the literature. 
(R)-t-Butyl 2-(2-iodophenoxy)-1-phenylethylcarbamate 
NH
O
O
O I
 
(R)-t-Butyl 2-hydroxy-1-phenylethylcarbamate (1.64 g, 6.91 mmol), 2-iodophenol (1.52 g, 
6.91mmol) and PPh3 (2.35 g, 8.98 mmol) were introduced into a 2-necked flask. The flask 
was evacuated and backfilled with N2 three times. Dried THF (60mL) was added by syringe. 
The mixture was cooled to 0 °C and DIAD (1.8 mL, 8.98 mmol) was added dropwise. The 
resulting mixture was stirred at RT for 36 h. The solvent was removed under reduced 
pressure and the residue was purified by flash chromatography on silica gel (petroleum ether 
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/ ethyl acetate, 20 : 1 to 10 : 1) to afford the desired product as a white solid (1.85 g, 61 % 
yield), m.p. 109-110 ºC (from petroleum ether / diethyl ether); []D -36.6 (c 0.9 in CHCl3). 
(Found: C 52.13; H 4.89, N 2.88; C19H22INO3 requires C 51.95; H 5.05; N 3.19); vmax (thin 
film, cm
-1
) 3426, 3351, 2931, 1712, 1448; δH (400 MHz, CDCl3) 1.46 [s, 9H, C(CH3)3], 4.19 
- 4.25 (m, 1H, 1 × OCH2), 4.29 (dd, 1H, J 9.1, 4.4, 1 × OCH2), 5.13 (br, s, 1H), 5.61 (br, s, 
1H), 6.72 - 6.79 (m, 2H, ArCH), 7.26 - 7.33 (m, 2H, ArCH), 7.36 - 7.41 (m, 2H, ArCH), 
7.51 (d, 2H, J 7.3, ArCH), 7.77 (dd, 1H, J 7.8, 1.4, ArCH);
 δC (100 MHz, CDCl3) 28.4 
[C(CH3)3], 53.8 (NCH), 72.1 (OCH2), 79.8 [C(CH3)3], 86.7 (ArCI), 112.3 (ArCH), 123.1 
(ArCH), 127.1 (2 × ArCH), 127.7 (ArCH), 128.6 (2 × ArCH), 129.5 (ArCH), 139.4 (ArCH), 
139.7 (ArC), 155.3 (ArC), 156.8 (CO); m/z (EI) 440 (3%, MH
+
), 439 (10, M
+
), 150 (100). 
(R)-2-(2-Iodophenoxy)-1-phenylethanamine 
O
INH2
 
Trifluoroacetic acid (2.54 g, 22 mmol) was added dropwise to an ice-cooled solution of (R)-
t-butyl 2-(2-iodophenoxy)-1-phenylethylcarbamate (1.63 g, 3.7 mmol) in DCM (10 mL). 
The mixture was stirred at room temperature for 12 h, then neutralized with 1 N aqueous 
NaOH and the aqueous phase was exacted with dichloromethane (3 × 30 mL). The combined 
organic phases were dried over MgSO4, the solvent was removed under reduced pressure 
and the residue was purified by chromatography on silica gel (petroleum ether / ethyl acetate, 
5:1~1:1) to afford the title compound as a colourless oil (1.2 g, 96 % yield); []D -63 (c 1 in 
CHCl3); (Found: C 49.22; H 3.97; N 3.90; C14H14INO requires C 49.58; H 4.16; N 4.13); 
vmax (thin film, cm
-1
) 3381, 3049, 2923, 2854, 1579, 1472; δH (400 MHz, CDCl3) 2.09 (s, br, 
2H, NH2), 3.96 (t, 1H, J 8.8, CHNH2), 4.18 (dd, 1H, J 8.8, 3.4, 1 × CH2O), 4.54 (dd, 1H, J 
8.8, 3.4, 1 × CH2O), 6.72 - 6.80 (m, 2H, ArH), 7.26 - 7.36 (m, 2H, ArH), 7.38 - 7.43 (m, 2H, 
ArH), 7.51 - 7.54 (m, 2H, ArH), 7.79 (dd, 1H, J 7.5, 1.5, ArH); δC (100 MHz, CDCl3) 55.2 
(NH2CH), 75.2 (OCH2), 86.7 (ArCI), 112.3 (ArCH), 122.8 (ArCH), 127.1 (2 × ArCH), 
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127.8 (ArCH), 128.6 (2 × ArCH), 129.5 (ArCH), 139.4 (ArCH), 141.5 (ArC), 157.1 (ArC); 
m/z (EI) 339 (3%, M
+
), 212 (3), 106 (100). 
(R)-3-Phenyl-3,4-dihydro-2H-1,4-benzoxazine 143
145
 
N
H
O
Ph
 
(R)-2-(2-Iodophenoxy)-1-phenylethanamine (169.5 mg, 0.5 mmol), BINAP (31 mg, 
0.05mmol), Pd2(dba)3 (14.4 mg, 0.025mmol) and t-BuONa (62.4 mg, 0.65 mmol) were 
introduced into a 2-necked flask, which was evacuated and refilled with nitrogen three times. 
Dry toluene (5 mL) was added and the resulting mixture was stirred at 95 °C for 16 h. After 
cooling to room temperature, AcOEt (10 mL) and saturated aqueous NH4Cl (20 mL) were 
added. The organic layer was separated and the aqueous layer was extracted with EtOAc (2 
× 20 mL). The combined organic layers were washed with brine (30 mL), and dried over 
MgSO4. The solvent was removed under reduced pressure and the residue was purified by 
chromatography on silica gel (petroleum ether/ethyl acetate, 30:1) to afford the title 
compound as a yellow oil (95 mg, 90 % yield); []D -140 (c 0.95 in CHCl3, lit.
145
 -118.1, c 
1.0 in CHCl3 , 98% ee R isomer); δH (400 MHz, CDCl3) 4.10 (dd, 1H, J 8.8, 10.8, 1 × OCH2), 
4.34 (dd, 1H, J 3.0, 10.8, 1 × OCH2), 4.55 (dd, 1H, J 8.8, 3.0, NCH), 6.71 - 6.91 (m, 4H, 
ArCH), 7.37 - 7.48 (m, 5H, ArCH); δC (100MHz, CDCl3) 54.3 (NCH), 71.0 (OCH2), 115.5 
(ArCH), 116.7 (ArCH), 119.1 (ArCH), 121.6 (ArCH), 127.2 (2 × ArCH), 128.4 (ArCH), 
128.9 (2 × ArCH), 133.9 (ArC), 139.2 (ArC), 143.6 (ArC). Data was in accordance with the 
literature. 
(S)-128 was prepared according to general procedure E (26% conversion, 21% ee); 
Enantiomeric excess was determined by chiral phase HPLC (Kromasil 3-cellucoat OD-H), 
5% ipa in hexane @ 1 mLmin
-1
, tR = 10.7 min (minor), 14.8 min (major). 
(S)-2-Phenylpyrrolidine 145
146
 
135 
 
N
H
Ph
 
Prepared according to the general procedure E (27%, 89% ee); yellow oil; []D  -31.6 (89% 
ee from GC, c 0.95 in MeOH, lit.
147
 -22, c 1.0 in MeOH, >98% ee); δH (250 MHz, CDCl3) 
1.62 - 2.03 (m, 3H, 3 × CH2), 2.14 - 2.27 (m, 1H, 1 × CH2), 2.56 (s, 1H, NH), 2.96 - 3.06 (m, 
1H, 1 × CH2), 3.16 - 3.26 (m, 1H, 1 × CH2), 4.12 (t, 1H, J 7.6, NCH), 7.21 - 7.41 (m, 5H, 
ArH); δC (63 MHz, CDCl3) 25.6 (CH2), 34.3 (CH2), 46.9 (NCH2), 62.6 (NCH), 126.6 (2 × 
ArCH), 126.8 (ArCH), 128.4 (2 × ArCH), 144.6 (ArC); Enantiomeric excess was determined 
by GC analysis of its trifluoromethyl-acetyl derivative on Astec Chiraldex B-DM at 140 ºC, 
tR = 8.35 min (major), 8.91 min (minor). Data was in accordance with the literature.  
The sample for GC analysis was prepared as below:  
Trifluoromethyl acetic anhydride (0.2 mL) was added into a solution of amine 145 (20 mg) 
and triethylamine (0.2 mL) in dichloromethane (3 mL) at room temperature and then stirring 
for 1 hour. The volatile material was evaporated under reduced pressure and the residue was 
directed used for GC analysis. 
(S)-2-Phenylpiperidine 146
148
 
N
H
Ph
 
Prepared according to general procedure E (53%, 73% ee); light yellow oil; []D -41 (89% 
ee from GC, c 0.5 in CHCl3, lit.
148
 -63.8, c 0.5 in CHCl3); δH (250 MHz, CDCl3) 1.46 - 1.93 
(m, 6H, 3 × CH2), 2.13 (br, s, 1H, NH), 2.81 (td, 1H, J 11.5, 3.1, 1 × NCH2), 3.21 (app. dq, 
1H, 11.5, 1.2, 1 × NCH2), 3.61 (app. dd, 1H, J 10.5, 2.5, NCH), 7.22 - 7.41 (m, 5H, ArH); δC 
(63 MHz, CDCl3) 25.4 (CH2), 25.8 (CH2), 34.9 (CH2), 47.8 (NCH2), 62.3 (NCH), 126.7 (2 × 
ArCH), 127.1 (ArCH), 128.4 (2 × ArCH), 145.3 (ArC); Enantiomeric excess was determined 
by GC analysis of its trifluoromethyl-acetyl derivative on Astec Chiraldex B-DM at 130 ºC, 
tR = 16.3 min (major), 17.3 min (minor). Data was in accordance with the literature. 
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The sample for GC analysis was prepared as below:  
Trifluoromethyl acetic anhydride (0.2 mL) was added into a solution of amine 146 (20 mg) 
and triethylamine (0.2 mL) in dichloromethane (3 mL) at room temperature and then stirring 
for 1 hour. The volatile material was evaporated under reduced pressure and the residue was 
directed used for GC analysis. 
N-(2-Hydroxyethyl)benzamide 150
149
 
N
H
O
OH
N
H
O
Ph CH2Cl2, 0 °C, 4h
117 (5 mol%)
 
Prepared according to the general procedure E as a white solid (66%); δH (400 MHz, CDCl3) 
3.03 (t, 1H, J 4.9, CH2OH), 3.62-3.66 (m, 2H, NCH2), 3.85 (q, 2H, J 4.9, CH2OH), 6.81 (br, 
s, 1H, NH), 7.41-7.46 (m, 2H, ArH), 7.50-7.54 (m, 1H, ArH), 7.78-7.81 (m, 2H, ArH); δC 
(100 MHz, CDCl3) 42.8 (NCH2), 62.0 (OCH2), 127.0 (2 × ArCH), 128.6 (2 × ArCH), 131.7 
(ArCH), 134.1 (ArC), 168.7 (CO); Data was in accordance with the literature. 
(S)-N-Methyl-1-phenylethanamine 160
150
 
Ph Me
HN
Me
 
Prepared according to general procedure E (89%, 77% ee) as colourless oil; []D -64.7 (77% 
ee from GC, c 1.05 in CHCl3, lit.
150 
[]D +77.7, c 1.0 CHCl3, pure R isomer); δH (250 MHz, 
CDCl3) 1.38 (d, 3H, J 6.6, CH3), 2.33 (s, 3H, NCH3), 3.66 (q, 1H, J 6.6, NCH), 7.22 - 7.39 
(m, 5H, ArH); Enantiomeric excess was determined by GC analysis of its trifluoromethyl-
acetyl derivative on Astec Chiraldex B-DM at 100 ºC, tR = 15.4 min (major), 16.3 min 
(minor). Data was in accordance with the literature. 
The sample for GC analysis was prepared as below:  
Trifluoromethyl acetic anhydride (0.2 mL) was added into a solution of amine 160 (20 mg) 
and triethylamine (0.2 mL) in dichloromethane (3 mL) at room temperature and then stirring 
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for 1 hour. The volatile material was evaporated under reduced pressure and the residue was 
directed used for GC analysis. 
(S)-N-2-Propyn-1-yl- phenylethanamine 161
151
 
Ph Me
HN
 
Prepared according to general procedure E (60%, 90% ee) as colourless oil; []D -161 (c 1.0 
in CHCl3, 90% ee from HPLC, lit.
151
 +169.6, c 0.1 CHCl3, R isomer ); δH (400 MHz, CDCl3) 
1.39 (d, 3H, J 6.2, CH3), 2.24 (t, 1H, J 2.4, CCH), 3.18 (dd, 1H, J 17.1, 2.4, 1 × CH2), 3.38 
(dd, 1H, J 17.1, 2.4, 1 × CH2), 3.99 (q, 1H, J 6.2, CH), 7.25 - 7.30 (m, 1H, ArCH), 7.33 - 
7.38 (m, 4H, ArCH); δC (100 MHz, CDCl3) 24.6 (CH3), 36.3 (CH2), 56.7 (NCH), 71.7 
(CCH), 82.7 (CCH), 127.3 (2 × ArCH), 127.6 (ArCH), 128.9 (2 × ArCH), 144.8 (ArC); 
Enantiomeric excess was determined by chiral phase HPLC (Phenomenex Lux 3 um 
Cellulose-1), 1% ipa in hexane @ 1 mL min
-1
 ( 210nm), tR = 6.2 min (major), 6.6 min 
(minor). Data was in accordance with the literature. 
(S)-N-(3-Phenylpropyl)-1-phenylethylamine 162
152
 
Ph
HN Ph
 
Prepared according to general procedure E as colourless oil; []D -41 (c 1.0 in CHCl3, 80% 
ee from HPLC, []D not reported in literature); δH (250 MHz, CDCl3) 1.30 (s, br, 1H, NH), 
1.37 (d, 3H, J 6.6, CH3), 1.75 - 1.87 (m, 2H, CH2), 2.45 - 2.74 (m, 4H, 4 × CH2), 3.77 (q, 
3H, J 6.6, CH3), 7.16 - 7.39 (m, 10H, ArCH); δC (63 MHz, CDCl3) 24.4 (CH3), 32.0 (CH2), 
33.8 (CH2), 47.4 (NCH2), 58.4 (NCH), 125.8 (ArCH), 126.6 (ArCH), 126.9 (ArCH), 128.4 
(3 × ArCH), 128.5 (2 × ArCH), 142.3 (ArC), 146.0 (ArC); Enantiomeric excess was 
determined by chiral phase HPLC (Phenomenex Lux 3 um Cellulose-1), 1% ipa in hexane @ 
1 mL min
-1
 ( 210nm), tR = 9.0 min (minor), 9.7 min (major). Data was in accordance with 
the literature. 
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(S)-Indan-1-yl-prop-2-ynyl-amine 163
153
 
NH
 
Prepared according to general procedure E as yellow oil (44%, 88% ee); []D -20.6 (c 1.7 in 
CHCl3, 88% ee from HPLC, lit.
153
 []D +18.8, c 1.7 CHCl3, R isomer); δH (400 MHz, 
CDCl3) 1.86 - 1.94 (m, 1H, CH2), 2.30 (t, 1H, J 2.5, CCH), 2.39 - 2.48 (m, 1H, 1 × CH2), 
2.82 - 2.90 (m, 1H, 1 × CH2), 3.04 - 3.11 (m, 1H, 1 × CH2), 3.56 (t, 2H, J 2.5, NCH2), 4.45 
(t, 1H, J 6.4, NCH), 7.21 - 7.30 (m, 3H, ArH), 7.37 - 7.39 (m, 1H, ArH); δC (100 MHz, 
CDCl3) 30.5 (CH2), 33.4 (CH2), 36.2 (CH2), 61.9 (NCH), 71.4 (CCH), 82.5 (CCH), 124.2 
(ArCH), 124.9 (ArCH), 126.3 (ArCH), 127.7 (ArCH), 143.8 (ArC), 144.6 (ArC); 
Enantiomeric excess was determined by chiral phase HPLC (Phenomenex Lux 3 um 
Cellulose-1), 1% ipa in hexane @ 1 mL min
-1
 ( 214nm), tR = 21.4 min (major), 48.3 min 
(minor). Data was in accordance with the literature. 
(S)-N-(2-Cyclopropyl-1-phenylethyl)-3-phenylpropan-1-amine 164 
Ph
HN Ph
 
Prepared according to general procedure E as colourless oil (68%, 57% ee); []D -14 (c 1.5 
CHCl3, 57% ee from HPLC); vmax (thin film, cm
-1
) 3062, 3025, 2921, 1603, 1495, 1454; δH 
(250 MHz, CDCl3) 0.06 - 0.15 (m, 2H, 2 × CH2), 0.30 - 0.62 (m, 2H, 2 × CH2), 1.39 - 1.50 
(m, 2H, 2 × CH2), 1.63 - 1.86 (m, 3H, 3 × CH2), 2.48 - 2.73 (m, 4H, 4 × CH2), 3.70 (t, 1H, J 
6.9, NCH), 7.15 - 7.34 (m, 10H, ArH); δC (63 MHz, CDCl3) 4.3 (CH2), 4.8 (CH2), 8.4 (CH), 
32.0 (CH2), 33.7 (CH2), 43.7 (CH2), 47.3 (CH2), 64.1 (NCH), 125.8 (ArCH), 126.9 (ArCH), 
127.3 (2 × ArCH), 128.4 (4 × ArCH), 128.5 (2 × ArCH), 142.4 (ArC), 144.9 (ArC); m/z 
(ES+) 280.2064 (MH
+
, C20H26N requires 280.2065); Enantiomeric excess was determined by 
chiral phase HPLC (Phenomenex Lux 3 um Cellulose-1), 1% ipa in hexane @ 1 mL min
-1
 ( 
214nm), tR = 6.6 min (major), 7.7 min (minor). Data was in accordance with the literature. 
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(S)-N-(1-(3,4-dimethoxyphenyl)propan-2-yl)prop-2-yn-1-amine 165 
H
NMeO
MeO  
Prepared according to general procedure E as colourless oil (77%, 53% ee); []D -3.2 (c 1.9 
in CHCl3, 53% ee from HPLC); vmax (thin film, cm
-1
) 3285, 2961, 2932, 1607, 1516, 1464; 
δH (250 MHz, CDCl3) 1.09 (d, 3H, J 7.0, CH3), 2.18 (t, 1H, J 2.4, CCH), 2.56 - 2.71 (m, 2H, 
CH2), 3.09 - 3.22 (m, 1H, NCH), 3.40 (dd, 1H, J 17.3, 2.5, NCH2C), 3.49 (dd, 1H, J 17.3, 
2.5, NCH2), 3.88 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 6.74 - 6.84 (m, 3H, ArH); δC (63 MHz, 
CDCl3) 19.6 (CH3), 35.5 (CH2), 48.1 (CH2), 52.4 (OCH3), 55.8 (OCH3), 71.2 (CCH), 82.0 
(CCH2), 111.3 (ArCH), 112.4 (ArCH), 121.2 (ArCH), 131.5 (ArC), 147.5 (ArC), 148.9 
(ArC); m/z (ES+) 234.1483 (MH
+
, C14H20NO2 requires 234.1494); Enantiomeric excess was 
determined by chiral phase HPLC (Phenomenex Lux 3 um Cellulose-1), 5% ipa in hexane @ 
0.8 mL min
-1
 ( 214nm), tR = 22.1 min (major), 25.6 min (minor). 
(S)-N-[1-(naphthalen-1-yl)ethyl]-3-phenylpropan-1-amine 166
152
 
H
N Ph
 
Prepared according to general procedure E as colourless oil (40%, 50% ee); []D +17.5 (c 
1.2 CHCl3, 50% ee from HPLC); δH (250 MHz, CDCl3) 1.52 (d, 3H, J 6.6, CH3), 1.82 - 1.93 
(m, 2H, CH2), 2.58 - 2.77 (m, 2H, 2  CH2), 4.65 (q, 1H, J 6.6, NCH), 7.17 - 7.32 (m, 5H, 
ArH), 7.47 - 7.58 (m, 3H, ArH), 7.68 (app. dd, 1H, J 6.9, 0.9, ArH), 7.78 (d, 1H, J 8.2, ArH), 
7.89 - 7.92 (m, 1H, ArH), 8.20 - 8.24 (m, 1H, ArH) ; δC (63 MHz, CDCl3) 23.8 (CH3), 32.2 
(CH2), 33.8 (CH2), 47.7 (CH2), 53.8 (NCH), 122.8 (ArCH), 123.1 (ArCH), 125.4 (ArCH), 
125.9 (2 × ArCH), 127.3 (ArCH), 128.4 (2 × ArCH), 128.5 (ArCH), 129.1 (ArCH), 131.5 
(ArC), 134.1 (ArC), 141.5 (ArC), 142.3 (ArC); Enantiomeric excess was determined by 
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chiral phase HPLC (Phenomenex Lux 3 um Cellulose-1), 1% ipa in hexane @ 1 mL min
-1
 ( 
214nm), tR = 12.5 min (major), 13.4 min (minor). Data was in accordance with the literature. 
Benzyl tricyclo[3.3.1.13,7]decane-1-(4-methoxyphenylamino)acetate 168 
OH
HN
O
OBn
OMe  
Prepared according to general procedure E (23%, 0% ee) as a yellow oil; vmax (thin film, cm
-1
) 
2909, 2852, 1728, 1513; δH (400MHz, CDCl3) 1.46 - 1.78 (m, 13H), 2.24 (s, 2H), 3.70 (s, 1H, 
NH), 3.76 (s, 3H, OCH3), 5.13 (s, 2H, OCH2), 6.64 [2H, (AX)2, ArCH], 6.76 [2H, (AX)2, 
ArCH], 7.26 - 7.30 (m, 2H, ArH), 7.33 - 7.35 (m, 3H, ArH); δC (100 MHz, CDCl3) 30.4 (2 × 
CH), 35.3 (CH2), 37.7 (CH2), 37.8 (CH2), 39.8 (CH2), 44.5 (CH2), 44.6 (CH2), 46.7 (CH2), 
55.7 (OCH3), 66.5 (OCH2), 67.4 (NCH), 68.7 (COH), 114.8 (2 × ArCH), 115.9 (2 × ArCH), 
128.4 (ArCH), 128.5 (4 × ArCH), 135.5 (ArC), 141.6 (ArC), 153.0 (ArC), 172.9 (CO); m/z 
(EI) 421.2236 (M
+
 C26H31NO4 requires 421.2253), 286 (100); Enantiomeric excess was 
determined by chiral phase HPLC (Phenomenex Lux 3 um Cellulose-1), 10% ipa in hexane 
@ 1 mL min
-1
, tR = 27.4 min, 30.7 min. 
Benzyl 2-(4-methoxyphenylamino)-3,3-dimethylbutanoate 170 
HN
O
O Ph
OMe
 
Prepared according to general procedure E (21%, 0% ee) as a white solid, mp 62-64 °C; 
(Found: C 73.35, H 7.74, N 4.26; C20H25NO3 requires C 73.37, H 7.70, N 4.28); vmax (thin 
film, cm
-1
) 3390, 2951, 1725, 1510; δ (400 MHz, CDCl3) 1.07 [s, 9H, C(CH3)3], 3.75 (s, 1H, 
NH), 3.76 (s, br, 1H, NCH), 3.77 (s, 3H, OCH3), 5.11 (s, 2H, OCH2Ph), 6.65 [2H, (AX)2, 
ArCH], 6.76 [2H, (AX)2, ArCH], 7.26 - 7.35 (m, 5H, ArH); δC (100 MHz, CDCl3) 26.8 
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[C(CH3)3], 34.4 [C(CH3)3], 55.7 (OCH3), 66.5 (OCH2Ph), 67.2 (NCH), 114.9 (2 × ArCH), 
115.8 (2 × ArCH), 128.3 (ArCH), 128.4 (2 × ArCH), 128.5 (2 × ArCH) 135.6 (ArC), 141.7 
(ArC), 152.9 (ArC), 173.7(CO); m/z (EI) 327 (M
+
, 56), 270 (55), 192 (75), 91 (100); 
Enantiomeric excess was determined by chiral phase HPLC (Phenomenex Lux 3 um 
Cellulose-1), 2% ipa in hexane @ 1 mL min
-1
, tR = 10.8 min, 13.4 min. 
(S)-N-(3,3-dimethylbutan-2-yl)-4-methoxyaniline 172 
HN
OMe
 
Prepared according to general procedure E (74%) as colorless oil; []D +18.4 (33% ee from 
HPLC, c 1.3 in CHCl3); max (thin film, cm
-1
) 3390, 2951, 1510; δH (400 MHz, CDCl3) 1.00 
[s, 9H, C(CH3)], 1.11 (d, 3H, J 6.4, CH3), 3.15 (q, 1H, J 6.4, NCH), 3.78 (s, 3H, OCH3), 6.61 
[2H, (AX)2, ArCH], 6.81 [2H, (AX)2, ArCH]; δC (100 MHz, CDCl3) 15.8 (CH3), 16.6 
[(C(CH3)], 34.7 [(C(CH3)], 55.9 (OCH3), 58.7 (NCH), 114.6 (2 × ArCH), 115.0 (2 × ArCH), 
142.9 (ArC), 151.6 (ArC); m/z (EI) 207.1621 (M
+
, C13H21NO requires 207.1623), 192 (8), 
150 (100); Enantiomeric excess was determined by chiral phase HPLC (Phenomenex Lux 3 
um Cellulose-1), 2% ipa in hexane @ 1 mL min
-1
, tR = 4.5 min (minor), 5.2 min (major). 
(R)-4-Methoxy-N-(2-methyl-1-phenylpropyl)aniline 253
83
 
HN
PMP
 
Prepared according to general procedure E as yellow oil (85% yield, 69% ee); []D +18.5 (c 
1.08 in CHCl3, 69% ee; lit.
83
 -22, c 1.0 in CHCl3, 97% ee for S isomer); δH (400 MHz, 
CDCl3) 0.93 (d, 3H, J 6.8, CH3), 1.00 (d, 3H, J 6.8, CH3), 2.00 - 2.08 (m, 1H, CH), 3.70 (s, 
3H, OCH3), 3.89 (br, s, 1H, NH), 4.07 (d, 1H, J 5.6, CH), 6.48 [(AX)2, 2H, ArH], 6.70 
[(AX)2, 2H, ArH], 7.21 - 7.25 (m, 1H, ArH), 7.27 - 7.32 (m, 4H, ArH); δC (100 MHz, 
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CDCl3) 18.7 (CH3), 19.8 (CH3), 35.0 (CH), 55.8 (OCH3), 64.7 (CH), 114.4 (2 × ArCH), 
114.8 (2 × ArCH), 126.8 (2 × ArCH), 127.3 (ArCH), 128.2 (2 × ArCH), 142.1 (ArC), 142.8 
(ArC), 151.7 (ArC); Enantiomeric excess was determined by chiral phase HPLC (Chiralpak 
IA) 1 % ipa in hexane @ 1 mL min
-1
, tR = 8.6 min (major), 9.4 min (minor). Data was in 
accordance with the literature. 
(S)-N-(Cyclopropyl(phenyl)methyl)-4-methoxyaniline 254
83
 
HN
PMP
 
Prepared according to general procedure E as yellow oil (98% yield, 36% ee); []D +24 (c 
1.9 in CHCl3, 36% ee; lit.
83
 +66, c 1.0 in CHCl3, 95% ee); δH (400 MHz, CDCl3) 0.38 - 0.44 
(m, 1H, 1 × CH2), 0.47 - 0.53 (m, 1H, 1 × CH2), 0.54 - 0.59 (m, 1H, 1 × CH2), 0.61 - 0.68 (m, 
1H, 1 × CH2), 1.16 - 1.25 (m, 1H, 1 × CH2), 3.59 (d, J 8.4, 1H, NCH), 3.71 (s, 3H, OCH3), 
4.15 (s, br, 1H, NH), 6.46 [(AX)2, 2H, ArH], 6.70 [(AX)2, 2H, ArH], 7.26 - 7.29 (m, 1H, 
ArH), 7.36 (app. t. 2H, J 7.6, ArH), 7.44 (app. d, 2H, J 7.7, ArH); δC (100 MHz, CDCl3) 
3.49 (CH2), 4.25 (CH2), 19.9 (CH), 55.8 (OCH3), 63.9 (CH), 114.6 (2 × ArCH), 114.7 (2 × 
ArCH), 126.5 (2 × ArCH), 127.0 (ArCH), 128.5 (2 × ArCH), 142.0 (ArC), 143.6 (ArC), 
151.9 (ArC); Enantiomeric excess was determined by chiral phase HPLC (Phenomenex Lux 
3 um Cellulose-1) 1 % ipa in hexane @ 1 mL min
-1
, tR = 12.4 min (minor), 17.1 min (major). 
Data was in accordance with the literature. 
(±)1-(1-Phenylethyl)piperidine 272
154
 
N
Ph  
Prepared according to general procedure E as colourless oil (49% yield, 0% ee); δH (400 
MHz, CDCl3) 1.37 - 1.43 (m, 2H, 2 × CH2), 1.39 (d, 3H, J 6.8, CH3), 1.54 - 1.60 (m, 4H, 4 × 
CH2), 2.31 - 2.45 (m, 4H, 4 × CH2), 3.41 (q, 1H, J 6.8, NCH), 7.23-7.33 (m, 5H, ArH); δC 
(100 MHz, CDCl3) 19.4 (CH3) , 24.6 (CH2), 26.3 (2 × CH2), 51.5 (2 × CH2), 65.2 (NCH), 
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126.7 (ArCH), 127.8 (2 × ArCH), 128.0 (2 × ArCH), 144.0 (ArC); Enantiomeric excess was 
determined by GC analysis on Astec Chiraldex B-DM at 140 ºC, tR = 43.2 min, 45.3 min. 
Data was in accordance with the literature. 
7.5 Asymmetric reduction of -enamino esters 
General procedure F for the synthesis of -enamino esters 
A mixture of -ketoester (10 mmol), amine (1.1~1.3 eq.) and p-TsOH (0.1 mmol) in ethanol 
was heated at reflux for overnight. The mixture was then cooled to room temperature and the 
solvent was evaporated under reduced pressure. The residue was purified by 
chromatography on silica gel to give the -enamino ester. 
(Z)-Ethyl 3-phenyl-3-(phenylamino)acrylate 183
155
 
NH
OEt
O
 
Obtained by general procedure F as a white solid (34%); m.p. 72-74 ºC (lit.
155
 65-66 C); δH 
(250 MHz, CDCl3) 1.34 (t, 3H, J 7.2, CH3), 4.22 (q, 2H, J 7.2, OCH2), 5.01 (s, 1H, CH), 
6.65 - 6.70 (m, 2H, ArH), 6.89 - 6.96 (m, 1H, ArH), 7.07 - 7.13 (m, 2H, ArH), 7.26 - 7.38 
(m, 5H, ArH), 10.32 (s, br, 1H, NH); δC (63 MHz, CDCl3) 14.6 (CH3), 59.3 (OCH2), 91.3 
(CH), 122.2 (2 × ArCH), 123.0 (2 × ArCH), 128.3 (2 × ArCH), 128.4 (2 × ArCH), 128.6 
(ArCH), 129.4 (ArCH), 136.1 (ArC), 140.1(ArC), 159.1 (C=CH), 170.1 (CO). Data was in 
accordance with the literature. 
(Z)-Ethyl 3-(4-methoxyphenylamino)-3-phenylacrylate 184
67
 
NH
OEt
O
MeO
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Obtained by general procedure F as a yellow solid (60%); m.p. 102-105 ºC (lit.
67
 96-98 ºC); 
δH (250 MHz, CDCl3) 1.33 (t, 3H, J 7.1, CH3), 3.72 (s, 3H, OCH3), 4.22 (q, 2H, J 7.1, 
OCH2), 4.95 (s, 1H, CH), 6.65 (s, 4H, ArH), 7.24 - 7.37 (m, 5H, ArH), 10.25 (s, br, 1H, 
NH); δC (63 MHz, CDCl3) 14.6 (CH3), 55.3 (OCH3), 59.2 (OCH2), 89.6 (CH), 113.9 (2 × 
ArCH), 124.3 (2 × ArCH), 128.3 (2 × ArCH), 128.4 (2 × ArCH), 129.2 (ArCH), 133.6 
(ArC), 136.1 (ArC), 155.9 (ArC), 159.9 (C=CH), 170.3 (CO). Data was in accordance with 
the literature. 
(Z)-Ethyl 3-phenyl-3-(p-tolylamino)acrylate 185 
NH
OEt
O
Me
 
Obtained by general procedure F as a white solid (53% yield); m.p. 72-74 ºC; (Found C 
76.71, H 6.77, N 4.87; requires C18H19NO2 C 76.84, H 6.81, N 4.98); max (thin film, cm
-1
) 
3259, 2979, 1657, 1598; δH (400 MHz, CDCl3) 1.34 (t, 3H, J 7.1, CH3), 2.23 (s, 3H, CH3), 
4.23 (q, 2H, J 7.1, OCH2), 4.98 (s, 1H, CH), 6.59 [(AX)2, 2H, ArH], 6.90 [(AX)2, 2H, ArH], 
7.28 - 7.38 (m, 5H, ArH), 10.28 (s, br, 1H, NH); δC (100 MHz, CDCl3) 14.6 (CH3), 20.7 
(CH3), 59.2 (OCH2), 90.4 (CH), 122.4 (2 × ArCH), 128.3 (2 × ArCH), 128.4 (2 × ArCH), 
129.2 (ArCH), 129.3 (2 × ArCH), 132.6 (ArC), 136.2 (ArC), 137.8 (ArC), 159.4 (C=CH), 
170.2 (CO); m/z (TOF ES+) 282 (100%, MH
+
), 236 (8). 
(Z)-Ethyl 3-(2-methoxyphenylamino)-3-phenylacrylate 186
156
 
NH
OEt
O
OMe
 
Obtained by general procedure F as a yellow crystal (60%); m.p. 90-91 ºC (lit.
156
 105 C); δH 
(400 MHz, CDCl3) 1.34 (t, 3H, J 7.1, CH3), 3.93 (s, 3H, OCH3), 4.24 (q, 2H, J 7.1, OCH2), 
5.02 (s, 1H, CH), 6.21 - 6.24 (m, 1H, ArH), 6.52 - 6.56 (m, 1H, ArH), 6.84 - 6.91 (m, 2H, 
ArH), 7.28 - 7.40 (m, 5H, ArH), 10.29 (s, br, 1H, NH); δC (100 MHz, CDCl3) 14.6 (CH3), 
55.7 (OCH3), 59.3 (OCH2), 91.6 (CH), 110.5 (ArCH), 120.0 (ArCH), 121.8 (ArCH), 122.9 
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(ArCH), 128.0 (2 × ArCH), 128.4 (2 × ArCH), 129.4 (ArCH), 129.6 (ArC), 136.4 (ArC), 
150.5 (ArC), 158.4 (C=CH), 169.9 (CO). Data was in accordance with the literature. 
(Z)-Ethyl 3-phenyl-3-(o-tolylamino)acrylate 187 
NH
OEt
O
Me
 
Obtained by general procedure F as a light yellow solid (41%); m.p. 103-105 ºC; (Found C 
76.73, H 6.83, N 4.91; requires C18H19NO2 C 76.84, H 6.81, N 4.98); max (thin film, cm
-1
) 
3253, 2978, 1655, 1617, 1595; δH (400 MHz, CDCl3) 1.35 (t, 3H, J 7.1, CH3), 2.45 (s, 3H, 
CH3), 4.24 (q, 2H, J 7.1, OCH2), 5.06 (s, 1H, CH), 6.35 (d, 1H, J 7.8, ArH), 6.83 (td, 1H, J 
7.8, 1.2, ArH), 6.88 (td, 1H, J 7.4, 1.0, ArH), 7.16 (d, 1H, J 7.4, ArH), 7.26 - 7.35 (m, 5H, 
ArH), 10.17 (s, br, 1H, NH); δC (100 MHz, CDCl3) 14.6 (CH3), 18.2 (CH3), 59.3 (OCH2), 
90.8 (CH), 123.5 (ArCH), 123.9 (ArCH), 125.8 (ArCH), 128.1 (2 × ArCH), 128.3 (2 × 
ArCH), 129.4 (ArCH), 130.2 (ArC), 130.4 (ArCH), 136.2 (ArC), 139.0 (ArC), 159.8 
(C=CH), 170.3 (CO); m/z (TOF ES+) 282.1 (100%, MH
+
), 236 (10). 
 (Z)-Ethyl 3-(4-fluorophenylamino)-3-phenylacrylate 188
157
 
NH
OEt
O
F
 
Obtained by general procedure F as a white solid (59% yield); m.p. 75-77 ºC (not reported in 
literature); δH (400 MHz, CDCl3) 1.34 (t, 3H, J 7.1, CH3), 4.23 (q, 2H, J 7.1, OCH2), 5.02 (s, 
1H, CH), 6.64 - 6.68 (m, 2H, ArH), 6.78 - 6.82 (m, 2H, ArH), 7.28 - 7.38 (m, 5H, ArH); δC 
(100 MHz, CDCl3) 14.5 (CH3), 59.3 (OCH2), 91.0 (CH), 115.3 (d, 
2
JC-F 22.7, 2  ArCH), 
124.0 (d, 
3
JC-F 7.9, 2  ArCH), 128.3 (2  ArCH), 128.5 (2  ArCH), 129.5 (ArCH), 135.7 
(ArC), 136.5 (ArC), 159.0 (d,
 3
JC-F 242.8, ArCH), 159.3 (C=CH), 170.2 (CO); F (235 MHz, 
CDCl3) -119.9. Data was in accordance with the literature, although 
19
F NMR not reported. 
(Z)-Ethyl 3-(benzylamino)-3-phenylacrylate 189
63
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Bn
NH
OEt
O
 
Obtained by general procedure F as a white solid (42% yield); m.p. 71-72 ºC (lit.
63
 66-67 
ºC); δH (400 MHz, CDCl3) 1.33 (t, 3H, J 7.1, CH3), 4.21 (q, 2H, J 7.1, OCH2), 4.32 (d, 2H, J 
6.5, NCH2), 4.75 (s, 1H, CH), 7.22 - 7.44 (m, 10H, ArH), 9.00 (s, br, 1H, NH); δC (100 
MHz, CDCl3) 14.7 (CH3), 48.4 (NCH2), 58.8 (OCH2), 86.6 (CH), 126.9 (2 × ArCH), 127.3 
(ArCH), 127.9 (2 × ArCH), 128.5 (2 × ArCH), 128.7 (2 × ArCH), 129.3 (ArCH), 136.1 
(ArC), 139.4 (ArC), 164.7 (C=CH), 170.4 (CO). Data was in accordance with the literature. 
(Z)-Ethyl 3-(methylamino)-3-phenylacrylate 190 
NH
OEt
O
Me
 
Obtained by general procedure F as light yellow oil except using methanaminium acetate 
instead of methylamine (55%); max (thin film, cm
-1
) 3296, 2978, 1650, 1613, 1595, 1574; δH 
(400 MHz, CDCl3) 1.30 (t, 3H, J 7.1, CH3), 2.79 (d, 3H, J 5.2, NCH3), 4.16 (q, 2H, J 7.1, 
CH2), 4.62 (s, 1H, CH), 7.28 - 7.43 (m, 5H, ArH), 8.52 (s, br, 1H, NH); δC (100 MHz, 
CDCl3) 14.6 (CH3), 31.4 (CH3), 58.6 (OCH2), 84.8 (CH), 127.8 (2 × ArCH), 128.3 (2 × 
ArCH), 129.1 (ArCH), 135.9 (ArC), 165.6 (C=CH), 170.6 (C=O); m/z (TOF ES+) 206.1172 
(MH
+
, C12H16NO2 requires 206.1181). 
(Z)-Ethyl 3-(4-methoxyphenylamino)-3-p-tolylacrylate 191 
NH
OEt
O
MeO
Me  
Obtained by general procedure F as yellow crystals (41% yield); mp 78-80 ºC; (Found C 
73.24, H 6.62, N 4.43; requires C19H21NO3 C 73.29, H 6.80, N 4.50); max (thin film, cm
-1
) 
3251, 2978, 1653, 1615, 1513; δH (400 MHz, CDCl3) 1.34 (t, 3H, J 7.1, CH3), 2.34 (s, 3H, 
CH3), 3.73 (s, 3H, OCH3), 4.22 (q, 2H, J 7.1, CH2), 4.94 (s, 1H, CH), 6.65 - 6.69 (m, 4H, 
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ArH), 7.09 [(AX)2, 2H, ArH], 7.23 [(AX)2, 2H, ArH], 10.23 (s, br, 1H, NH); δC (100 MHz, 
CDCl3) 14.6 (CH3), 21.3 (CH3), 55.3 (OCH3), 59.1 (OCH2), 89.3 (CH), 113.9 (2 × ArCH), 
124.2 (2 × ArCH), 128.3 (2 × ArCH), 129.0 (2 × ArCH), 133.1 (ArC), 133.7 (ArC), 139.3 
(ArC), 155.8 (ArC), 160.0 (C=CH), 170.4 (CO); m/z (TOF ES+) 312 (100, MH+), 266 (10). 
(Z)-Ethyl 3-(4-methoxyphenyl)-3-(4-methoxyphenylamino)acrylate 192
67
 
NH
OEt
O
MeO
MeO  
Obtained by general procedure F as brown sticky oil (50% yield); δH (400 MHz, CDCl3) 
1.33 (t, 3H, J 7.1, CH3), 3.74 (s, 3H, OCH3), 3.83 (s, 3H, OCH3), 4.20 (q, 2H, J 7.1, OCH2), 
4.93 (s, 1H, CH), 6.65 - 6.69 (m, 4H, ArH), 6.80 [(AX)2, 2H, ArH], 7.26 [(AX)2, 2H, ArH], 
10.21 (s, br, 1H, NH); δC (100 MHz, CDCl3) 14.6 (CH3), 55.3 (OCH3), 55.3 (OCH3), 59.1 
(OCH2), 88.9 (CH), 113.8 (2 × ArCH), 113.9 (2 × ArCH), 124.3 (2 × ArCH), 128.2 (ArC), 
129.8 (2 × ArCH), 133.8 (ArC), 155.7 (ArC), 159.7 (ArC), 160.4 (C=CH), 170.4 (CO). Data 
was in accordance with the literature. 
(Z)-Ethyl 3-(4-methoxyphenylamino)-3- (thiophen-2-yl)acrylate 193
83
 
NH
OEt
O
PMP
S  
Obtained by general procedure F as yellow crystals (45% yield); m.p. 54-56 ºC (lit.
83
 52-53 
ºC); δH (400 MHz, CDCl3) 1.34 (t, 3H, J 7.1, CH3), 3.77 (s, 3H, OCH3), 4.22 (q, 2H, J 7.1, 
CH3), 5.15 (s, 1H, CH), 6.73 [(AX)2, 2H, ArH], 6.83 [(AX)2, 2H, ArH], 6.92 (dd, 1H, J 5.0, 
3.7, ArH), 7.01 (dd, 1H, J 3.7, 1.2, ArH), 7.30 (dd, 1H, J 5.0, 1.2, ArH); δC (100 MHz, 
CDCl3) 14.6 (CH3), 55.4 (OCH3), 59.3 (OCH2), 89.5 (CH), 114.0 (2 × ArCH), 125.3 (3 × 
ArCH), 127.1 (ArCH), 127.6 (ArCH), 129.0 (ArCH), 133.5 (ArC), 137.6 (ArC), 153.0 
(ArC), 156.5 (C=CH), 170.1 (CO). Data was in accordance with the literature. 
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(Z)-Ethyl 3-(4-methoxyphenylamino)-3-(4-nitrophenyl)acrylate 194 
NH
OEt
O
MeO
O2N  
Obtained by general procedure F as yellow needle-like crystals (82% yield); m.p. 126-128 
ºC; (Found C 63.29, H 5.26, N 8.17; requires C18H18N2O5 C 63.15, H 5.30, N 8.18); max 
(thin film, cm
-1
) 3258, 2979, 1658, 1615, 1591, 1514; δH (400 MHz, CDCl3) 1.35 (t, 3H, J 
7.1, CH2CH3), 3.73 (s, 3H, OCH3), 4.24 (q, 2H, J 7.1, CH2CH3), 5.00 (s, 1H, CH), 6.64-6.69 
(m, 4H, ArH), 7.51 [(AX)2, 2H, ArH], 8.14 [(AX)2, 2H, ArH], 10.17 (s, br, 1H, NH); δC (100 
MHz, CDCl3) 14.5 (CH3), 55.3 (OCH3), 59.5 (OCH2), 91.3 (CH), 114.2 (2 × ArCH), 123.6 
(2 × ArCH), 124.8 (2 × ArCH), 129.3 (2 × ArCH), 132.7 (ArC), 142.7 (ArC), 148.0 (ArC), 
156.4 (ArC), 157.2 (C=CH), 169.8 (CO); m/z (TOF ES+) 343.1290 (MH
+
, C18H19N2O5 
requires 343.1294). 
(Z)-Ethyl 3-(4-methoxyphenylamino)-3-o-tolylacrylate 195
67
 
NH
OEt
O
MeO
Me  
Obtained by general procedure F as a white solid (11%); m.p. 58-61 ºC (lit.
67
 51-53 ºC); δH 
(400 MHz, CDCl3) 1.34 (t, 3H, J 7.1, CH2CH3), 2.13 (s, 3H, CH3), 3.71 (s, 3H, OCH3), 4.22 
(q, 2H, J 7.1, CH2CH3), 4.72 (s, 1H, CH), 6.57 - 6.62 (m, 4H, ArH), 7.08 (d, 1H, J 7.4, 
ArH), 7.20 (td, 1H, J 7.4, 0.7, ArH), 7.26 (td, 1H, J 7.4, 1.6, ArH), 7.32 (dd, J 7.4, 1.5, 1H, 
ArH), 10.51 (s, br, 1H, NH); δC (100 MHz, CDCl3) 14.6 (CH3), 19.5 (CH3), 55.3 (OCH3), 
59.1 (OCH2), 88.1 (CH), 113.9 (2 × ArCH), 122.9 (2 × ArCH), 125.8 (ArCH), 129.0 
(ArCH), 130.3 (2 × ArCH), 133.1 (ArC), 135.5 (ArC), 135.9 (ArC), 155.8 (ArC), 160.2 
(C=CH), 170.5 (CO). Data was in accordance with the literature. 
(Z)-Ethyl 3-(4-methoxyphenylamino)-4-phenylbut-2-enoate 196 
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NH
OEt
O
Ph
MeO
 
Obtained by general procedure F as white needle-like crystals (56% yield), m.p. 70-72 ºC; 
(Found C 73.52, H 6.78, N 4.47; requires C19H21NO3 C 73.29, H 6.80, N 4.50); max (thin 
film, cm
-1
) 3252, 1651, 1613, 1514; δH (400 MHz, CDCl3) 1.30 (t, 3H, J 7.1, CH2CH3), 3.52 
(s, 2H, CH2), 3.81 (s, 3H, OCH3), 4.16 (q, 2H, J 7.1, OCH2), 4.62 (s, 1H, CH), 6.81 [(AX)2, 
2H, ArH], 6.96 [(AX)2, 2H, ArH], 7.03-7.06 (m, 2H, ArH), 7.18-7.26 (m, 3H, ArH), 10.15 
(s, br, NH); δC (100 MHz, CDCl3) 14.6 (CH3), 38.7 (CH2), 55.4 (OCH3), 58.8 (OCH2), 86.1 
(CH), 114.1 (2 × ArCH), 126.6 (ArCH), 127.8 (2 × ArCH), 128.4 (2 × ArCH), 128.9 (2 × 
ArCH), 131.8 (ArC), 137.0 (ArC), 157.8 (ArC), 162.4 (C=CH), 170.7 (CO); m/z (TOF ES+) 
312.1610 (MH
+
, C18H22NO3 requires 312.1600). 
(Z)-Ethyl 3-(4-methoxyphenylamino)but-2-enoate 197
155
 
NH
Me OEt
O
MeO
 
Obtained by general procedure F as white needle-like crystals (66% yield), m.p. 42-44 ºC 
(lit.
155 
43-44 ºC); δH (400 MHz, CDCl3) 1.31 (t, 3H, J 7.2, CH3), 1.91 (s, 3H, CH3), 3.83 (s, 
3H, OCH3), 4.17 (q, 2H, J 7.2, CH2), 4.67 (s, 1H, CH), 6.69 [(AX)2, 2H, ArH], 7.05 [(AX)2, 
2H, ArH], 10.17 (s, br, 1H, NH); δC (100 MHz, CDCl3) 14.6 (CH3), 20.1 (CH3), 55.4 
(OCH3), 58.6 (OCH2), 84.7 (CH), 114.2 (2 × ArCH), 126.8 (2 × ArCH), 132.1 (ArC), 157.5 
(ArC), 160.0 (C=CH), 170.5 (CO). Data was in accordance with the literature. 
(Z)-Ethyl 3-(4-methoxyphenylamino)-4-methylpent-2-enoate 198
67
 
NH
OEt
O
MeO
 
Obtained by general procedure F as a white solid (42% yield); m.p. 37-39 ºC (lit.
67 
36 -39 
ºC); δH (400 MHz, CDCl3) 1.08 [d, 6H, J 6.8, CH(CH3)2], 1.32 (t, 3H, J 7.1, CH3), 2.68-2.78 
(sept, 1H, J 6.8, CH), 3.83 (s, 3H, CH3), 4.17 (q, 2H, J 7.1, CH2), 4.73 (s, 1H, CH), 6.89 
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[(ArX)2, 2H, ArH], 7.05  [(ArX)2, 2H, ArH], 10.19 (s, br, 1H, NH); δC (100 MHz, CDCl3) 
14.6 (CH3), 22.0 (2  CH3), 28.4 (CH), 55.4 (OCH3), 58.7 (OCH2), 80.3 (CH), 114.3 (2 × 
ArCH), 127.8 (2 × ArCH), 131.8 (ArC), 157.7 (ArC), 171.1 (C=CH), 171.3 (CO). Data was 
in accordance with the literature. 
(E)-Ethyl 3-phenyl-3-(pyrrolidin-1-yl)acrylate 215
158
 
N
O OEt 
A mixture of ketoester (1.92 g, 10 mmol), pyrrolidine (1.07 g, 15 mmol) and Zn(OAc)2 (91.5 
mg, 0.5 mmol) was stirred for 20 hours at 50 ºC. The mixture was cooled to room 
temperature and purified by chromatography on alumina (petroleum ether / ethyl acetate, 
20:1~5:1) to afford the product as yellow oil (69%); δH (400 MHz, CDCl3) 1.09 (t, 3H, J 7.1, 
CH3), 1.84 - 1.97 (m, 4H, 4 × CH2), 3.02 - 3.29 (m, 4H, 4 × CH2), 3.93 (q, 2H, J 7.1, OCH2), 
4.70 (s, 1H, CH), 7.23 - 7.25 (m, 2H, ArH), 7.38 - 7.45 (m, 3H, ArH); δC (100 MHz, CDCl3) 
14.4 (CH3), 25.3 (2 × CH2), 58.2 (2 × CH2), 85.2 (CH), 127.4 (2 × ArCH), 128.0 (ArCH), 
128.2 (2 × ArCH), 137.8 (ArC), 160.9 (C=CH), 168.0 (CO). Data was in accordance with 
the literature. 
General procedure G 
-Ketoester (0.5 mmol), catalyst 117 (0.1 mmol), benzoic acid (0.05 mmol) and dry 
dichloromethane (1 mL) were added into a 20 mL Schlenk tube. The mixture was stirred 
until complete dissolution, then cooled to 0 ºC and trichlorosilane (0.2 mmol) was added by 
syringe. The resulting mixture was left to stir for 10 hours at 0 ºC. The reaction was diluted 
by CH2Cl2 (20 mL), quenched by water (2 mL) and followed by addition of aqueous sodium 
hydroxide (1 M, 20 mL). This mixture was stirred until the precipitate was completely 
dissolved and no gas was evolved. The organic phase was separated and the aqueous phase 
was extracted with CH2Cl2 (2  20 mL). The combined organic phases were washed with 
brine (20 mL) and dried over MgSO4. Filtration and concentration gave crude product, 
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which was purified by chromatography on silica gel using 2%  20% solution of diethyl 
ether in petroleum ether. 
(S)-Ethyl 3-(4-methoxyphenylamino)-3-phenylpropanoate 199
67
 
NH
OEt
O
MeO
 
Obtained by general procedure G as a white solid (76% yield, 91% ee); m.p. 68-70 ºC (lit.
67
 
51-53 ºC); []D -5.7 (c 0.7 in CHCl3, 91% ee; lit.
67
 -5.6, c 1.0 in CHCl3, 92.3% ee); δH (400 
MHz, CDCl3) 1.22 (t, 3H, J 7.1, CH3), 2.75 - 2.85 (m, 2H, CH2), 3.72 (s, 3H, OCH3), 4.09 - 
4.16 (m, 2H, OCH2), 4.33 (s, br. 1H, NH), 4.77 (t, 1H, J 6.7, NCH), 6.55 [(AX2)2, 2H, ArH], 
6.72 [(AX)2, 2H, ArH], 7.24 - 7.28 (m, 1H, ArH), 7.32 - 7.40 (m, 4H, ArH); δC (100 MHz, 
CDCl3) 14.2 (CH3), 43.0 (CH2), 55.7 (NCH), 56.0 (OCH3), 60.8 (OCH2), 114.8 (2 × ArCH), 
115.2 (2 × ArCH), 126.3 (2 × ArCH), 127.4 (ArCH), 128.7 (2 × ArCH), 141.0 (ArC), 142.5 
(ArC), 152.3 (ArC), 171.3 (CO); Enantiomeric excess was determined by chiral phase HPLC 
(Phenomenex Lux 3 um Cellulose-1) 5 % ipa in hexane @ 1 mL min
-1
, tR = 13.3 min 
(minor), 17.7 min (major). Data was in accordance with the literature. 
(S)-Ethyl 3-phenyl-3-(phenylamino)propanoate 200
159
 
NH
OEt
O
 
Obtained by general procedure G as a white solid (64% yield, 85% ee); m.p. 74-76 ºC (lit.
159
 
77-79 ºC); []D 0 (c 1.0 in CHCl3, 85% ee; lit.
101
 -1.3, c 1.0 in CHCl3, 92.3% ee); δH (400 
MHz, CDCl3) 1.22 (t, 3H, J 7.2, CH3), 2.81 (dd, 1H, J 14.8, 7.5, 1  CH2), 2.85 (dd, 1H, J 
14.8, 5.9, 1  CH2), 4.07 - 4.19 (m, 2H, CH2), 4.65 (s, br, 1H, NH), 4.86 (app. t, J 6.5, 
NCH), 6.58 - 6.60 (m, 2H, ArH), 6.68 - 6.72 (m, 1H, ArH), 7.11 - 7.15 (m, 2H, ArH), 7.23 - 
7.29 (m, 1H, ArH), 7.33 - 7.37 (m, 2H, ArH), 7.40 - 7.42 (m, 2H, ArH); δC (100 MHz, 
CDCl3) 14.2 (CH3), 42.9 (CH2), 55.0 (NCH), 60.8 (OCH2), 113.7 (2 × ArCH), 117.8 
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(ArCH), 126.3 (2 × ArCH), 127.5 (ArCH), 128.8 (2 × ArCH), 129.2 (2 × ArCH), 142.2 
(ArC), 146.8 (ArC), 171.1 (CO); Enantiomeric excess was determined by chiral phase HPLC 
(Phenomenex Lux 3 um Cellulose-1) 5 % ipa in hexane @ 1 mL min
-1
, tR = 12.2 min 
(major), 12.8 min (minor). Data was in accordance with the literature. 
(S)-Ethyl 3-phenyl-3-(4-methylphenylamino)propanoate 201 
NH
OEt
O
Me
 
Obtained by general procedure G as a white solid (68% yield, 87% ee); m.p. 58-60 ºC; []D -
5.7 (c 0.7 in CHCl3, 87% ee); (Found C 76.09, H 7.38, N 4.72; requires C18H21NO2 C 76.29, 
H 7.47, N 4.94); max (thin film, cm
-1
) 3392, 2981, 1728, 1618, 1520; δH (400 MHz, CDCl3) 
1.22 (t, 3H, J 7.2, CH3), 2.22 (s, 3H, CH3), 2.80 (dd, 1H, J 14.7, 7.5, 1  CH2), 2.84 (dd, 1H, 
J 14.7, 6.0, 1  CH2), 4.08 - 4.19 (m, 2H, CH2), 4.48 (s, br, 1H, NH), 4.83 (t, J 6.5, NCH), 
6.52 [(AX)2, 2H, ArH], 6.95 [(AX)2, 2H, ArH], 7.25-7.29 (m, 1H, ArH), 7.33-7.37 (m, 2H, 
ArH), 7.40-7.42 (m, 2H, ArH); δC (100 MHz, CDCl3) 14.2 (CH3), 20.4 (CH3), 43.0 (CH2), 
55.3 (NCH), 60.8 (OCH2), 113.9 (2 × ArCH), 126.3 (2 × ArCH), 127.0 (ArCH), 127.4 
(ArC), 128.8 (2 × ArCH), 129.7 (2 × ArCH), 142.5 (ArC), 144.6 (ArC), 171.2 (CO); m/z 
(TOF ES+) 284 (MH
+
, 100); Enantiomeric excess was determined by chiral phase HPLC 
(Phenomenex Lux 3 um Cellulose-1) 5 % ipa in hexane @ 1 mL min
-1
, tR = 9.5 min (minor), 
11.7 min (major). 
(S)-Ethyl 3-phenyl-3-(4-fluorophenylamino)propanoate 202 
NH
OEt
O
F
 
Obtained by general procedure G as a white solid (59% yield, 71% ee); m.p. 50-52 ºC; []D 
+10 (c 1.2 in CHCl3, 71% ee); (Found C 70.75, H 6.29, N 4.77; requires C19H23NO3 C 71.06, 
H 6.31, N 4.87); max (thin film, cm
-1
) 3393, 2982, 1727, 1510; δH (400 MHz, CDCl3) 1.22 
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(t, 3H, J 7.2, CH3), 2.78 (dd, 1H, J 14.8, 7.9, 1  CH2), 2.83 (dd, 1H, J 14.8, 5.5, 1  CH2), 
4.10 - 4.17 (m, 2H, CH2), 4.51 (s, br, 1H, NH), 4.75 - 4.79 (m, 1H, NCH), 6.49 - 6.52 (m, 
2H, ArH), 6.80 - 6.84 (m, 2H, ArH), 7.25 - 7.39 (m, 5H, ArH); δC (100 MHz, CDCl3) 14.1 
(CH3), 42.9 (CH2), 55.7 (NCH) 60.8 (OCH2), 114.6 (d, 
3
JC-F 7.5, 2  ArCH), 115.6 (d, 
2
JC-F 
22.3, 2  ArCH), 126.3 (2 × ArCH), 127.5 (ArCH), 128.8 (2 × ArCH), 142.1 (ArC), 143.2 
(ArC), 156.0 (d,
 1
JC-F 235.4, ArCF), 171.2 (CO); δF (235 MHz, CDCl3) -127.6; m/z (TOF 
ES+) 288.1393 (MH
+
, C17H19NO2F requires 288.1400); Enantiomeric excess was 
determined by chiral phase HPLC (Phenomenex Lux 3 um Cellulose-1) 5 % ipa in hexane @ 
1 mL min
-1
, tR = 9.4 min (minor), 11.7 min (major). 
(S)-Ethyl 3-(2-methylphenylamino)-3-phenylpropanoate 203 
NH
OEt
O
Me
 
Obtained by general procedure G as a colourless oil (contaminated by ketoester and failed to 
isolate the pure product; 53% yield, 86% ee); max (thin film, cm
-1
) 3419, 2980, 1728, 1606, 
1588; δH (400 MHz, CDCl3) 1.23 (t, 3H, J 7.1, CH3), 2.28 (s, 3H, CH3), 2.84 (dd, 1H, J 14.5, 
7.7, 1  CH2), 2.89 (dd, 1H, J 14.5, 5.5, 1  CH2), 4.11 - 4.17 (m, 2H, CH2), 4.65 (s, br, 1H, 
NH), 4.88 (dd, J 7.7, 5.5, NCH), 6.41 (d, 1H, J 8.0, ArH), 6.65 (br, t, 1H, J 7.3, ArH), 6.99 
(br. t, 1H, J 8.0, ArH), 7.08 (br. d, 1H, J 7.3, ArH), 7.25-7.29 (m, 1H, ArH), 7.33-7.42 (m, 
4H, ArH); δC (100 MHz, CDCl3) 14.2 (CH3), 17.6 (CH3), 43.2 (CH2), 55.0 (NCH), 60.9 
(OCH2), 111.2 (ArCH), 117.3 (ArCH), 122.3 (ArC), 126.2 (2 × ArCH), 127.0 (ArCH), 127.4 
(ArCH), 128.8 (2 × ArCH), 130.1 (ArCH), 142.3 (ArC), 144.8 (ArC), 171.3 (CO); m/z (TOF 
ES+) 284.1644 (MH
+
, C18H22NO2 requires 284.1651); Enantiomeric excess was determined 
by chiral phase HPLC (Phenomenex Lux 3 um Cellulose-1) 5 % ipa in hexane @ 1 mL min
-
1
, tR = 10.1 min (major), 13.8 min (minor). 
(S)-Ethyl 3-(2-methoxyphenylamino)-3-phenylpropanoate 204
160
 
154 
 
NH
OEt
O
OMe
 
Obtained by general procedure G as a colourless oil (41% yield, 13% ee); []D +3.0 (c 2.3 in 
CHCl3, 13% ee; lit.
160
 -19, c 1.2 in CHCl3, 83% ee for R isomer); δH (400 MHz, CDCl3) 1.22 
(t, 3H, J 7.2, CH3), 2.83 (dd, 1H, J 14.6, 6.0, 1  CH2), 2.88 (dd, 1H, J 14.6, 7.7, 1  CH2), 
3.90 (s, 3H, OCH3), 4.07 - 4.19 (m, 2H, CH2), 4.87 (app. q, 1H,  J 6.8, NCH), 5.10 (d, 1H, J 
6.2, NH),  6.65 (td, 1H, J 7.7, 1.5, ArH), 6.74 (td, 1H, J 7.7, 1.4, ArH), 6.79 (dd, 1H, J 7.8, 
1.2, ArH), 7.24 - 7.28 (m, 1H, ArH), 7.73 - 7.36 (m, 2H, ArH), 7.40 - 7.42 (m, 2H, ArH); δC 
(100 MHz, CDCl3) 14.1 (CH3), 43.3 (CH2), 54.9 (NCH), 55.5 (OCH3), 60.7 (OCH2), 109.5 
(ArCH), 111.2 (ArCH), 116.9 (ArCH), 121.2 (ArCH), 126.3 (2 × ArCH), 127.4 (ArCH), 
128.7 (2 × ArCH), 136.8 (ArC), 142.5 (ArC), 146.9 (ArC), 171.0 (CO); Enantiomeric excess 
was determined by chiral phase HPLC (Phenomenex Lux 3 um Cellulose-1) 5 % ipa in 
hexane @ 1 mL min
-1
, tR = 15.3 min (minor), 19.3 min (major). Data was in accordance with 
the literature. 
(S)-Ethyl 3-(benzylamino)-3-phenylpropanoate 205
161
 
Bn
NH
OEt
O
 
Obtained by general procedure G as a colourless oil (57% yield, 93% ee); []D -41 (c 1.5 in 
acetone, 93% ee; lit.
162
 -5.7, c 0.5, 40% ee ); δH (400 MHz, CDCl3) 1.21 (t, 3H, J 7.1, CH3), 
2.12 (s, br. 1H, NH), 2.64 (dd, 1H, J 15.5, 5.2, 1  CH2), 2.74 (dd, 1H, J 15.5, 8.8, 1  CH2), 
3.57 (d, 1H, J 13.2, 1  NCH2), 3.67 (d, J 13.2, 1  NCH2), 4.09 - 4.15 (m, 3H, NCH and 
OCH2), 7.23-7.40 (m, 10H, ArCH); δC (100 MHz, CDCl3) 14.2 (CH3), 43.2 (CH2), 51.4 
(NCH2), 58.9 (NCH), 60.5 (OCH2), 126.9 (ArCH), 127.2 (2 × ArCH), 127.5 (ArCH), 128.3 
(2 × ArCH), 128.4 (2 × ArCH), 128.6 (2 × ArCH), 140.3 (ArC), 142.6 (ArC), 171.8 (CO); 
Enantiomeric excess was determined by chiral phase HPLC (Phenomenex Lux 3 um 
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Cellulose-1) 5 % ipa in hexane @ 1 mL min
-1
 at  210nm, tR = 6.8 min (minor), 9.6 min 
(major). Data was in accordance with the literature. 
(S)-Ethyl 3-(methylamino)-3-phenylpropanoate 206 
Me
NH
OEt
O
 
Obtained by general procedure G as a colourless oil (59% yield, 94% ee); []D -25 (c 1.3 in 
CHCl3, 94% ee); max (thin film, cm
-1
) 3345, 2978, 1731, 1453; δH (400 MHz, CDCl3) 1.22 
(t, 3H, J 7.1, CH2CH3), 1.70 (br, s, 1H, NH), 2.29 (s, 3H, NCH3), 2.63 (dd, 1H, J 15.5, 5.4, 1 
 CH2), 2.73 (dd, 1H, J 15.5, 8.5, 1  CH2), 3.98 (dd, J 8.5, 5.4, NCH), 4.12 (q, 2H, J 7.1, 
OCH2), 7.28 - 7.36 (m, 5H, ArH); δC (100 MHz, CDCl3) 14.1 (CH3), 34.4 (CH3), 42.8 (CH2), 
60.5 (OCH2), 61.5 (NCH), 127.1 (2 × ArCH), 127.4 (ArCH), 128.5 (2 × ArCH), 142.4 
(ArC), 171.9 (CO); m/z (TOF ES+) 208.1345 (MH
+
, C12H18NO2 requires 208.1338); 
Enantiomeric excess was determined by comparison of the integrals in the 
1
H NMR 
spectrum in CDCl3 of the diastereomeric salts formed by addition of excess L-mandelic acid. 
(S)-Ethyl 3-(4-methoxyphenylamino)-3-(4-methylphenyl)propanoate 207 
NH
OEt
O
MeO
Me  
Obtained by general procedure G as a colourless oil (75%, yield, 92% ee); []D -19.4 (c 0.62 
in CHCl3, 92% ee); (Found C 72.94, H 7.75, N 4.43; requires C19H23NO3 C 72.82, H 7.40, N 
4.47); max (thin film, cm
-1
) 3386, 2983, 1731, 1513, 1239; δH (400 MHz, CDCl3) 1.22 (t, 
3H, J 7.1, CH3), 2.23 (s, 3H, CH3), 2.78 (d, 2H, J 6.8, CH2), 3.72 (s, 3H, OCH3), 4.07 - 4.18 
(m, 2H, OCH2), 4.28 (s, br, 1H, NH), 4.74 (t, 1H, J 6.8, NCH), 6.54 [(AX)2, 2H, ArH], 6.72 
[(AX)2, 2H, ArH], 7.14 [(AX)2, 2H, ArH], 7.27 [(AX)2, 2H, ArH]; δC (100 MHz, CDCl3) 
14.2 (CH3), 21.1 (CH3) 43.0 (CH2), 55.7 (NCH), 60.7 (OCH2), 114.8 (2 × ArCH), 115.2 (2 × 
ArCH), 126.2 (2 × ArCH), 129.4 (2 × ArCH), 137.0 (ArC), 139.5 (ArC), 141.2 (ArC), 152.3 
(ArC), 171.3 (CO); m/z (TOF ES+) 314.1750 (MH
+
, C19H24NO3 requires 314.1756); 
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Enantiomeric excess was determined by chiral phase HPLC (Phenomenex Lux 3 um 
Cellulose-1) 5 % ipa in hexane @ 1 mL min
-1
, tR = 11.6 min (minor), 12.8 min (major). 
(S)-Ethyl 3-(4-methoxyphenylamino)-3-(4-methoxyphenyl)propanoate 208
67
 
NH
OEt
O
MeO
MeO  
Obtained by general procedure G as a colourless oil (70% yield, 91% ee); (Phenomenex Lux 
3 um Cellulose-1, flow rate 1 ml/min, 90:10 hexane/2-propanol); []D -20 (c 1.0 in CHCl3, 
91% ee; lit.
67
 -17.9, c 1.0 in CHCl3, 88% ee); δH (400 MHz, CDCl3) 1.22 (t, 3H, J 7.1, CH3), 
2.74 - 2.83 (m, 2H, CH2), 3.72 (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 4.09 - 4.17 (m, 2H, 
OCH2), 4.28 (s, br, 1H, NH), 4.73 (t, 1H, J 6.8, NCH), 6.55 [(AX)2, 2H, ArH], 6.73 [(AX)2, 
2H, ArH], 6.88 [(AX)2, 2H, ArH], 7.30 [(AX)2, 2H, ArH]; δC (100 MHz, CDCl3) 14.2 (CH3), 
43.0 (CH2), 55.2 (NCH), 55.4 (OCH3), 55.7 (OCH3), 60.7 (OCH2), 114.1 (2 × ArCH), 114.8 
(2 × ArCH), 115.2 (2 × ArCH), 127.4 (2 × ArCH), 134.5 (ArC), 141.1 (ArC), 152.3 (ArC), 
158.8 (ArC), 171.3 (CO); Enantiomeric excess was determined by chiral phase HPLC 
(Phenomenex Lux 3 um Cellulose-1) 5 % ipa in hexane @ 1 mL min
-1
, tR = 12.9 min 
(minor), 14.1 min (major). Data was in accordance with the literature. 
(S)-Ethyl 3-(4-methoxyphenylamino)-3-(thiophen-2-yl)propanoate 209
67
 
NH
OEt
O
MeO
S  
Obtained by general procedure G as a colourless oil (66% yield, 90% ee); []D -15 (c 1.0 in 
CHCl3, 90% ee; lit.
67
 -9.1, c 1.0, 70% ee); δH (400 MHz, CDCl3) 1.25 (t, 3H, J 7.1, CH3), 
2.88 - 3.00 (m, 2H, CH2), 3.75 (s, 3H, OCH3), 4.16 (q, 2H, J 7.1, OCH2), 4.23 (s, br. NH), 
5.09 (t, 1H, J 6.5, NCH), 6.67 [(ArX)2, 2H, ArH], 6.78 [(AX)2, 2H, ArH], 6.94-7.19 (m, 2H, 
ArH), 7.20 (dd, 1H, J 5.0, 1.2, ArH); δC (100 MHz, CDCl3) 14.2 (CH3), 42.6 (CH2), 52.3 
(NCH), 55.7 (OCH3), 60.8 (OCH2), 114.8 (2 × ArCH), 115.8 (2 × ArCH), 123.8 (ArCH), 
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124.2 (ArCH), 126.8 (ArCH), 140.6 (ArC), 147.3 (ArC), 152.9 (ArC), 170.9 (CO); 
Enantiomeric excess was determined by chiral phase HPLC (Phenomenex Lux 3 um 
Cellulose-1) 10 % ipa in hexane @ 1 mL min
-1
, tR = 10.6 min (minor), 13.0 min (major). 
Data was in accordance with the literature. 
(S)-Ethyl 3-(4-methoxyphenylamino)-3-(4-nitrophenyl)propanoate 210 
NH
OEt
O
MeO
O2N  
Obtained by general procedure G as an orange oil (50% yield, 82% ee); []D -23 (c 0.8 in 
CHCl3, 82% ee); max (thin film, cm
-1
) 3386, 2983, 1730, 1514; δH (400 MHz, CDCl3) 1.22 
(t, 3H, J 7.2, CH3), 2.78 - 2.88 (m, 2H, CH2), 3.71 (s, 3H, OCH3), 4.14 (q, 2H, J 7.2, OCH2), 
4.48 (s, br, 1H, NH), 4.86 (t, 1H, J 6.2, NCH), 6.49  [(AX)2, 2H, ArH], 6.72  [(AX)2, 2H, 
ArH], 7.58  [(AX)2, 2H, ArH], 8.19  [(AX)2, 2H, ArH]; δC (100 MHz, CDCl3) 14.1 (CH3), 
42.3 (CH2), 55.5 (NCH), 55.6 (OCH3), 61.1 (OCH2), 114.9 (2× ArCH), 115.2 (2 × ArCH), 
124.0 (2× ArCH), 127.4 (2× ArCH), 140.2 (ArC), 147.3 (ArC), 150.3 (ArC), 152.7 (ArC), 
170.6 (CO); m/z (TOF ES+) 345.1435 (MH
+
, C18H21N2O5 requires 345.1450); Enantiomeric 
excess was determined by chiral phase HPLC (Chiralpak IA) 10 % ipa in hexane @ 1 mL 
min
-1
, tR = 27.9 min (minor), 30.5 min (major). 
(S)-Ethyl 3-(4-methoxyphenylamino)-3-(2-methylphenyl)propanoate 211 
NH
OEt
O
MeO
Me  
Obtained by general procedure G as a light yellow oil (27% yield, 3% ee); []D 0 (c 1.0 in 
CHCl3, 3% ee; lit.
67
 +1.4, c 1.0 in CHCl3, 79% ee); δH (400 MHz, CDCl3) 1.23 (t, 3H, J 7.2, 
CH3), 2.48 (s, 3H, CH3), 2.68 (dd, 1H, J 14.8, 8.4, 1  CH2), 2.77 (dd, 1H, J 14.8, 5.1, 1  
CH2), 3.72 (s, 3H, OCH3), 4.08 - 4.19 (m, 2H, OCH2), 4.27 (s, br, 1H, NH), 4.96 (dd, 1H, J 
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8.4, 5.1, NCH), 6.48 [(AX)2, 2H, ArH], 6.72 [(AX)2, 2H, ArH], 7.15 - 7.21 (m, 3H, ArH), 
7.40 - 7.44 (m, 1H, ArH); δC (100 MHz, CDCl3) 14.2 (CH3), 19.1 (CH3), 41.3 (CH2), 52.4 
(NCH), 55.7 (OCH3), 60.8 (OCH2), 114.8 (2 × ArCH), 114.9 (2 × ArCH), 125.2 (ArCH), 
126.6 (ArCH), 127.2 (ArCH), 130.8 (ArCH), 135.0 (ArC), 140.2 (ArC), 141.1 (ArC), 152.3 
(ArC), 171.3 (CO); Enantiomeric excess was determined by chiral phase HPLC 
(Phenomenex Lux 3 um Cellulose-1) 5 % ipa in hexane @ 1 mL min
-1
, tR = 10.2 min 
(minor), 15.6 min (major). Data was in accordance with the literature. 
(S)-Ethyl 3-(4-methoxyphenylamino)-4-phenylbutanoate 223 
NH
OEt
O
MeO
Ph
 
Obtained by general procedure G as a light yellow oil (56% yield, 30% ee); []D +2.3 (c 1.3 
in CHCl3, 30% ee); max (thin film, cm
-1
) 3371, 2981, 2934, 1728, 1512; δH (400 MHz, 
CDCl3) 1.26 (t, 3H, J 7.1, CH3), 2.44 (dd, 1H, J 15.3, 6.3, 1  CH2), 2.51 (dd, 1H, J 15.3, 
6.0, 1  CH2), 2.87 (dd, 1H, J 13.6, 7.2, 1  CH2), 2.97 (dd, 1H, J 13.6, 5.1, 1  CH2), 3.64 
(s, br, 1H, NH), 3.78 (s, 3H, OCH3), 4.01 - 4.07 (m, 1H, NCH), 4.14 (q, 2H, J 7.1, OCH2), 
6.66 [(AX)2, 2H, ArH], 6.82 [(AX)2, 2H, ArH], 7.19 - 7.33 (m, 5H, ArH); δC (100 MHz, 
CDCl3) 14.2 (CH3), 38.3 (CH2), 40.0 (CH2), 52.6 (NCH), 55.8 (OCH3), 60.5 (OCH2), 115.0 
(2× ArCH), 115.5 (2× ArCH), 126.6 (ArCH), 128.5 (2 × ArCH), 129.5 (2 × ArCH), 137.9 
(ArC), 140.9 (ArC), 152.5 (ArC), 172.0 (CO); m/z (TOF ES+) 314.1749 (MH
+
, C19H24NO3 
requires 314.1756); Enantiomeric excess was determined by chiral phase HPLC 
(Phenomenex Lux 3 um Cellulose-1) 10 % ipa in hexane @ 1 mL min
-1
, tR = 8.7 min 
(major), 9.8 min (minor). 
(S)-Ethyl 3-(4-methoxyphenylamino)butanoate 224
101
 
NH
Me OEt
O
MeO
 
Obtained by general procedure G as a light yellow oil (63% yield, 20% ee); []D 0 (c 1.0 in 
CHCl3, 20% ee; lit.
101
 -4, c 0.5 in MeOH, 94% ee);  δH (400 MHz, CDCl3) 1.27 (d, 3H, J 6.4, 
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CH3), 1.28 (t, 3H, J 7.2, CH3), 2.42 (dd, 1H, J 15.0, 6.8, 1  CH2), 2.62 (dd, 1H, J 15.0, 6.8, 
1  CH2), 3.51 (s, br, 1H, NH), 3.37 (s, 3H, OCH3), 3.83 - 3.91 (m, 1H, NCH), 4.16 (q, 2H, J 
7.2, OCH2), 6.64 [(AX)2, 2H, ArH], 6.80 [(AX)2, 2H, ArH]; δC (100 MHz, CDCl3) 14.2 
(CH3), 20.6 (CH3), 41.0 (CH2), 47.3(NCH), 55.7 (OCH3), 60.4 (OCH2), 114.9 (2 × ArCH), 
115.5 (2 × ArCH), 141.0 (ArC), 152.4 (ArC), 172.0 (CO); Enantiomeric excess was 
determined by chiral phase HPLC (Phenomenex Lux 3 um Cellulose-1) 5 % ipa in hexane @ 
1 mL min
-1
, tR = 10.2 min (minor), 10.9 min (major). Data was in accordance with the 
literature. 
Ethyl 3-(4-methoxyphenylamino)-4-methylpentanoate 225
67
 
NH
OEt
O
MeO
 
Obtained by general procedure G as a light yellow oil (44% yield, 56% ee); []D +20 (c 1.0 
in CHCl3, 56% ee; lit
67
 +21.3, c 1.0 in CHCl3, 59% ee); δH (400 MHz, CDCl3) 0.95 (d, 3H, J 
6.8, CH3), 1.00 (d, 3H, J 6.8, CH3), 1.23 (t, 3H, J 7.1, CH3), 1.86 - 1.98 (m, 1H, CH), 2.43 
(dd, 1H, J 14.8, 7.3, 1  CH2), 2.52 (dd, 1H, J 14.8, 5.3, 1 × CH2), 3.46 (s, br, 1H, NH), 3.61 
- 3.65 (m, 1H, NCH), 3.76 (s, 3H, OCH3), 4.10 (q, 2H, J 7.1, OCH2), 6.63 [(AX)2, 2H, ArH], 
6.78 [(AX)2, 2H, ArH]; δC (100 MHz, CDCl3) 14.2 (CH3), 18.6 (CH3), 18.7 (CH3), 31.7 
(CH), 36.9 (CH2), 55.8 (OCH3), 57.2 (NCH), 60.4 (OCH2), 114.9 (2 × ArCH), 115.0 (2 × 
ArCH), 141.9 (ArC), 152.1 (ArC), 172.4 (CO); Enantiomeric excess was determined by 
chiral phase HPLC (Phenomenex Lux 3 um Cellulose-1) 5 % ipa in hexane @ 1 mL min
-1
, tR 
= 9.1 min (minor), 9.9 min (major). Data was in accordance with the literature. 
(±)-Ethyl 3-phenyl-3-(pyrrolidin-1-yl)propanoate 216
163
 
N
OEt
O
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Obtained by general procedure G as a yellow oil (62%, 0% ee); δH (400 MHz, CDCl3) 1.08 
(t, 3H, J 7.1, CH3), 1.72 - 1.82 (m, 4H, 4 × CH2), 2.37 - 2.46 (m, 2H, 2 × CH2), 2.51 - 2.60 
(m, 2H, 2 × CH2), 2.71 (dd, 1H, J 14.6, 9.1, 1 × CH2), 3.00 (dd, 1H, J 14.6, 5.7, 1 × CH2), 
3.70 (dd, 1H, J 9.1, 5.7, 1 × CH2), 3.98 (q, 2H, J 7.1, OCH2), 7.23 - 7.36 (m, 5H, ArH); δC 
(100 MHz, CDCl3) 14.01 (CH3), 23.3 (2 × CH2), 41.7 (CH2), 52.2 (2 × CH2), 60.2 (CH2), 
66.5 (CH), 85.2 (CH), 127.4 (ArCH), 128.0 (2 × ArCH), 128.2 (2 × ArCH), 141.7 (ArC), 
171.6 (CO); Enantiomeric excess was determined by chiral phase HPLC (Chiralcel OD-H) 5 
% ipa in hexane @ 1 mL min
-1
 and at  205 nm, tR = 4.1 min, 5.3 min (major). Data was in 
general accordance with the literature, although 
1
H NMR data has missed the signals of the 
eight protons on the pyrrolidinyl ring in reference 163. 
7.6 Asymmetric reductive amination of ketones 
General procedure H 
Ketone (1 mmol), amine (1.5 mmol), catalyst 117 (0.01 mmol) and dry CH2Cl2 (0.5mL) 
were introduced into an oven-dried 25mL two-necked flask or an oven-dried carousel tube. 
The mixture was stirred until complete dissolution, then cooled to 0 ºC and trichlorosilane (2 
mmol, 0.2 mL) was added by syringe. A suspension was formed immediately upon addition 
of trichlorosilane. The resulting reaction mixture was left to stir for 24 h at 0 ºC. The 
reaction was diluted by CH2Cl2 (20 mL), quenched by water (2 mL) and followed by 
addition of aqueous sodium hydroxide (1 M, 20 mL). This mixture was stirred until the 
precipitate was completely dissolved and no gas was evolved. The organic phase was 
separated and the aqueous phase was extracted with CH2Cl2 (2  20 mL). The combined 
organic phase was wash with brine (20 mL) and dried over MgSO4. Filtration and 
concentration gave crude product, which was purified by chromatography on silica gel using 
2%  10% solution of diethyl ether in petroleum ether. 
General procedure I 
Ketone (1 mmol), amine (1.5 mmol),and 4 Å molecular sieves (200 mg) was introduced into 
a microwave tube (10 mL) and the mixture was heated at 150 C for 40 min under 
161 
 
microwave irradiation. After the reaction mixture was cooled to room temperature, catalyst 
117 (0.01 mmol) and dry CH2Cl2 (0.5mL or as mentioned) were added, the vessel cooled to 
0 ºC and trichlorosilane (2 mmol, 0.2 mL) added by syringe. The resulting reaction mixture 
was left to stir at 0 ºC for 8 h. The reaction was diluted by CH2Cl2 (20 mL), quenched by 
water (2 mL) and followed by addition of aqueous sodium hydroxide (1 M, 20 mL). This 
mixture was stirred until the precipitate was completely dissolved and no gas was evolved. 
The organic phases were separated and the aqueous phases were extracted with CH2Cl2 (2  
20 mL). The combined organic phase was wash with brine (20 mL) and dried over MgSO4. 
Filtration and concentration gave crude product, which was purified by chromatography on 
silica gel using 2%  20% solution of diethyl ether in petroleum ether. 
(S)-N-[1-(4’-Methoxyphenyl)ethyl]-4-methoxyaniline 22279 
 
Obtained using general procedure H as a white solid (76% yield, 81% ee); m.p. 93-95 ºC 
(not reported in literature); []D -14.5 (c 0.96 in CHCl3, 81% ee, lit.
79
 -15.5, c 1.1 in CHCl3, 
85% ee); H (250 MHz, CDCl3) 1.49 (d, 3H, J 6.6, CH3), 3.72 (s, 3H, OCH3), 3.76 (s, br, 1H, 
NH), 3.80 (s, 3H, OCH3), 4.39 (q, 1H, J 6.6, NCH), 6.49 [(AX)2, 2H, ArCH], 6.71 [(AX)2, 
2H, ArCH], 6.87 [(AX)2, 2H, ArCH], 7.29 [(AX)2, 2H, ArCH]; C (63 MHz, CDCl3) 25.1 
(CH3), 53.7 (NCH), 55.3 (OCH3), 55.8 (OCH3), 114.0 (2 × ArCH), 114.6 (2 × ArCH), 114.8 
(2 × ArCH), 127.0 (2 × ArCH), 137.6 (ArC), 141.7 (ArC), 151.9 (ArC), 158.5 (ArC); 
Enantiomeric excess was determined by chiral phase HPLC (Phenomenex Lux 3 um 
Cellulose-1) 10 % ipa in hexane @ 1 mL min
-1
, tR = 9.1 min (minor), tR = 10.1 min (major). 
Data was in accordance with the literature. 
(S)- (N-[1-(4’-Methylphenyl)ethyl]-4-methoxyaniline 224164 
162 
 
 
Obtained using general procedure H as a yellow solid (66% yield, 83% ee); mp 50-52 ºC 
(not reported in literature); []D -17.8 (c 1.05 in CHCl3, 83% ee, lit.
164 
+13.3, c 2 in CHCl3, 
79% ee); H (250 MHz, CDCl3) 1.50 (d, 3H, J 6.6, CH3), 2.34 (s, 3H, CH3), 3.72 (s, 3H, 
OCH3), 3.78 (s, br, 1H, NH), 4.41 (q, 1H, J 6.6, NCH), 6.49 [(AX)2, 2H, ArCH], 6.71 
[(AX)2, 2H, ArCH], 7.13 - 7.16 (m, 2H, ArH), 7.26 - 7.29 (m, 2H, ArH); C (63 MHz, 
CDCl3) 21.2 (CH3), 25.2 (CH3), 54.0 (NCH), 55.8 (OCH3), 114.7 (2 × ArCH), 114.9 (2 × 
ArCH), 125.9 (2 × ArCH), 129.4 (2 × ArCH), 136.4 (ArC), 141.8 (ArC), 142.6 (ArC), 152.0 
(ArC); Enantiomeric excess was determined by chiral phase HPLC (Chiralcel OD-H) 5% ipa 
in hexane @ 1 mL min
-1
, tR = 7.5 min (minor), tR = 8.6 min (major). Data was in accordance 
with the literature. 
(S)-N-[1-(4’-Chlorophenyl)ethyl]-4-methoxyaniline 22447b 
 
Obtained using general procedure H as a yellow oil (61% yield, 83% ee); []D -10.9 (c 1.1 in 
CHCl3, 83% ee, lit.
47b
 +8.9, c 1.16 in CHCl3, 97% ee, R isomer); H (400 MHz, CDCl3) 
11.50 (d, 3H, J 6.6, CH3), 3.73 (s, 3H, OCH3), 3.81 (s, br, 1H, NH), 4.41 (q, 1H, J 6.6, 
NCH), 6.47 [(AX)2, 2H, ArCH], 6.73 [(AX)2, 2H, ArCH], 7.28 - 7.35 (m, 4H, ArH); C (100 
MHz, CDCl3) 25.2 (CH3), 53.8 (NCH), 55.8 (OCH3), 114.6 (2 × ArCH), 114.9 (2 × ArCH), 
127.4 (2 × ArCH), 128.8 (2 × ArCH), 132.4 (ArC), 141.4 (ArC), 144.2 (ArC), 152.1 (ArC); 
Enantiomeric excess was determined by chiral phase HPLC (Phenomenex Lux 3 µm 
Cellulose-1) 8% ipa in hexane @ 1 mL min
-1
, tR = 10.6 min (minor), tR = 12.6 min (major). 
Data was in accordance with the literature. 
(S)-N-[1-(4’-Nitrophenyl)ethyl]-4-methoxyaniline 22579 
163 
 
 
Obtained using general procedure H as a brown oil (46% yield, 83% ee); []D -30.8 (c 1.0 in 
CHCl3, 83% ee, lit.
79
 -25.9, c 0.54 in CHCl3, 86% ee); H (400 MHz, CDCl3) 1.55 (d, 3H, J 
6.8, CH3), 3.72 (s, 3H, OCH3), 3.93 (br s, 1H, NH), 4.53 (q, 1H, J 6.8, NCH), 6.43 [(AX)2, 
2H, ArH], 6.72 [(AX)2, 2H, ArH], 7.57 [(AX)2, 2H, ArH], 8.20 [(AX)2, 2H, ArH]; C (100 
MHz, CDCl3) 25.0 (CH3), 54.0 (NCH), 55.7 (OCH3), 114.5 (2 × ArCH), 114.8 (2 × ArCH), 
124.1 (2 × ArCH), 126.8 (2 × ArCH), 140.7 (ArC), 147.0 (ArC), 152.3 (ArC), 153.6 (ArC); 
Enantiomeric excess was determined by chiral phase HPLC (Phenomenex Lux 3 µm 
Cellulose-1) 10% ipa in hexane @ 1 mL min
-1
, tR = 28.3 min (minor), tR = 34.8 min (major); 
Data was in accordance with the literature. 
(S)-N-[1-(2’-Methoxyphenyl)ethyl]-4-methoxyaniline 22738 
 
Obtained using general procedure H as a light yellow solid (71% yield, 70% ee), mp 56 – 58 
C (not reported in literature); []D +11.8 (c 1.5 in CHCl3, 70% ee, lit.
38
 +14.0 c 0.25 in 
CDCl3, 90% ee, absolute configuration assumed to be S); H (250 MHz, CDCl3) 1.58 (d, 3H, 
J 6.6, CH3), 3.77 (s, 3H, OCH3), 3.96 (s, 3H, OCH3), 4.04 (s, br, 1H, NH), 4.90 (q, 1H, J 6.6, 
NCH), 6.59 [(AX)2, 2H, ArH], 6.80 [(AX)2, 2H, ArH], 6.99 (t, 2H, J 7.4, ArH), 7.29 (td, 1H, 
J 7.4, 1.6, ArH), 7.42 (dd, 1H, J 7.4, 1.6, ArH); C (63 MHz, CDCl3) 23.0 (CH3), 49.0 
(NCH), 55.4 (OCH3), 55.8 (OCH3), 110.6 (ArCH), 114.7 (2 × ArCH), 114.9 (2 × ArCH), 
120.9 (ArCH), 126.6 (ArCH), 127.7 (ArCH), 133.1 (ArC), 141.9 (ArC), 151.9 (ArC), 156.9 
(ArC); Enantiomeric excess was determined by chiral phase HPLC (Chiralcel OD-H) 5% ipa 
in hexane @ 1 mL min
-1
, tR = 7.9 min (minor), tR = 9.2 min (major); Data was in accordance 
with the literature. 
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(S)-N-[1-(2’-Methylphenyl)ethyl]-4-methoxyaniline 22644b 
 
Obtained using general procedure H as a yellow oil (12% yield, 81% ee); []D +35.4 (c 0.48 
in MeOH, 81% ee, lit.
44b
 -33.5, c 2.2 in MeOH, 78% ee, R isomer); H (250 MHz, CDCl3) 
1.50 (d, 3H, J 6.6, CH3), 2.49 (s, 3H, CH3), 3.74 (s, 3H, OCH3), 4.65 (q, 1H, J 6.6, NCH), 
6.45 [(AX)2, 2H, ArH], 6.74 [(AX)2, 2H, ArH], 7.17 - 7.25 (m, 3H, ArH), 7.46 - 7.50 (m, 
1H, ArH); H (63 MHz, CDCl3) 19.0 (CH3), 23.2 (CH3), 50.5 (NCH), 55.8 (OCH3), 114.3 (2 
× ArCH), 114.9 (2 × ArCH), 124.7 (ArCH), 126.6 (2 × ArCH), 130.6 (ArCH), 134.6 (ArC), 
141.7 (ArC), 143.1 (ArC), 151.9 (ArC); Enantiomeric excess was determined by chiral phase 
HPLC (Phenomenex Lux 3 µm Cellulose-1) 10% ipa in hexane @ 1 mL min
-1
, tR = 6.3 min 
(minor), tR = 7.7 min (major); Data was in accordance with the literature. 
(S)-N-[1-(Naphthalen-1-yl)ethyl]-4-methoxyaniline 228
79
 
 
Obtained using general procedure H as a yellow solid (11% yield, 77% ee), m.p. 88-89 C 
(lit.
79
 61 ºC); []D +135 (c 0.4 in CHCl3, 77% ee, lit.
79
 +123.8, c 0.44 in CHCl3, 74% ee); H 
(400 MHz, CDCl3) 1.70 (d, J 6.6, 3H, CH3), 3.73 (s, 3H, OCH3), 4.00 (s, br, 1H, NH), 5.28 
(q, 1H, J 6.6, NCH), 6.50 [(AX)2, 2H, ArH], 6.73 [(AX)2, 2H, ArH], 7.48 (t, 1H, J 7.6, ArH), 
7.56 - 7.65 (m, 2H, ArH), 7.73 (d, 1H, J 7.1, ArH), 7.81 (d, 1H, J 8.1, ArH), 7.97 (d, 1H, J 
8.1, ArH), 8.24 (d, 1H, J 8.3, ArH); H (100 MHz, CDCl3) 23.9 (CH3), 50.2 (NCH), 55.8 
(OCH3), 114.4 (2 × ArCH), 114.9 (2 × ArCH), 122.4 (ArCH), 122.7 (ArCH), 125.5 (ArCH), 
126.0 (ArCH), 126.1 (ArCH), 127.5 (ArCH), 129.2 (ArCH), 130.9 (ArC), 134.2 (ArC), 
140.3 (ArC), 141.5 (ArC), 151.9 (ArC); Enantiomeric excess was determined by chiral phase 
HPLC (Phenomenex Lux 3 µm Cellulose-1) 5% ipa in hexane @ 1 mL min
-1
, tR = 12.9 min 
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(minor), tR = 19.0 min (major); Data was in accordance with literature. 
(S)-N-[1-(Naphthalen-2-yl)ethyl]-4-methoxyaniline 229
79 
 
Obtained using general procedure H as a light yellow solid (63% yield, 85% ee), mp 96 – 98 
C (lit.79 95 – 96 ºC); []D -24 (c 1.0 in CHCl3, 85% ee, lit.
79
 -26.0, c 1.0 in CHCl3, 86% ee); 
H (250 MHz, CDCl3) 1.59 (d, 3H, J 6.9, CH3), 3.70 (s, 3H, OCH3), 3.90 (s, br, 1H, NH), 
4.59 (q, 1H, J 6.9, NCH), 6.53 [(AX)2, 2H, ArH], 6.71 [(AX)2, 2H, ArH], 7.42 - 7.55 (m, 
3H, ArH), 7.80 - 7.86 (m, 4H, ArH); C (63 MHz, CDCl3) 25.2 (CH3), 54.6 (NCH), 55.8 
(OCH3), 114.7 (2 × ArCH), 114.8 (2 × ArCH), 124.4 (ArCH), 124.5 (ArCH), 125.5 (ArCH), 
126.0 (ArCH), 127.7 (ArCH), 127.9 (ArCH), 128.5 (ArCH), 132.8 (ArC), 133.7 (ArC), 
141.7 (ArC), 143.1 (ArC), 152.0 (ArC); Enantiomeric excess was determined by chiral phase 
HPLC (Phenomenex Lux 3 µm Cellulose-1) 10% ipa in hexane @ 1 mL min
-1
, tR = 10.1 min 
(minor), tR = 12.0 min (major); Data was in accordance with the literature. 
(S)-N-[1-(Thiophen-2-yl)ethyl]-4-methoxyaniline 231
83
 
S
HN OMe
 
Obtained using general procedure H as a yellow oil (61% yield, 79% ee); []D -8.0 (c 1.0 in 
CHCl3, 79% ee, lit.
83
 -9.0, c 1.0 in CHCl3, 89% ee); H (250 MHz, CDCl3) 1.63 (d, 3H, J 6.6, 
CH3), 3.75 (s, 3H, OCH3), 4.76 (q, 1H, J 6.6, NCH), 6.62 [(AX)2, 2H, ArH], 6.75 [(AX)2, 
2H, ArH], 6.94 - 6.98 (m, 2H, ArH), 7.18 (dd, 1H, J 4.7, 1.6, ArH); C (63 MHz, CDCl3) 
24.8 (CH3), 50.6 (NCH), 55.8 (OCH3), 114.9 (2 × ArCH), 115.2 (2 × ArCH), 123.0 (ArCH), 
123.6 (ArCH), 126.7 (ArCH), 141.2 (ArC), 150.6 (ArC), 152.5 (ArC); Enantiomeric excess 
was determined by chiral phase HPLC (Phenomenex Lux 3µm Cellullose-1) 2% ipa in 
hexane @ 1 mL min
-1
, tR = 15.1 min (minor), tR = 17.3 min (major); Data was in accordance 
with the literature. 
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(S)-N-[1-(Furan-2-yl)ethyl]-4-methoxyaniline 230
165
 
O
HN OMe
 
Obtained using general procedure H as a yellow oil (72% yield, 44% ee); []D -46 (c 1.0 in 
CHCl3, 44% ee, lit.
83 
-48, c 1.0 in CHCl3, 62% ee); H (250 MHz, CDCl3) 1.57 (d, 3H, J 6.6, 
CH3), 3.63 (br, s, 1H, NH), 3.76 (s, 3H, OCH3), 4.58 (q, 1H, J 6.6, NCH), 6.18 (app. d, 1H, J 
3.2, ArH), 6.32 (dd, 1H, J 3.2, 1.8 ArH), 6.63 [(AX)2, 2H, ArH], 6.79 [(AX)2, 2H, ArH], 
7.36 (app. s, 1H, ArH); C (63 MHz, CDCl3) 21.0 (CH3), 48.4 (NCH), 55.7 (OCH3), 105.1 
(ArCH), 110.1 (ArCH), 114.8 (2 × ArCH), 115.2 (2 × ArCH), 141.2 (ArC), 141.4 (ArCH), 
152.5 (ArC), 157.6 (ArC); Enantiomeric excess was determined by chiral phase HPLC 
(Chiralcel OJ) 10% ipa in hexane @ 1 mL min
-1
, tR = 45.1 min (major), tR = 56.4 min 
(minor); Data was in accordance with the literature. 
(S)-N-(1-Phenylpropyl)-4-methoxyaniline 232
79
 
 
Obtained using general procedure H as a yellow oil (15% yield, 85% ee); []D -22 (c 1.0 in 
CHCl3, 85% ee, lit.
79
 -26.9, c 1.0, CHCl3, 84% ee); H (250 MHz, CDCl3) 0.96 (t, 3H, J 7.2, 
CH3), 1.74-1.90 (m, 2H, CH2), 3.71 (s, 3H, OCH3), 3.85 (s, br, 1H, NH), 4.17 (t, 1H, J 6.6, 
NCH), 6.58 [(AX)2, 2H, ArH], 6.72 [(AX)2, 2H, ArH], 7.20 - 7.37 (m, 5H, ArH); C (63 
MHz, CDCl3) 11.0 (CH2CH3), 31.8 (CH2CH3), 55.8 (OCH3), 60.7 (NCH), 114.6 (2 × 
ArCH), 114.9 (2 × ArCH), 126.7 (2 × ArCH), 127.0 (ArCH), 128.6 (2 × ArCH), 142.0 
(ArC), 144.3 (ArC), 152.0 (ArC); Enantiomeric excess was determined by chiral phase 
HPLC (Chiralcel OD-H) 5% ipa in hexane @ 1 mL min
-1
, tR = 7.0 min (minor), tR = 7.7 min 
(major); Data was in accordance with the literature. 
(S)-N-[2-(4’-Phenylbutyl)]-4-methoxyaniline 235166 
167 
 
HN
OMe
 
Obtained using general procedure H as light yellow oil (82% yield, 14% ee); []D +0.7 (c 5.1 
in CHCl3, 14% ee, lit.
166 
-4.0, c 2.06 in CHCl3, 91% ee, R isomer); H (250 MHz, CDCl3) 
1.25 (d, 3H, J 6.3, CH3), 1.72 - 2.00 (m, 2H, CH2), 2.78 (t, 2H, J 7.8, CH2), 3.17 (br, s, 1H, 
NH), 3.46 (m, 1H, NCH), 3.80 (s, 3H, OCH3), 6.57 [(AX)2, 2H, ArH], 6.83 [(AX)2, 2H, ArH], 
7.22 - 7.37 (m, 5H, ArH); C (63 MHz, CDCl3) 20.9 (CH3), 32.6 (CH2), 38.9 (CH2), 49.0 
(NCH), 55.9 (OCH3), 114.8 (2 × ArCH), 115.0 (2 × ArCH), 125.9 (ArCH), 128.4 (2 × 
ArCH), 128.5 (2 × ArCH), 141.9 (ArC), 142.2 (ArC), 151.9 (ArC); Enantiomeric excess was 
determined by chiral phase HPLC (Chiralcel OD-H) 5% ipa in hexane @ 1 mL min
-1
, tR = 
10.7 min (minor), tR = 11.8 min (major); Data was in accordance with the literature. 
(±)-(E)-N-(4-Phenylbut-3-en-2-yl)-4-methoxyaniline 236
65
 
 
Obtained using general procedure H as yellow oil (77% yield, 0% ee); H (250 MHz, CDCl3) 
1.41 (d, 3H, J 7.6, CH3), 3.45 (s, br, 1H, NH), 3.76 (s, OCH3), 4.04 - 4.14 (m, 1H, NCH), 
6.24 (dd, 1H, J 16.0, 6.0, CHCH), 6.55 - 6.68 (m, 3H, 2 ArH and CH=CH), 6.76 - 6.81 (m, 
2H, ArH), 7.20 - 7.40 (m, 5H, ArH); C (63 MHz, CDCl3) 22.2 (CH3), 51.9 (NCH), 55.8 
(OCH3), 115.0 (2  ArCH), 115.1 (2  ArCH), 126.5 (2  ArCH), 127.4 (ArCH), 128.6 (2  
ArCH), 129.4 (CH), 133.7 (CH), 137.2 (ArC), 141.8 (ArC), 152.2 (ArC); Enantiomeric 
excess was determined by chiral phase HPLC (Kromasil 3-Cellucoat OD-H) 5% ipa in 
hexane @ 1 mL min
-1
, tR = 10.2 min, tR = 11.9 min; Data was in accordance with the 
literature. 
 (S)-N-[2-(3’,4’-Dimethoxyphenylpropyl)]-4-methoxyaniline 237167 
168 
 
 
Obtained using general procedure H as light yellow oil (81% yield); []D +4.5 (c 1.0 in 
CHCl3, 15% ee, lit.
167
 -3.5, c 0.3 in CHCl3, 66% ee R isomer); H (250 MHz, CDCl3) 1.15 (d, 
3H, J 6.3Hz , CH3), 2.70 (dd, 1H, J 13.5, 6.9, CH2), 2.84 (dd, 1H, J 13.5, 4.7, CH2), 3.27 (s, 
br, 1H, NH), 3.62 - 3.72 (m, 1H, NCH), 3.72 (s, 3H, OCH3), 3.86 (s, 3H, OCH3), 3.88 (s, 
3H, OCH3), 6.60 - 6.84 (m, 7H, ArH); H (63 MHz, CDCl3) 20.3 (CH3), 41.7 (CH2), 50.3 
(NCH), 55.8 (OCH3), 55.9 (2  OCH3), 111.3 (ArCH), 113.0 (ArCH), 115.0 (4 × ArCH), 
121.6 (ArCH), 131.2 (ArC), 141.6 (ArC), 147.6 (ArC), 148.8 (ArC), 152.1 (ArC); 
Enantiomeric excess was determined by chiral phase HPLC (Phenomenex Lux Cellulose-2) 
5% ipa in hexane @ 1 mL min
-1
, tR = 29.4 min (minor), tR = 34.9 min (major); Data was in 
accordance with the literature. 
 (S)-N-Benzyl-1-phenylethylamine 238
168
 
HN Ph
 
Obtained using general procedure I as a colourless oil (63% yield); []D -44.3 (c 0.7 in 
EtOH, 80% ee, lit.
168
 -41.1, c 0.6 in EtOH, 91% ee) 
 δH (250 MHz, CDCl3) 1.39 (d, 3H, J 
6.6, CH3), 1.59 (br s, 1H, NH), 3.60 (d, 1H, J 13.1, 1 × PhCH2), 3.68 (d, 1H, J 13.1, 1 × 
PhCH2), 3.84 (q, 1H, J 6.6, NCH), 7.23 - 7.41 (m, 10H, ArH);
 δC (63 MHz, CDCl3) 24.5 
(CH3), 51.7 (NCH2), 57.6 (NCH), 126.8 (2  ArCH), 126.9 (2  ArCH), 127.0 (ArCH), 
128.2 (ArCH), 128.4 (2  ArCH), 128.5 (2  ArCH), 140.7 (ArC), 145.7 (ArC); 
Enantiomeric excess was determined by comparison of the integrals in the 
1
H NMR 
spectrum in CDCl3 of the diastereomeric salts formed by addition of excess L-mandelic acid. 
Data was in accordance with the literature. 
(S)-N-(2-Phenylethyl)-1-phenylethylamine 239
154
 
169 
 
HN
Ph
 
Obtained using general procedure I as a light yellow oil (65% yield); []D -47.8 (c 1.1 in 
CHCl3, 86% ee, lit.
154
 +54.2, c 2.84 in CHCl3, 97% ee R-isomer); δH (250 MHz, CDCl3) 1.34 
(d, 3H, J 6.6, CH3), 2.70 - 2.84 (m, 4H, CH2CH2), 3.81 (q, 1H, J 6.6, NCH), 7.16-7.36 (m, 
10H, ArH);
 δC (63 MHz, CDCl3) 24.3 (CH3), 36.5 (CH2Ph), 48.9 (NCH2), 58.2 (NCH), 126.1 
(ArCH), 126.6 (2  ArCH), 126.9 (ArCH), 128.4 (4  ArCH), 128.7 (2  ArCH), 140.1 
(ArC), 145.7 (ArC); Enantiomeric excess was determined by comparison of the integrals in 
the 
1
H NMR spectrum in CDCl3 of the diastereomeric salts formed by addition of excess L-
mandelic acid; Data was in general accordance with the literature – the signal at  145.7 ppm 
is missing in the reported 
13
C NMR data in reference 154. 
(S)-N-(Furan-2-ylmethyl)-1-phenylethylamine 240
169
 
HN
O
 
Obtained using general procedure I as a colourless oil (65% yield); []D -78 (c 0.4 in CHCl3, 
86% ee, []D not reported in literature); δH (250 MHz) 1.38 (d, 3H, J 6.6, CH3), 1.66 (s, br, 
1H, NH), 3.59 (d, 1H, J 14.4, 2 × NCH2), 3.69 (d, 1H, J 14.4, 2 × NCH2), 3.80 (q, 1H, J 6.6, 
NCH), 6.12 (dd, 1H, J 0.4, 3.1, ArH), 6.32 (dd, 1H, J 1.8, 3.1, ArH), 7.23 - 7.40 (m, 6H, 
ArH); δC (63 MHz, CDCl3) 24.3 (CH3), 44.0 (NCH2), 57.1(NCH), 106.8 (ArCH), 110.1 
(ArCH), 126.8 (2 × ArCH), 127.0 (ArCH), 128.5 (2 × ArCH), 141.7 (ArCH), 145.1 (ArC), 
154.1 (ArC); Enantiomeric excess was determined by comparison of the integrals in the 
1
H 
NMR spectrum in CDCl3 of the diastereomeric salts formed by addition of excess L-
mandelic acid; Data was in accordance with the literature. 
(S)-N-(Thiophen-2-ylmethyl)-1-phenylethylamine 241 
HN
S
 
170 
 
Obtained using general procedure I as a yellow oil (64% yield); []D -42.5 (c 0.8 in CHCl3, 
83% ee); vmax (ATR) / cm
-1
 2963, 1492, 1451; δH (400 MHz, CDCl3) 1.40 (d, 3H, J 6.6, 
CH3), 1.65 (br s, 1H, NH), 3.81 - 3.89 (m, 2H, CH2), 3.88 (q, 1H, J 6.6, NCH), 6.88 - 6.89 
(m, 1H, ArH), 6.96 (dd, 1H, J 3.4, 5.1, ArH), 7.23 (dd, 1H, J 1.2, 5.1, ArH), 7.26 - 7.31 (m, 
1H, ArH), 7.35 - 7.39 (m, 4H, ArH);
 δC (100 MHz, CDCl3) 24.4 (CH3), 46.1 (NCH2), 57.1 
(NCH), 124.3 (ArCH), 124.7 (ArCH), 126.6 (ArCH), 126.8 (2 × ArCH), 127.1 (ArCH), 
128.5 (2 × ArCH), 144.5 (ArC), 145.2 (ArC); m/z (EI
+
) 217.0923 (4%, M
+
, C13H15NS 
requires 217.0925), 202 (60), 97 (100); Enantiomeric excess was determined by comparison 
of the integrals in the 
1
H NMR spectrum in CDCl3 of the diastereomeric salts formed by 
addition of excess L-mandelic acid. 
(S)-N-Benzyl-1-phenylpropylamine 142
84
 
HN Ph
 
Obtained using general procedure I as a colourless oil (66% yield); []D -37 (c 1.0 in CHCl3, 
73% ee, lit.
84
 +32, c 0.2 in CHCl3, 89% ee for R-isomer);
 δH (400 MHz, CDCl3) 0.86 (t, 3H, 
J 7.4, CH3), 1.65 - 1.87 (m, 3H, CH2 and NH), 3.57 - 3.61 (m, 2H, NCH and 2 × NCH2), 
3.71 (d, 1H, J 13.2, 2 × NCH2), 7.27 - 7.42 (m, 10H, ArH); δC (100 MHz, CDCl3) 10.8 
(CH3), 31.2 (CH2), 51.6 (NCH2), 64.2 (NCH), 126.8 (ArCH), 126.9 (ArCH), 127.5 (2 × 
ArCH), 128.2 (2 × ArCH), 128.3 (4 × ArCH), 140.8 (ArC), 144.1 (ArC); Enantiomeric 
excess was determined by comparison of the integrals in the 
1
H NMR spectrum in CDCl3 of 
the diastereomeric salts formed by addition of excess L-mandelic acid; Data was in 
accordance with the literature. 
(R)-N-Benzyl-2-methyl-1-phenylpropylamine 243
170
 
 
171 
 
Obtained using general procedure I as a colourless oil (62% yield); []D +56 (c 1.05 in 
CHCl3, 76% ee, lit.
170
 +63.1, c 1.4 in CHCl3 94% ee for R isomer); δH (400 MHz, CDCl3) 
0.77 (d, 3H, J 6.8, CH3), 1.00 (d, 3H, J 6.6, CH3), 1.61 (br s, 1H, NH), 1.86 - 1.92 (m, 1H, 
CH), 3.37 (d, 1H, J 9.0, NCH), 3.49 (d, 1H, J 13.3, 2 × NCH2), 3.67 (d, 1H, J 13.3, 2 × 
NCH2), 7.24 - 7.38 (m, 10H, ArH); δC (100 MHz, CDCl3) 19.5 (CH3), 19.7 (CH3), 34.5 
(CH), 51.8 (NCH2), 68.8 (NCH), 126.8 (2  ArCH), 128.0 (2  ArCH), 128.2 (4  ArCH), 
128.3 (2  ArCH), 141.0 (ArC), 142.9 (ArC); Enantiomeric excess was determined by 
comparison of the integrals in the 
1
H NMR spectrum in CDCl3 of the diastereomeric salts 
formed by addition of excess L-mandelic acid; Data was in accordance with the literature. 
3-(2-Chlorophenyl)-propylamine 
Cl
O
H KOH, CH3CN
r.t. 24 h
CN CoCl2, NaBH4
MeOH
Cl Cl
NH2
 
KOH powder (2 g, 36.1 mmol) and 2-chlorobenzaldehyde (5.07 g, 36.1 mmol) were stirred 
in acetonitrile (300 mL) at room temperature for 24 h and then poured into a 1:1 mixture of 
ice-water (300 g). The mixture was extracted with dichloromethane (3  150 mL), the 
combined extracts washed with brine (50 mL) and dried over MgSO4. After filtration, the 
filtrate was concentrated and the residue was purified by chromatography on silica gel (5% ~ 
17% ethyl acetate in petroleum ether) to give 1.57 g 2-chloro-cinnamonitrile as white solid; 
mp 35-37 ºC (not reported in literature); δH (250 MHz, CDCl3) 5.92 (d, 1H, J 16.6, CH), 
7.28 - 7.48 (m, 3H, ArH), 7.56 (dd, 1H, J 1.9, 7.5, ArH), 7.51 (d, 1H, J 16.6, CH); δC (63 
MHz, CDCl3) 99.0 (CH), 117.8 (CN), 127.0 (CH), 127.4 (CH), 130.3 (CH), 131.6 (C), 132.1 
(CH), 134.4 (C), 146.3 (CH); 
13
C NMR not reported in the literature, while reported 
1
H 
NMR data is at much lower resolution.
171
 
A suspension of 2-chloro-cinnamonitrile (1.57 g, 9.6 mmol) and CoCl2 (2.42 g, 18.6 mmol) 
in MeOH (60 mL) was cooled to 0 ºC under N2 atmosphere. NaBH4 (3.5 g, 93 mmol) was 
added portionwise over 30 min. The resulting mixture was allowed to warm to room 
temperature and stirred overnight. 6N HCl (20 mL) was added, and the reaction carefully 
172 
 
basified with 2N aqueous NaOH to pH 11. The resulting mixture was extracted with diethyl 
ether (3  150 mL), the combined organic phases washed with brine (50 mL) and dried over 
MgSO4. After filtration, the solvent was evaporated under reduced pressure to afford the 
desired amine (1.2 g) as light brown oil; δH (250 MHz, CDCl3) 1.14 (br s, 2H, NH2), 1.73 - 
1.85 (m, 2H, CH2), 2.70 - 2.82 (m, 4H, 2  CH2), 7.11 - 7.37 (m, 4H, ArH); δC (63 MHz, 
CDCl3) 30.9 (CH2), 33.9 (CH2), 41.9 (CH2), 126.7 (ArCH), 127.3 (ArCH), 129.5 (ArCH), 
130.3 (ArCH), 139.7 (ArCH); Data was in general accordance with the literature, although 
one signal in the 
13
C NMR was ambiguous due to the low concentration of the sample.
152
 
(R)-3-(2-Chlorophenyl)-N-(1-(3-methoxyphenyl)ethyl)propan-1-amine 6 [(+)-NPS R-
56]
172
 
OMe
HN
Cl
 
Obtained using general procedure I as a light brown oil, except 2 mL of CH2Cl2 was used 
with 1 mol% of (R)-117 as catalyst (67% yield); []D +41.2 (c 0.8 in CHCl3, 89% ee; lit.
172
 
+41.9, c 1.1 in CHCl3 assumed to be 100% ee); δH (250 MHz, CDCl3) 1.37 (d, 3H, J 6.6, 
CH3), 1.74 - 1.89 (m, 2H, CH2), 2.47 - 2.65 (m, 2H, CH2), 2.68 - 2.86 (m, 2H, CH2), 3.77 (q, 
1H, J 6.6, NCH), 3.84 (s, 3H, OCH3), 6.80 (ddd, 1H, J 1.0, 2.4, 8.3, ArH), 6.91 - 6.93 (m, 
2H, ArH), 7.09 - 7.35 (m, 5H, ArH); δH (63 MHz, CDCl3) 24.3 (CH3), 30.2 (CH2), 31.3 
(CH2), 47.3 (CH2), 55.2 (OCH3), 58.3 (NCH), 112.1 (ArCH), 112.2 (ArCH), 119.0 (ArCH), 
126.7 (ArCH), 127.2 (ArCH), 129.4 (2  ArCH), 130.3 (ArCH), 133.9 (ArC), 139.8 (ArC), 
147.7 (ArC), 159.8 (ArC); Enantiomeric excess was determined by comparison of the 
integrals in the 
1
H NMR spectrum in CDCl3 of the diastereomeric salts formed by addition 
of excess L-mandelic acid; Data was in general agreement with the literature, although 
13
C 
NMR data in reference 172 has an additional signal and data has been mis-assigned. 
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Appendix 1 Crystal structure of the salt of amine 144 
 
Table 1.  Crystal data and structure refinement for OSJ230P1. 
Identification code  osj230p1 
Empirical formula  C24 H29 N O5 S 
Formula weight  443.54 
Temperature  150(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P1 
Unit cell dimensions a = 7.4795(2) Å = 93.8720(10)°. 
 b = 11.7976(4) Å = 95.2810(10)°. 
 c = 13.1065(4) Å  = 104.7550(10)°. 
Volume 1108.65(6) Å3 
Z 2 
Density (calculated) 1.329 Mg/m3 
Absorption coefficient 0.182 mm-1 
F(000) 472 
Crystal size 0.42 x 0.38 x 0.32 mm3 
Theta range for data collection 2.83 to 27.57°. 
Index ranges -9<=h<=9, -15<=k<=15, -16<=l<=17 
185 
 
Reflections collected 14299 
Independent reflections 5102 [R(int) = 0.0174] 
Completeness to theta = 27.57° 99.3 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9441 and 0.9275 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5102 / 3 / 565 
Goodness-of-fit on F2 0.961 
Final R indices [I>2sigma(I)] R1 = 0.0282, wR2 = 0.0763 
R indices (all data) R1 = 0.0285, wR2 = 0.0767 
Absolute structure parameter ? 
Largest diff. peak and hole 0.354 and -0.254 e.Å-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (Å2x 103) 
for OSJ230P1.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
S(1) 5652(1) 6332(1) 4249(1) 22(1) 
S(2) 4080(1) 3429(1) 11167(1) 22(1) 
N(1) 6250(2) 6652(1) 1593(1) 18(1) 
N(2) 2566(2) 3352(1) 3825(1) 21(1) 
O(1) 8916(2) 8618(1) 631(1) 24(1) 
O(2) 396(2) 1488(2) 5044(1) 33(1) 
O(3) 5240(2) 7073(1) 3446(1) 28(1) 
O(4) 6858(2) 5609(1) 3939(1) 29(1) 
O(5) 3965(2) 5640(1) 4619(1) 30(1) 
O(6) 6057(2) 3585(2) 11424(1) 36(1) 
O(7) 3610(2) 4557(1) 11081(1) 26(1) 
O(8) 2921(2) 2702(1) 11845(1) 33(1) 
C(1) 5757(2) 7486(2) 906(1) 19(1) 
C(2) 3849(3) 7353(2) 684(2) 26(1) 
C(3) 3189(3) 8079(2) 38(2) 32(1) 
C(4) 4428(3) 8941(2) -399(2) 32(1) 
C(5) 6322(3) 9090(2) -165(2) 28(1) 
C(6) 7007(3) 8384(2) 500(1) 20(1) 
C(7) 9857(2) 8635(2) 1603(1) 20(1) 
C(8) 11173(3) 9670(2) 1977(2) 25(1) 
C(9) 12237(3) 9705(2) 2913(2) 28(1) 
C(10) 11987(3) 8720(2) 3452(2) 28(1) 
C(11) 10645(3) 7689(2) 3073(2) 23(1) 
C(12) 9572(2) 7631(2) 2130(1) 19(1) 
C(13) 8195(2) 6496(2) 1687(1) 19(1) 
C(14) 8610(3) 5970(2) 667(2) 25(1) 
C(15) 3352(3) 2634(2) 4525(1) 21(1) 
C(16) 5289(3) 2882(2) 4651(2) 26(1) 
C(17) 6181(3) 2259(2) 5290(2) 30(1) 
C(18) 5137(3) 1360(2) 5796(2) 32(1) 
C(19) 3219(3) 1113(2) 5669(2) 30(1) 
C(20) 2310(3) 1753(2) 5048(2) 25(1) 
C(21) -698(3) 1234(2) 4100(2) 26(1) 
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C(22) -1911(3) 122(2) 3874(2) 35(1) 
C(23) -3118(3) -114(2) 2980(2) 38(1) 
C(24) -3122(3) 746(2) 2317(2) 34(1) 
C(25) -1904(3) 1862(2) 2545(2) 27(1) 
C(26) -685(2) 2120(2) 3451(2) 22(1) 
C(27) 539(3) 3338(2) 3798(2) 21(1) 
C(28) 219(3) 4288(2) 3126(2) 28(1) 
C(29) 6869(3) 7385(2) 5268(1) 22(1) 
C(30) 7420(3) 6998(2) 6309(1) 20(1) 
C(31) 6216(3) 5838(2) 6670(2) 27(1) 
C(32) 7454(3) 5603(2) 7611(2) 33(1) 
C(33) 9171(3) 6659(2) 7717(2) 29(1) 
C(34) 8519(4) 7722(2) 8114(2) 34(1) 
C(35) 7353(3) 7931(2) 7168(2) 26(1) 
O(10) 6519(3) 8685(1) 7101(1) 36(1) 
C(38) 10936(3) 8014(2) 6474(2) 41(1) 
C(39) 9899(4) 5857(2) 5969(2) 39(1) 
C(40) 3547(3) 2627(2) 9927(2) 22(1) 
C(41) 1663(2) 2492(2) 9312(1) 19(1) 
C(42) -42(3) 2546(2) 9899(2) 31(1) 
C(43) -1521(3) 2705(2) 9053(2) 40(1) 
C(44) -565(3) 2669(2) 8074(2) 34(1) 
C(48) -497(3) 1395(2) 7830(2) 29(1) 
C(49) 995(3) 1293(2) 8666(2) 26(1) 
O(9) 1539(3) 436(1) 8804(2) 47(1) 
C(45) 1499(3) 3314(2) 8448(2) 28(1) 
C(46) 1823(4) 4609(2) 8813(2) 41(1) 
C(47) 2840(4) 3245(2) 7635(2) 44(1) 
C(37) 9443(3) 6881(2) 6581(2) 26(1) 
________________________________________________________________________________ 
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 Table 3.   Bond lengths [Å] and angles [°] for  OSJ230P1. 
_____________________________________________________  
S(1)-O(4)  1.4558(15) 
S(1)-O(5)  1.4604(15) 
S(1)-O(3)  1.4726(15) 
S(1)-C(29)  1.7703(19) 
S(2)-O(6)  1.4470(16) 
S(2)-O(8)  1.4638(15) 
S(2)-O(7)  1.4686(15) 
S(2)-C(40)  1.783(2) 
N(1)-C(1)  1.470(2) 
N(1)-C(13)  1.507(2) 
N(1)-H(1A)  0.9200 
N(1)-H(1B)  0.9200 
N(2)-C(15)  1.471(2) 
N(2)-C(27)  1.509(2) 
N(2)-H(2A)  0.9200 
N(2)-H(2B)  0.9200 
O(1)-C(6)  1.375(2) 
O(1)-C(7)  1.394(2) 
O(2)-C(20)  1.385(2) 
O(2)-C(21)  1.390(3) 
C(1)-C(6)  1.394(3) 
C(1)-C(2)  1.396(2) 
C(2)-C(3)  1.389(3) 
C(2)-H(2)  0.9500 
C(3)-C(4)  1.386(3) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.385(3) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.395(3) 
C(5)-H(5)  0.9500 
C(7)-C(8)  1.385(2) 
C(7)-C(12)  1.390(2) 
C(8)-C(9)  1.391(3) 
C(8)-H(8)  0.9500 
C(9)-C(10)  1.383(3) 
C(9)-H(9)  0.9500 
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C(10)-C(11)  1.392(3) 
C(10)-H(10)  0.9500 
C(11)-C(12)  1.398(3) 
C(11)-H(11)  0.9500 
C(12)-C(13)  1.508(2) 
C(13)-C(14)  1.527(2) 
C(13)-H(13)  1.0000 
C(14)-H(14A)  0.9800 
C(14)-H(14B)  0.9800 
C(14)-H(14C)  0.9800 
C(15)-C(20)  1.392(3) 
C(15)-C(16)  1.394(3) 
C(16)-C(17)  1.385(3) 
C(16)-H(16)  0.9500 
C(17)-C(18)  1.394(3) 
C(17)-H(17)  0.9500 
C(18)-C(19)  1.381(3) 
C(18)-H(18)  0.9500 
C(19)-C(20)  1.392(3) 
C(19)-H(19)  0.9500 
C(21)-C(22)  1.386(3) 
C(21)-C(26)  1.390(3) 
C(22)-C(23)  1.377(4) 
C(22)-H(22)  0.9500 
C(23)-C(24)  1.381(4) 
C(23)-H(23)  0.9500 
C(24)-C(25)  1.392(3) 
C(24)-H(24)  0.9500 
C(25)-C(26)  1.394(3) 
C(25)-H(25)  0.9500 
C(26)-C(27)  1.508(2) 
C(27)-C(28)  1.523(3) 
C(27)-H(27)  1.0000 
C(28)-H(28A)  0.9800 
C(28)-H(28B)  0.9800 
C(28)-H(28C)  0.9800 
C(29)-C(30)  1.523(2) 
C(29)-H(29A)  0.9900 
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C(29)-H(29B)  0.9900 
C(30)-C(35)  1.534(3) 
C(30)-C(37)  1.565(3) 
C(30)-C(31)  1.564(3) 
C(31)-C(32)  1.556(3) 
C(31)-H(31A)  0.9900 
C(31)-H(31B)  0.9900 
C(32)-C(33)  1.533(3) 
C(32)-H(32A)  0.9900 
C(32)-H(32B)  0.9900 
C(33)-C(34)  1.534(3) 
C(33)-C(37)  1.552(3) 
C(33)-H(33)  1.0000 
C(34)-C(35)  1.521(3) 
C(34)-H(34A)  0.9900 
C(34)-H(34B)  0.9900 
C(35)-O(10)  1.213(3) 
C(38)-C(37)  1.533(3) 
C(38)-H(38A)  0.9800 
C(38)-H(38B)  0.9800 
C(38)-H(38C)  0.9800 
C(39)-C(37)  1.532(3) 
C(39)-H(39A)  0.9800 
C(39)-H(39B)  0.9800 
C(39)-H(39C)  0.9800 
C(40)-C(41)  1.523(2) 
C(40)-H(40A)  0.9900 
C(40)-H(40B)  0.9900 
C(41)-C(49)  1.539(2) 
C(41)-C(45)  1.555(2) 
C(41)-C(42)  1.561(3) 
C(42)-C(43)  1.548(3) 
C(42)-H(42A)  0.9900 
C(42)-H(42B)  0.9900 
C(43)-C(44)  1.529(4) 
C(43)-H(43A)  0.9900 
C(43)-H(43B)  0.9900 
C(44)-C(48)  1.530(3) 
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C(44)-C(45)  1.554(3) 
C(44)-H(44)  1.0000 
C(48)-C(49)  1.524(3) 
C(48)-H(48A)  0.9900 
C(48)-H(48B)  0.9900 
C(49)-O(9)  1.201(3) 
C(45)-C(46)  1.521(3) 
C(45)-C(47)  1.542(3) 
C(46)-H(46A)  0.9800 
C(46)-H(46B)  0.9800 
C(46)-H(46C)  0.9800 
C(47)-H(47A)  0.9800 
C(47)-H(47B)  0.9800 
C(47)-H(47C)  0.9800 
 
O(4)-S(1)-O(5) 112.35(9) 
O(4)-S(1)-O(3) 112.64(9) 
O(5)-S(1)-O(3) 112.21(9) 
O(4)-S(1)-C(29) 108.92(9) 
O(5)-S(1)-C(29) 107.52(9) 
O(3)-S(1)-C(29) 102.58(8) 
O(6)-S(2)-O(8) 114.01(10) 
O(6)-S(2)-O(7) 112.14(9) 
O(8)-S(2)-O(7) 111.44(10) 
O(6)-S(2)-C(40) 104.84(10) 
O(8)-S(2)-C(40) 105.95(9) 
O(7)-S(2)-C(40) 107.85(9) 
C(1)-N(1)-C(13) 119.86(13) 
C(1)-N(1)-H(1A) 107.4 
C(13)-N(1)-H(1A) 107.4 
C(1)-N(1)-H(1B) 107.4 
C(13)-N(1)-H(1B) 107.4 
H(1A)-N(1)-H(1B) 106.9 
C(15)-N(2)-C(27) 119.89(14) 
C(15)-N(2)-H(2A) 107.3 
C(27)-N(2)-H(2A) 107.3 
C(15)-N(2)-H(2B) 107.3 
C(27)-N(2)-H(2B) 107.3 
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H(2A)-N(2)-H(2B) 106.9 
C(6)-O(1)-C(7) 120.42(14) 
C(20)-O(2)-C(21) 118.14(16) 
C(6)-C(1)-C(2) 119.31(17) 
C(6)-C(1)-N(1) 125.94(15) 
C(2)-C(1)-N(1) 114.73(16) 
C(3)-C(2)-C(1) 120.77(19) 
C(3)-C(2)-H(2) 119.6 
C(1)-C(2)-H(2) 119.6 
C(2)-C(3)-C(4) 119.99(18) 
C(2)-C(3)-H(3) 120.0 
C(4)-C(3)-H(3) 120.0 
C(5)-C(4)-C(3) 119.33(19) 
C(5)-C(4)-H(4) 120.3 
C(3)-C(4)-H(4) 120.3 
C(4)-C(5)-C(6) 121.35(19) 
C(4)-C(5)-H(5) 119.3 
C(6)-C(5)-H(5) 119.3 
O(1)-C(6)-C(5) 114.33(17) 
O(1)-C(6)-C(1) 126.37(16) 
C(5)-C(6)-C(1) 119.16(17) 
C(8)-C(7)-C(12) 122.13(17) 
C(8)-C(7)-O(1) 116.61(17) 
C(12)-C(7)-O(1) 121.10(16) 
C(7)-C(8)-C(9) 118.80(18) 
C(7)-C(8)-H(8) 120.6 
C(9)-C(8)-H(8) 120.6 
C(10)-C(9)-C(8) 120.32(18) 
C(10)-C(9)-H(9) 119.8 
C(8)-C(9)-H(9) 119.8 
C(9)-C(10)-C(11) 120.29(18) 
C(9)-C(10)-H(10) 119.9 
C(11)-C(10)-H(10) 119.9 
C(10)-C(11)-C(12) 120.29(18) 
C(10)-C(11)-H(11) 119.9 
C(12)-C(11)-H(11) 119.9 
C(7)-C(12)-C(11) 118.15(16) 
C(7)-C(12)-C(13) 121.33(16) 
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C(11)-C(12)-C(13) 120.49(16) 
C(12)-C(13)-N(1) 110.16(14) 
C(12)-C(13)-C(14) 115.11(15) 
N(1)-C(13)-C(14) 110.62(14) 
C(12)-C(13)-H(13) 106.8 
N(1)-C(13)-H(13) 106.8 
C(14)-C(13)-H(13) 106.8 
C(13)-C(14)-H(14A) 109.5 
C(13)-C(14)-H(14B) 109.5 
H(14A)-C(14)-H(14B) 109.5 
C(13)-C(14)-H(14C) 109.5 
H(14A)-C(14)-H(14C) 109.5 
H(14B)-C(14)-H(14C) 109.5 
C(20)-C(15)-C(16) 119.64(17) 
C(20)-C(15)-N(2) 124.86(17) 
C(16)-C(15)-N(2) 115.50(16) 
C(17)-C(16)-C(15) 120.50(19) 
C(17)-C(16)-H(16) 119.7 
C(15)-C(16)-H(16) 119.7 
C(16)-C(17)-C(18) 119.84(19) 
C(16)-C(17)-H(17) 120.1 
C(18)-C(17)-H(17) 120.1 
C(19)-C(18)-C(17) 119.58(19) 
C(19)-C(18)-H(18) 120.2 
C(17)-C(18)-H(18) 120.2 
C(18)-C(19)-C(20) 121.02(19) 
C(18)-C(19)-H(19) 119.5 
C(20)-C(19)-H(19) 119.5 
O(2)-C(20)-C(19) 115.76(18) 
O(2)-C(20)-C(15) 124.78(17) 
C(19)-C(20)-C(15) 119.38(19) 
C(22)-C(21)-C(26) 121.6(2) 
C(22)-C(21)-O(2) 118.44(19) 
C(26)-C(21)-O(2) 119.70(18) 
C(23)-C(22)-C(21) 119.2(2) 
C(23)-C(22)-H(22) 120.4 
C(21)-C(22)-H(22) 120.4 
C(22)-C(23)-C(24) 120.44(19) 
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C(22)-C(23)-H(23) 119.8 
C(24)-C(23)-H(23) 119.8 
C(23)-C(24)-C(25) 120.2(2) 
C(23)-C(24)-H(24) 119.9 
C(25)-C(24)-H(24) 119.9 
C(24)-C(25)-C(26) 120.2(2) 
C(24)-C(25)-H(25) 119.9 
C(26)-C(25)-H(25) 119.9 
C(21)-C(26)-C(25) 118.37(18) 
C(21)-C(26)-C(27) 118.49(18) 
C(25)-C(26)-C(27) 122.97(17) 
C(26)-C(27)-N(2) 110.55(14) 
C(26)-C(27)-C(28) 114.51(16) 
N(2)-C(27)-C(28) 107.35(15) 
C(26)-C(27)-H(27) 108.1 
N(2)-C(27)-H(27) 108.1 
C(28)-C(27)-H(27) 108.1 
C(27)-C(28)-H(28A) 109.5 
C(27)-C(28)-H(28B) 109.5 
H(28A)-C(28)-H(28B) 109.5 
C(27)-C(28)-H(28C) 109.5 
H(28A)-C(28)-H(28C) 109.5 
H(28B)-C(28)-H(28C) 109.5 
C(30)-C(29)-S(1) 120.47(13) 
C(30)-C(29)-H(29A) 107.2 
S(1)-C(29)-H(29A) 107.2 
C(30)-C(29)-H(29B) 107.2 
S(1)-C(29)-H(29B) 107.2 
H(29A)-C(29)-H(29B) 106.8 
C(29)-C(30)-C(35) 109.67(15) 
C(29)-C(30)-C(37) 119.80(16) 
C(35)-C(30)-C(37) 100.19(15) 
C(29)-C(30)-C(31) 119.54(16) 
C(35)-C(30)-C(31) 102.77(15) 
C(37)-C(30)-C(31) 102.01(15) 
C(32)-C(31)-C(30) 103.58(16) 
C(32)-C(31)-H(31A) 111.0 
C(30)-C(31)-H(31A) 111.0 
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C(32)-C(31)-H(31B) 111.0 
C(30)-C(31)-H(31B) 111.0 
H(31A)-C(31)-H(31B) 109.0 
C(33)-C(32)-C(31) 103.42(16) 
C(33)-C(32)-H(32A) 111.1 
C(31)-C(32)-H(32A) 111.1 
C(33)-C(32)-H(32B) 111.1 
C(31)-C(32)-H(32B) 111.1 
H(32A)-C(32)-H(32B) 109.0 
C(32)-C(33)-C(34) 105.8(2) 
C(32)-C(33)-C(37) 102.81(16) 
C(34)-C(33)-C(37) 103.08(16) 
C(32)-C(33)-H(33) 114.6 
C(34)-C(33)-H(33) 114.6 
C(37)-C(33)-H(33) 114.6 
C(35)-C(34)-C(33) 101.86(16) 
C(35)-C(34)-H(34A) 111.4 
C(33)-C(34)-H(34A) 111.4 
C(35)-C(34)-H(34B) 111.4 
C(33)-C(34)-H(34B) 111.4 
H(34A)-C(34)-H(34B) 109.3 
O(10)-C(35)-C(34) 126.83(18) 
O(10)-C(35)-C(30) 126.34(18) 
C(34)-C(35)-C(30) 106.83(16) 
C(37)-C(38)-H(38A) 109.5 
C(37)-C(38)-H(38B) 109.5 
H(38A)-C(38)-H(38B) 109.5 
C(37)-C(38)-H(38C) 109.5 
H(38A)-C(38)-H(38C) 109.5 
H(38B)-C(38)-H(38C) 109.5 
C(37)-C(39)-H(39A) 109.5 
C(37)-C(39)-H(39B) 109.5 
H(39A)-C(39)-H(39B) 109.5 
C(37)-C(39)-H(39C) 109.5 
H(39A)-C(39)-H(39C) 109.5 
H(39B)-C(39)-H(39C) 109.5 
C(41)-C(40)-S(2) 120.01(13) 
C(41)-C(40)-H(40A) 107.3 
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S(2)-C(40)-H(40A) 107.3 
C(41)-C(40)-H(40B) 107.3 
S(2)-C(40)-H(40B) 107.3 
H(40A)-C(40)-H(40B) 106.9 
C(40)-C(41)-C(49) 111.27(14) 
C(40)-C(41)-C(45) 119.28(16) 
C(49)-C(41)-C(45) 99.31(14) 
C(40)-C(41)-C(42) 119.04(15) 
C(49)-C(41)-C(42) 103.06(15) 
C(45)-C(41)-C(42) 102.02(16) 
C(43)-C(42)-C(41) 104.17(17) 
C(43)-C(42)-H(42A) 110.9 
C(41)-C(42)-H(42A) 110.9 
C(43)-C(42)-H(42B) 110.9 
C(41)-C(42)-H(42B) 110.9 
H(42A)-C(42)-H(42B) 108.9 
C(44)-C(43)-C(42) 103.02(17) 
C(44)-C(43)-H(43A) 111.2 
C(42)-C(43)-H(43A) 111.2 
C(44)-C(43)-H(43B) 111.2 
C(42)-C(43)-H(43B) 111.2 
H(43A)-C(43)-H(43B) 109.1 
C(43)-C(44)-C(48) 106.9(2) 
C(43)-C(44)-C(45) 103.08(17) 
C(48)-C(44)-C(45) 102.90(17) 
C(43)-C(44)-H(44) 114.2 
C(48)-C(44)-H(44) 114.2 
C(45)-C(44)-H(44) 114.2 
C(49)-C(48)-C(44) 101.19(16) 
C(49)-C(48)-H(48A) 111.5 
C(44)-C(48)-H(48A) 111.5 
C(49)-C(48)-H(48B) 111.5 
C(44)-C(48)-H(48B) 111.5 
H(48A)-C(48)-H(48B) 109.3 
O(9)-C(49)-C(48) 126.58(19) 
O(9)-C(49)-C(41) 126.23(19) 
C(48)-C(49)-C(41) 107.19(16) 
C(46)-C(45)-C(47) 107.0(2) 
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C(46)-C(45)-C(44) 114.24(19) 
C(47)-C(45)-C(44) 113.76(18) 
C(46)-C(45)-C(41) 115.39(16) 
C(47)-C(45)-C(41) 112.31(18) 
C(44)-C(45)-C(41) 94.08(16) 
C(45)-C(46)-H(46A) 109.5 
C(45)-C(46)-H(46B) 109.5 
H(46A)-C(46)-H(46B) 109.5 
C(45)-C(46)-H(46C) 109.5 
H(46A)-C(46)-H(46C) 109.5 
H(46B)-C(46)-H(46C) 109.5 
C(45)-C(47)-H(47A) 109.5 
C(45)-C(47)-H(47B) 109.5 
H(47A)-C(47)-H(47B) 109.5 
C(45)-C(47)-H(47C) 109.5 
H(47A)-C(47)-H(47C) 109.5 
H(47B)-C(47)-H(47C) 109.5 
C(39)-C(37)-C(38) 108.6(2) 
C(39)-C(37)-C(33) 113.30(18) 
C(38)-C(37)-C(33) 113.11(18) 
C(39)-C(37)-C(30) 114.58(17) 
C(38)-C(37)-C(30) 112.78(17) 
C(33)-C(37)-C(30) 94.07(15) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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 Table 4.   Anisotropic displacement parameters  (Å2x 103) for OSJ230P1.  The anisotropic 
displacement factor exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
S(1) 27(1)  20(1) 16(1)  0(1) 1(1)  2(1) 
S(2) 21(1)  20(1) 21(1)  4(1) -3(1)  -1(1) 
N(1) 17(1)  18(1) 17(1)  1(1) 2(1)  1(1) 
N(2) 21(1)  17(1) 23(1)  6(1) 1(1)  2(1) 
O(1) 18(1)  30(1) 24(1)  10(1) 3(1)  2(1) 
O(2) 26(1)  40(1) 35(1)  19(1) 9(1)  8(1) 
O(3) 37(1)  32(1) 18(1)  2(1) 1(1)  14(1) 
O(4) 39(1)  24(1) 26(1)  1(1) 6(1)  11(1) 
O(5) 28(1)  31(1) 26(1)  -2(1) 3(1)  -2(1) 
O(6) 25(1)  34(1) 43(1)  8(1) -12(1)  1(1) 
O(7) 26(1)  19(1) 26(1)  -2(1) -1(1)  0(1) 
O(8) 41(1)  28(1) 22(1)  4(1) 1(1)  -6(1) 
C(1) 19(1)  20(1) 17(1)  -1(1) 2(1)  5(1) 
C(2) 19(1)  32(1) 25(1)  0(1) 2(1)  6(1) 
C(3) 24(1)  43(1) 30(1)  -1(1) -1(1)  15(1) 
C(4) 36(1)  38(1) 26(1)  5(1) 0(1)  20(1) 
C(5) 33(1)  29(1) 24(1)  8(1) 3(1)  11(1) 
C(6) 20(1)  23(1) 18(1)  2(1) 2(1)  6(1) 
C(7) 15(1)  21(1) 23(1)  2(1) 2(1)  5(1) 
C(8) 18(1)  17(1) 38(1)  1(1) 8(1)  3(1) 
C(9) 15(1)  26(1) 38(1)  -9(1) 3(1)  2(1) 
C(10) 20(1)  34(1) 29(1)  -6(1) -3(1)  8(1) 
C(11) 22(1)  24(1) 24(1)  1(1) 0(1)  9(1) 
C(12) 17(1)  18(1) 21(1)  0(1) 2(1)  4(1) 
C(13) 17(1)  17(1) 21(1)  2(1) 1(1)  3(1) 
C(14) 25(1)  23(1) 25(1)  -3(1) 6(1)  3(1) 
C(15) 24(1)  20(1) 21(1)  3(1) 2(1)  7(1) 
C(16) 25(1)  26(1) 27(1)  2(1) 5(1)  8(1) 
C(17) 26(1)  38(1) 29(1)  2(1) 2(1)  14(1) 
C(18) 38(1)  36(1) 26(1)  6(1) 0(1)  20(1) 
C(19) 39(1)  29(1) 26(1)  10(1) 7(1)  12(1) 
C(20) 26(1)  26(1) 24(1)  6(1) 4(1)  8(1) 
C(21) 22(1)  22(1) 37(1)  9(1) 9(1)  7(1) 
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C(22) 25(1)  20(1) 66(2)  13(1) 16(1)  8(1) 
C(23) 21(1)  21(1) 68(2)  -7(1) 13(1)  1(1) 
C(24) 22(1)  32(1) 44(1)  -11(1) 3(1)  4(1) 
C(25) 22(1)  26(1) 32(1)  -1(1) 3(1)  6(1) 
C(26) 19(1)  16(1) 30(1)  2(1) 5(1)  5(1) 
C(27) 22(1)  17(1) 26(1)  2(1) 3(1)  5(1) 
C(28) 27(1)  19(1) 39(1)  6(1) 0(1)  8(1) 
C(29) 31(1)  16(1) 18(1)  2(1) -1(1)  3(1) 
C(30) 25(1)  17(1) 19(1)  2(1) 1(1)  4(1) 
C(31) 32(1)  20(1) 25(1)  7(1) 2(1)  0(1) 
C(32) 42(1)  24(1) 30(1)  9(1) -1(1)  5(1) 
C(33) 36(1)  25(1) 24(1)  2(1) -6(1)  7(1) 
C(34) 50(1)  30(1) 21(1)  -4(1) -6(1)  12(1) 
C(35) 35(1)  22(1) 21(1)  -1(1) 1(1)  5(1) 
O(10) 50(1)  30(1) 31(1)  -4(1) -1(1)  19(1) 
C(38) 28(1)  45(1) 44(1)  12(1) -1(1)  -2(1) 
C(39) 43(1)  49(1) 32(1)  0(1) 2(1)  27(1) 
C(40) 20(1)  23(1) 24(1)  -1(1) 1(1)  7(1) 
C(41) 20(1)  18(1) 19(1)  0(1) 2(1)  6(1) 
C(42) 21(1)  45(1) 27(1)  -4(1) 2(1)  8(1) 
C(43) 25(1)  52(1) 43(1)  -14(1) -7(1)  18(1) 
C(44) 41(1)  32(1) 30(1)  -6(1) -14(1)  18(1) 
C(48) 34(1)  25(1) 25(1)  -4(1) -5(1)  6(1) 
C(49) 24(1)  19(1) 32(1)  -3(1) -1(1)  5(1) 
O(9) 44(1)  22(1) 71(1)  -10(1) -20(1)  13(1) 
C(45) 41(1)  18(1) 22(1)  2(1) -5(1)  8(1) 
C(46) 60(2)  22(1) 38(1)  0(1) -12(1)  12(1) 
C(47) 56(2)  42(1) 24(1)  2(1) 8(1)  -4(1) 
C(37) 26(1)  27(1) 26(1)  3(1) -1(1)  8(1) 
______________________________________________________________________________ 
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 Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 3) 
for OSJ230P1. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1A) 5446 5924 1387 22 
H(1B) 6008 6871 2243 22 
H(2A) 2766 3127 3169 25 
H(2B) 3251 4121 3982 25 
H(2) 2993 6760 978 31 
H(3) 1887 7984 -103 38 
H(4) 3983 9426 -856 38 
H(5) 7171 9684 -462 33 
H(8) 11345 10343 1602 30 
H(9) 13139 10410 3182 33 
H(10) 12734 8746 4085 34 
H(11) 10459 7021 3456 27 
H(13) 8236 5908 2197 23 
H(14A) 8646 6538 153 38 
H(14B) 7634 5248 430 38 
H(14C) 9816 5785 764 38 
H(16) 6002 3484 4296 31 
H(17) 7501 2443 5383 36 
H(18) 5741 920 6226 38 
H(19) 2509 497 6011 36 
H(22) -1910 -470 4331 42 
H(23) -3952 -873 2820 45 
H(24) -3960 576 1702 41 
H(25) -1902 2448 2083 32 
H(27) 296 3558 4512 26 
H(28A) -1078 4322 3112 42 
H(28B) 484 4101 2424 42 
H(28C) 1046 5052 3408 42 
H(29A) 8024 7839 5019 27 
H(29B) 6100 7941 5389 27 
H(31A) 5022 5945 6873 32 
H(31B) 5954 5181 6120 32 
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H(32A) 6808 5574 8239 39 
H(32B) 7798 4854 7481 39 
H(33) 10289 6542 8132 35 
H(34A) 7764 7537 8693 41 
H(34B) 9586 8413 8338 41 
H(38A) 12143 7957 6794 62 
H(38B) 10610 8686 6818 62 
H(38C) 11009 8125 5743 62 
H(39A) 8929 5130 6008 58 
H(39B) 11103 5764 6260 58 
H(39C) 9958 6021 5248 58 
H(40A) 4514 3003 9498 27 
H(40B) 3686 1826 10011 27 
H(42A) -501 1810 10225 37 
H(42B) 289 3219 10437 37 
H(43A) -2676 2059 9009 48 
H(43B) -1825 3467 9184 48 
H(44) -1124 3013 7487 41 
H(48A) -1707 832 7887 35 
H(48B) -128 1268 7133 35 
H(46A) 3112 4926 9126 62 
H(46B) 974 4692 9323 62 
H(46C) 1593 5044 8225 62 
H(47A) 4108 3680 7916 65 
H(47B) 2461 3592 7019 65 
H(47C) 2804 2420 7452 65 
________________________________________________________________________________   
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Appendix 2 nOe experiments of imine 246 
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Appendix 3 nOe experiments of imine 248 
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